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The balance between excitatory and inhibitory synaptic transmission within 
and across neurons in active networks is crucial for cortical function and may 
allow for rapid transitions between stable network states. GABAergic 
interneurons mediate the majority of inhibitory transmission in the cortex, and 
therefore contribute to the global balance of activity in neuronal networks. 
Disruption in the network balance due to impaired inhibition has been 
implicated in several neuropsychiatric diseases (Marin 2012). Both 
schizophrenia and autism are two highly heritable cognitive disorders with 
complex genetic aetiologies but overlapping behavioural phenotypes that 
share common imbalances in neuronal network activity (Gao & Penzes 2015). 
An increasing body of evidence suggests that functional abnormalities in a 
particular group of cortical GABAergic interneurons expressing the calcium-
binding protein parvalbumin (PV) are involved in the pathology of these 
disorders (Marin 2012). As deficits in this neuronal population have been 
linked to these disorders it could be useful to target them and increase their 
activity. 
A conserved feature in PV cells is their unusually low input resistance 
compared to other neuronal populations. This feature is regulated by the 
expression of leak K+ channels, believed to be mediated in part by TASK and 
TREK subfamily two-pore K+ channels (Goldberg et al. 2011). The selective 
blockade of specific leak K+ channels could therefore be applied to increase 
the activity of PV cells.  
In this thesis, specific TASK-1/3 and TREK-1 channel blockers were applied 
in cortical mouse slices in an attempt to increase the output of PV cells. The 
blockade of either channel did not successfully increase the amplitude of PV 
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cell-evoked inhibitory postsynaptic currents (IPSCs) onto principal cells. 
However, while the blockade of TASK-1/3 channels failed to depolarise the 
membrane or alter the input resistance, the blockade of TREK-1 channels 
resulted in a small but significant depolarisation of the membrane potential in 
PV cells. Interestingly, TREK-1 channel blockade also increased action 
potential firing of PV cells in response to given current stimuli, suggesting 
that TREK-1 could be a useful target for PV cell modulation. 
These results demonstrate for the first time the functional effects of using 
specific two-pore K+ channel blockers in PV cells. Furthermore, these data 
provide electrophysiological evidence against the functional expression of 
TASK-1/3 in PV cells. It could therefore be interesting to further characterise 
the precise subtypes of leak K+ channels responsible for their low resistivity. 
This would help to classify the key contributors of the background K+ 
conductances present in PV cells in addition to finding suitable targets to 





Excitatory neurons specialise in transmitting information between distinct 
areas of the brain, whereas inhibitory interneurons provide the fundamental 
means of controlling network activity, and therefore prevent hyperexcitability. 
Interneurons responsible for inhibition account for just a small fraction of all 
the neurons, and are highly diverse, yet they manage to maintain an important 
role in regulating the activity of the neuronal population. Consequently, 
imbalances between excitation and inhibition have been implicated in a 
number of psychiatric diseases including schizophrenia and autism. 
Both schizophrenia and autism are cognitive disorders with complicated 
genetic origins but share several behavioural symptoms, which comprise 
social interaction abnormalities in addition to emotional processing deficits. 
While the genetics are diverse, the two disorders converge upon common 
deficits in the ratio between excitatory and inhibitory activity. Notably, 
several lines of evidence suggest that abnormalities in the function of a 
particular group of inhibitory interneurons known as fast-spiking interneurons 
are involved in these disorders. As their name suggests, fast-spiking 
interneurons are responsible for rapid inhibitory signalling which is important 
for synchronising the activity of excitatory neurons, necessary for normal 
cognitive function. Consistent with this finding, patients with schizophrenia or 
autism exhibit reductions in long-range network synchrony across the brain. 
It could therefore be beneficial to amend some of the deficits associated with 
fast-spiking interneurons in patients with schizophrenia and autism. This 
project focuses on finding a specific target in fast-spiking cells that could be 
used to boost their activity. If successful, a drug could be given to patients 
with the aim of increasing the activity of fast-spiking interneurons to alleviate 
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IPSP   Inhibitory postsynaptic potential 
K2P   Two-pore-domain channel 
Kir   Inwardly rectifying potassium channel 
Kv   Voltage-gated potassium channel 
LGE   Lateral ganglionic eminence 
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RT-PCR  Reverse transcription PCR    
SNPs   Single nucleotide polymorphisms 
Sst   Somatostatin 
TALK   TWIK-related alkaline-sensitive K+ channel 
TASK   TWIK-related acid-sensitive K+ channel 
TEA   Tetraethylammonium 
THIK   Tandem pore domain halothane-inhibited K+ channel 
TREK   TWIK-related K+ channel 
TRESK  TWIK-related spinal cord K+ channel 
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1.1 Neuropsychiatric disorders 
Schizophrenia and autism are cognitive disorders characterised by disruptions in 
social interaction, communication, emotion processing and executive function 
(Cheung et al. 2010). Both schizophrenia and autism are highly prevalent 
neuropsychiatric disorders with complicated genetic aetiologies but overlapping 
behavioural phenotypes and may share common imbalances in neuronal network 
activity (Gao & Penzes 2015). Within the network, growing evidence suggests that a 
disruption of inhibitory circuits in the cortex might be responsible, in part, for the 
clinical features of these disorders (Lewis et al. 2012; Fatemi et al. 2010). Recent 
studies in humans and animal models indicate that the underlying pathology in both 
diseases may emerge from deficits in the development and function of interneurons – 
the cells that are responsible for maintaining inhibitory balance in neuronal circuits 
(Marín 2012). These cells not only maintain inhibition in the brain, but also provide a 
temporal structure for information processing believed to contribute to cognitive 
function (Haider et al. 2006). Aberrant interneuron function could therefore dictate 
common imbalances associated with schizophrenia and autism which may contribute 
to the development of novel therapeutic targets. 
1.1.1 Prevalence 
Schizophrenia affects 1% of the world’s population and is often diagnosed in late 
adolescence or early adulthood (Owen et al. 2016). The illness is characterised by 
three clusters of symptoms: positive or psychotic symptoms, such as delusions, 
hallucinations and disorganisation of thought; negative symptoms, such as social 
withdrawal and apathy; and cognitive symptoms, including abnormalities in attention 
and working memory (Owen et al. 2016). Although positive symptoms present the 
most prominent manifestation in schizophrenia, disturbances in cognition are 
conceivably the most distinctive, leading to the conception that the very core of the 
disease manifests from cognitive deficits (Elvevåg & Goldberg 2000). Moreover, 
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cognitive tests in patients are routinely used to assist in diagnosis, as cognitive 
disturbances are present before the onset of psychosis (Elvevåg & Goldberg 2000). 
Autism is a complex neurodevelopmental disorder affecting between 0.1-0.2% of the 
entire population and is characterised by severe and pervasive deficits in reciprocal 
socialisation, impairments in verbal and non-verbal communication in addition to 
repetitive or unusual behaviours (Levy et al. 2009). Autism is usually diagnosed by 
the age of 3 years, although prospective studies assessing at-risk infants 
demonstrated that a subset of clinic symptoms could manifest as early as 6-12 
months (Chattopadhyaya & Di Cristo 2012). The incidence of autism has escalated 
dramatically over the last two decades predominantly because of the adoption of a 
broader diagnostic criteria in addition to increased awareness within the medical 
community (Levy et al. 2009). New administrative classifications of children in 
educational systems and the subsequent reclassifications of children from other 
categories to autism may explain part of this reported increase (Shattuck 2006). 
Consequently, autism has been classified as a heterogeneous disorder which can 
resemble or be comorbid with intellectual disability, obsessive compulsive disorder 
and attention deficit hyperactivity disorder (ADHD) (Gillberg & Billstedt 2000). 
1.1.2 Impact 
Schizophrenia and autism have profound consequences on both the individuals 
affected and society. More than 50% of individuals that are diagnosed with 
schizophrenia endure intermittent but long term psychiatric complications, and 
around 20% carry chronic symptoms and disability (Barbato 1998). Unemployment 
is strikingly high at 80-90% (Owen et al. 2016), and average life expectancy is 
reduced by up to 20 years (Chesney et al. 2014). Schizophrenia in England alone 
costs the economy £11.8 billion per year, with approximately a third of this figure 
spent directly on health and social care provided by hospitals and the community 
(Schizophrenia Commission 2012). 
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Autism affects over 700,000 people including their families in the United Kingdom 
and is estimated to cost £32 billion per year (McCall 2017). Despite this figure, many 
children and adults with autism remain secluded from society living in specialised 
communities. A recent report indicates that 84% of people diagnosed with autism are 
not in full-time employment, and two-thirds are unemployed (McCall 2017). 
Furthermore, the need for improved management of the general health of individuals 
with autism in society is evidently required, with most of the burden being placed on 
parents because of the communication challenges present, resulting in heightened 
stress within affected families. 
1.1.3 Shared clinical features 
The behavioural symptoms of schizophrenia and autism are intriguingly similar: 
Both disorders feature cognitive deficits, social interaction problems, emotional 
processing abnormalities and deficits in executive function (Cheung et al. 2010; 
Rapin & Tuchman 2008). Moreover, a subset of patients with autism experience 
visual and auditory hallucinations, similar to a subset of affected individuals with 
schizophrenia (Toal et al. 2009). Furthermore, several studies reported comorbidity 
between schizophrenia and autism: A study of 129 subjects with autism found that 
7.8% of them had schizophrenia (Stahlberg et al. 2004), while another case-control 
study following 61 Danish individuals with atypical autism for 45 years found that 
34% had been diagnosed with schizophrenia (Mouridsen et al. 2008). 
1.1.4 Genetics and environment 
Epidemiological studies indicate that schizophrenia and autism are highly heritable 
and arise from distinct families of genes. The contribution of different DNA variants 
and specific types of risk alleles have also led to the understanding that the two 
disorders are highly polygenic. Genome-wide association studies identified over 100 
independent genetic loci comprising common alleles of small effect between 
schizophrenia patients and control groups, suggesting that many single nucleotide 
polymorphisms (SNPs) may act together to contribute to the aetiology of the disorder 
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(Ripke et al. 2014). Genomic studies have also identified copy number variations 
(CNVs) in 11 high risk genes in schizophrenia (Rees .et al. 2014). Interestingly, 
several of the strongly associated CNVs – such as the gene encoding the presynaptic 
protein neurexin 1 (NRXN1) which is essential for synapse differentiation and 
function - may also be involved in autism (Kirov et al. 2014) highlighting that 
although the genetics between the two disorders are diverse, some of the high risk 
genes may converge. 
Genetic risk may also be highly pleiotropic in schizophrenia and autism. One gene or 
allele could thus influence multiple seemingly unrelated phenotypic attributes which 
– at the genetic level - may not have previously been categorised with known pre-
existing mutations in the disease. Studies have reported significant sharing of 
common risk alleles between schizophrenia and a number of psychiatric disorders 
including ADHD, bipolar disorder, major depressive disorder and autism (Cross-
Disorder Group of the Psychiatric Genomics Consortium et al. 2013), demonstrating 
the difficulty of categorising neurological disorders at the genetic level. 
Although the convergence of individual risk genes is likely to control most of the 
aetiology, several environmental risk factors have been identified in schizophrenia, 
and to a lesser extent, autism. Meta-analytical studies have indicated that risk factors 
for schizophrenia include childhood trauma, immigration, drug abuse and living in 
urban environments (van Os et al. 2010). In autism, birth complications associated 
with trauma or hypoxia have been shown to have a strong association with the 
disorder (Modabbernia et al. 2017). Furthermore, prenatal exposure to valproate – a 
drug used in epilepsy - has been reported to be strongly associated with autism, thus 
highlighting chemical influences as a cause for the disorder (Modabbernia et al. 
2017). Nonetheless, it is unlikely that environmental factors alone are enough to 
directly result in the development of schizophrenia or autism, however they may 
increase the probability when combined with risk genes. 
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Genetic linkage and genome-wide association studies have determined many disease-
associated genes, although few have been reproducible because most genetic 
contributions likely involve a combination of alleles that make small influences on 
the overall disease pathogenesis (Harrison & Weinberger 2005; Toro et al. 2010). 
Furthermore, given the extreme heterogeneous nature of both conditions, most 
studies lack the necessary power to consistently reproduce these weak correlations 
(Owen et al. 2004). While there are strong candidate genes that increase the 
susceptibility of developing schizophrenia or autism (see sections 1.2.8 and 1.2.9), it 
is evident that the vast majority of these disorders arise from the amalgamation of 
many genetic factors. Finally, environmental influences may also combine onto the 
underlying genetic pathology accelerating the onset of the diseases. 
1.1.5 Neuropathological features of schizophrenia and autism 
One of the most consistent neuropathological features of schizophrenia is grey matter 
loss. Post-mortem studies reported that brain regions showing the greatest loss of 
grey matter display significant reductions in spine density (Glausier & Lewis 2013). 
Furthermore, these areas were also associated with behavioural functions that are 
perturbed in the disease (Sullivan et al. 1996). One of the affected areas is the 
dorsolateral prefrontal cortex (DLPFC) which is crucial for working memory 
function, and was demonstrated to exhibit decreased activity during working memory 
tasks in schizophrenics (Cho et al. 2006). Spine loss has been consistently reported 
particularly in layer III neurons of the DLPFC (Glantz & Lewis 2000). Similarly, 
considerable reductions in spine density on pyramidal cells in the primary auditory 
cortex are present in some schizophrenic brains, which could explain the origin of 
auditory hallucinations perceived by a subset of individuals with the disorder (Sweet 
et al. 2009). Furthermore, symptoms of schizophrenia have routinely been linked to 
dopamine, as patients appear to show elevated levels of dopamine D2 receptors 
particularly in the limbic system (Kestler et al. 2001). Changes in other 
neurotransmitter systems, including the reduction in N-methyl-D-aspartic acid 
(NMDA) receptor function, which plays a key role in excitatory signalling has also 
been suggested to occur in schizophrenia (Krystal et al. 2003). 
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In autism, early brain overgrowth and circuit hyperexcitability govern the two most 
well-established phenotypes of the disorder. Around a quarter of children with 
autism exhibit an increase in brain size during the first two years of life in 
comparison to healthy controls (Courchesne et al. 2004). Moreover, approximately 
30% of autistic children have epilepsy (Tuchman & Rapin 2002). One possible 
mechanistic explanation connecting the two phenotypes is elevated spine density. 
Several post-mortem studies revealed increases in spine density on the apical 
dendrites of pyramidal cells in layer II of the cortex (Hutsler & Zhang 2010). On the 
other hand, contradicting studies reported smaller neurons with simplified dendritic 
morphologies in the limbic system compared to controls, consistent with deficits in 
developmental maturation rather than malformation (Raymond et al. 1995). Although 
the discrepancy in these studies should be taken with care due to the small number of 
post-mortem autistic brains that have been examined in the past few decades, they 
also support the idea that the pathophysiology in the autistic brain is highly 
heterogeneous. With this in mind, functional magnetic resonance imaging studies 
analysing brain connectivity have consistently shown local over-connectivity in 
addition to long-distance under-connectivity in adult patients with autism (Wass 
2011). 
Finally, deficits in fast rhythmic network activity are consistently reported in 
schizophrenia and autism (see section 1.2.7). This highly dynamic process enables 
neuronal networks to synchronise and fire in oscillations which allows for 
coordinated activity during normal brain function, and underlies cognitive processes 
such as memory and attention (Bartos et al. 2007). Strong evidence suggests that fast 
network oscillations are governed by the robust firing of inhibitory interneurons 
(Cardin et al. 2009). Hence, in addition to structural abnormalities described above, 




1.1.6 Current treatments for schizophrenia and autism 
The core symptoms of autism have not been demonstrated to respond to medication, 
however other drugs may be used to treat comorbid psychiatric conditions such as 
epilepsy (Young & Findling 2015). Antipsychotics, such as clozapine, which block 
the dopamine receptor D2, but also other neurotransmitter receptors including 
serotonin receptor 5HT2a, tend to be the most widely used amongst individuals with 
schizophrenia (Meltzer 1989). However, although they appear to be effective in 
reducing the positive symptoms of schizophrenia, they seem to have limited effects 
on negative symptoms and cognitive impairment (Miyamoto et al. 2012). 
Furthermore, antipsychotics have been reported to carry a number of severe side 
effects such as agranulocytosis and eosinophilia, and less severe effects including 
sedation, tachycardia and weight gain, which may make them undesirable to some 
patients (Meltzer 2013). Non-pharmacological treatment options are also currently 
used to treat individuals with schizophrenia and autism. These include behavioural, 
psychosocial and educational interventions that are routinely used from disease 
onset, which aim to facilitate social integration and tasks to improve cognitive skills 
(Pina-Camacho et al. 2016). To summarise, current treatments only alleviate several 
of the positive symptoms of schizophrenia, and unfortunately are prone to many 
unwanted side effects, whilst the development of treatments for autism have so far 
been unsuccessful. A new pharmacological approach is thus evidently required for 
the development of a more suitable method to address the cognitive and negative 
symptoms associated with schizophrenia; a mechanism that targets an alternative 
pathological pathway, and one that potentially could be used to treat symptoms 
associated with autism. 
1.1.7 Proposed circuit deficits in schizophrenia and autism 
Information transfer in the brain is heavily dependent on the functional balance 
between excitatory and inhibitory networks (see section 1.2.4). This balance relies 
upon the maintenance of appropriate ratios of excitatory and inhibitory inputs that 
each individual neuron receives, which can affect the overall activity of higher order 
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networks. A disruption in this balance during development has been proposed to 
result in network hyperexcitability and epilepsy, as well as deficits in network 
processing, which is believed to be associated with motor and cognitive impairments 
(Marín 2012). Increasing evidence suggests that imbalances between excitation and 
inhibition in synaptic transmission within neuronal circuits may be implicated in 
schizophrenia and autism (Cline 2005). 
Defects in inhibitory neurotransmission have now been associated with multiple 
neuropsychiatric diseases (see sections 1.2.8 and 1.2.9). Post-mortem studies indicate 
a reduction in the number of interneurons in the prefrontal cortex of individuals with 
schizophrenia leading to the proposition that a decline in inhibitory inputs onto 
pyramidal cells may contribute to the pathophysiology of the disease (Benes et al. 
2001). Although interneuron loss might be the case in some patients with the 
disorder, deficits occurring preferentially at the level of inhibitory synapses are now 
more widely accepted (Woo et al. 1998). With autism, as post-mortem brain tissue 
examinations are still relatively sparse, much less is known about the human 
pathology, however, several studies demonstrate a reduction in inhibitory signalling 
and therefore a disruption in the excitatory-inhibitory balance that manifests in 
cortical circuits (Fatemi et al. 2002). 
These findings indicate that while the genetics are diverse, both disorders may 
converge on similar pathophysiological processes. An emerging hypothesis suggests 
that modifications in the excitatory to inhibitory ratio of cortical activity could be 
responsible for the cognitive and social deficits observed in patients with 
schizophrenia and autism. Post-mortem studies consistently describe a reduction in 
the expression of molecular markers that govern the inhibitory system (see sections 
1.2.8 and 1.2.9). Furthermore, as interneurons are essential for the establishment and 
maintenance of synchronised, rhythmic network activity, – a phenotype that is 
consistently aberrant during working memory tasks in schizophrenics – these cells 
may form part of the underlying aetiology. Thus, the ability to modulate the activity 
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of inhibitory interneurons could therefore contribute to the development of more 
efficacious therapeutic interventions. 
1.2 Interneurons 
Excitation and inhibition are the fundamental means of signalling within the 
mammalian brain (Isaacson & Scanziani 2011). Cortical networks are comprised of 
glutamatergic excitatory neurons and GABAergic inhibitory interneurons that play a 
critical role in gating signal flow and sculpting network activity (Tremblay et al. 
2016). Although GABAergic interneurons represent a minority of the entire neuronal 
population, they are however much more diverse in terms of their morphological, 
biochemical and biophysical properties, as well as in their connectivity with other 
cells (Markram et al. 2004). By releasing GABA which acts as a primary inhibitory 
neurotransmitter in the CNS, interneurons maintain the stability of cortical networks 
by temporally controlling principal cell firing, modulating dynamic range, balancing 
excitation with inhibition, and generating network synchrony (Haider & McCormick 
2009). Malfunctions of these neurons has been associated with the establishment of 
schizophrenia and autism (Marín 2012). 
1.2.1 GABAergic transmission 
Two major neurotransmitters induce ionotropic inhibitory responses: GABA and 
glycine (Ito 2016). GABA is the major inhibitory transmitter in the cerebrum, while 
glycine is more abundant in the spinal cord and brain stem (Van den Pol & Gorcs 
1988). GABA is synthesized by two different isoforms of glutamic acid 
decarboxylase (GAD), GAD65 and GAD67, both of which are present in most 
interneurons.  GAD67 is distributed throughout the cell body where it synthesises 
cytoplasmic GABA, while GAD65 is specifically targeted to nerve endings where it 
synthesises GABA destined for vesicular release (Soghomonian & Martin 1998). 
GABA is released from presynaptic nerve terminals of GABAergic interneurons and 
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triggers the activation of three different types of GABA receptors, each of which has 
been identified based on their pharmacology and electrophysiology. GABAA and 
GABAC receptors are ligand-gated ion channels that control the flow of Cl- and 
HCO-3 ions across the cell membrane (Jentsch et al. 2002). Both channels are 
predominantly expressed at the postsynapse where they mediate fast inhibitory 
transmission. GABAA receptors are pentameric transmembrane receptors composed 
of a group of subunits from eight different classes (a1-6, b1-3, g1-3, d, e, q, p, and 
r1-3), most often assembling with a 2a:2b:g stoichiometry (Laurie et al. 1992). 
GABAB receptors however belong to a family of heptahelical metabotropic G-
protein receptors that are linked via G-proteins to inwardly-rectifying K+ channels 
and Ca2+ channels (Kaupmann et al. 1998). These receptors are mostly located at 
non-synaptic sites and presynaptic terminals where their effects tend to have a 
delayed onset and favour a longer duration (Kulik et al. 2003). 
Low extracellular concentrations of GABA are required between synaptic release to 
prevent tonic GABA receptor activation. Extracellular concentrations of GABA are 
maintained by four specific high-affinity, Na+/Cl- dependent transporters encoded by 
the genes GAT-1, GAT-2, GAT-3 and BGT-1, of which GAT-1 and GAT-3 are 
expressed in the cerebral cortex. At birth, GATs are expressed at relatively low levels 
in rodents before progressively reaching adult levels during the first postnatal month, 
where they function to quickly remove GABA from the synaptic cleft, thus 
terminating the effect of the neurotransmitter (Conti et al. 2004). In the adult brain, 
the effects of GABA are mainly inhibitory due to the hyperpolarised nature of the Cl- 
reversal potential (ECl). ECl depends on the Cl- concentration gradient across the 
membrane, which is regulated by the opposite action of Cl- cotransporters NKCC1 
and KCC2, required in Cl- uptake and extrusion, respectively. During the first 
postnatal week, KCC2 is upregulated, leading to a reduction in the concentration of 
intracellular Cl-, shifting ECl to a negative value (Rivera et al. 1999). Upon 




During neuronal maturation, the time course of GABAergic currents speed up due to 
changes in GABAA receptor subunit composition. In late embryonic stages of 
development, predominant expression of a3, a5 and b3 subunits generate IPSCs 
with slow decay. Throughout postnatal development, the transcription of these three 
genes decreases, while expression of a1, a4 and d subunits gradually increase. This 
developmental change in subunit expression is paralleled by a reduction in the decay 
time constant of GABAergic IPSCs (tIPSC). Interestingly, tEPSC only marginally 
decreases during development, whereas tIPSC reduces almost 10-fold (Okaty et al. 
2009). It has been demonstrated that tIPSC is inversely related to the ratio of a1 to a5 
subunits and takes approximately 3 postnatal weeks until IPSCs acquire their mature 
properties (Dunning et al. 1999). Importantly, it highlights that as the brain matures, 
GABAA receptor mediated inhibitory currents become more temporally precise.  
1.2.2 Interneuron diversity 
Inhibitory interneurons represent a minority of all cortical neurons constituting 
approximately 10-15% (Meyer et al. 2011). While excitatory glutamatergic neurons 
of the cortex and olfactory bulb are produced locally by progenitor cells in the 
developing pallium, GABAergic interneurons originate in the subpallium, at the base 
of the telencephalon (Ma et al. 2013). Studies over the past decade have determined 
that nearly all neocortical interneurons in the brain originate from four main sources 
in the subpallium: the medial, lateral and caudal ganglionic eminences (MGE, LGE 
and CGE, respectively), and the preoptic area (POA) (Gelman & Marín 2010). 
Although glutamatergic neurons migrate radially to adopt their analogous laminar 
position in the cortex, interneurons first move to the pallium and subsequently spread 
tangentially to occupy the entire cortex. Finally, they spread out radially and 
integrate specific layers of the cortex (Marín 2013). A large body of evidence 
suggests that different classes of interneurons (explained in further detail below) 
originate from specific regions in the subpallium and are controlled by various 




GABAergic interneurons are a highly diverse cell population in terms of 
morphology, molecular expression and electrophysiology (Tremblay et al. 2016). 
Anatomically, they display a variety of somatic, dendritic, and axonal morphologies, 
in addition to specific subcellular domains targeted by their axons. 
Electrophysiologically, an array of firing patterns has been described, a consequence 
of the interplay between ion channel composition and membrane cable properties. 
Thus, the active and passive membrane biophysical properties will differ among 
interneuron subtypes. In addition, synapses of specific subtypes are coordinated with 
GABA receptors differing in subunit composition, resulting in distinct kinetics of the 
GABAergic response (Dunning et al. 1999). Interneurons also express receptors for 
different neuromodulators such as acetylcholine, serotonin, noradrenaline, and 
dopamine, which can have dramatic effects on the function of neocortical circuits, 
leading to dynamic changes associated with different brain states (Tremblay et al. 
2016). Finally, interneurons differ in their expression of molecules that include 
calcium-binding proteins and neuropeptides. All these characteristics highlight the 
vast number of interneuron subtypes present in the brain, and most have substantial 
consequences on cellular and network computations. Although they represent a small 
proportion of all cortical neurons, their differences in subcellular targeting, 
connectivity, synaptic kinetics, and intrinsic membrane properties enable them to 
control the activity of principal cells with high spatiotemporal specificity and 
precision (Fig 1.1 & 1.2). 
Classification of interneurons has been relatively successful in the hippocampal CA1 
region. Morphological features including somatic location and dendritic and axonal 
innervation fields are used to reliably map out different populations of interneurons 
within CA1, which subsequently match nicely to functional and molecular properties 
based on these morphological criteria (Klausberger & Somogyi 2008). The success 
of this classification system depends predominantly on the simplified laminar layout 
of the hippocampus, where a given interneuron subtype can easily be identified based 
on its cellular and axonal location. In contrast, in the neocortex, the amalgamation of 
different cell types in most cortical layers has made a similar attempt very difficult. 






morphological characteristics alone demonstrated that there are too many 
ambiguities, resulting in overlapping subgroups (Defelipe et al. 2013). 
More recently, the expression of certain molecular markers has provided an initial 
platform to begin characterising specific interneuron subtypes in the cortex. 
Advances in molecular genetics have made it possible to express fluorescent proteins 
or enzymes such as Cre recombinase, which, when under the control of a promoter 
encoding a marker gene, allows for identification of specific groups of interneurons 
(Taniguchi et al. 2011). Three major distinct and largely non-overlapping subgroups 
of interneurons, which account for nearly 100% of GAD67 mRNA-expressing 
neurons in the neocortex have been identified (Fig 1.1). These cells either express the 
Ca2+-binding protein parvalbumin (PV), the neuropeptide somatostatin (SST), or the 
ionotropic serotonin 5HT3a receptor (5HT3aR). Furthermore, the developmental 
origins of these cortical interneuron groups can be defined by their molecular 
markers. PV and SST interneurons originate in the MGE of the subpallium from 
progenitors expressing Nkx2.1 amongst other transcription factors, whereas 5HT3aR 
interneurons are derived from the CGE (DeBoer & Anderson 2016). Importantly, 
interneurons belonging to each of these groups show a preference in functionally 
relevant properties that are either exclusive or not as distinguished in other groups, as 
well as in gene expression patterns (Zeisel et al. 2015).  
The PV and 5HT3aR interneuron groups can each be separated into two more, clearly 
disparate subgroups. The PV group accounts for approximately 40% of GABAergic 
neurons and includes fast-spiking basket cells and chandelier cells (Xu et al. 2010). 
Basket cells, which form most of the PV group make perisomatic “basket” terminals 
on principal cells and interneurons. Chandelier, or axo-axonic cells however, target 
the axon initial segment (AIS) of principal cells. The 5HT3aR group can be 
segregated into two subgroups based on whether the cells express vasointestinal 
peptide (VIP), a neuropeptide that is not expressed in PV or SST interneurons (Lee et 
al. 2010). The SST group, which predominatly target dendrites of principal cells, 
include Martinotti cells, which have axonal projections that reach into layer I, as well 
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as a subset of neurons that specifically target layer IV. In addition to the three main 
molecular markers and along with VIP, other markers are frequently used to label 
cortical interneurons. These include the glycoprotein reelin, the Ca2+-binding 
proteins calbindin (CB) and calretinin (CR), the neuropeptides cholecystokinin 
(CCK) and neuropeptide Y (NPY), and several neurotransmitter precursor proteins 
(Tac-1 and Tac-2) (Tremblay et al. 2016). In comparison to the first four, these 
additional markers are not expressed in non-overlapping groups. 
1.2.3 Function of interneuron subtypes 
While glutamatergic synapses from principal cells are limited to the dendritic tree of 
postsynaptic neurons, GABAergic synapses made from interneurons are dispersed 
along the entire axis of both excitatory and inhibitory cell types (Megı́as et al. 2001; 
Glickfeld et al. 2009). Thus, excitatory and inhibitory inputs coexist on the peripheral 
dendritic tree, whereas the proximal areas receive only inhibition (Pouille et al. 
2013). Furthermore, depending on the driving force, synaptic inputs can produce 
either a depolarising or hyperpolarising response, or simply no change in the 
membrane potential of postsynaptic cell. The activation of postsynaptic GABAA 
receptors, where the membrane potential is often very close to the reversal potential 
may only generate very small or no hyperpolarising responses, however still in these 
cases, the net effect will be inhibitory. This is because the net synaptic conductance 
is increased, thus lowering the input resistance of the postsynaptic cell, resulting in 
the shunting of excitatory inputs. As a result, GABAergic synaptic inhibition can 
decrease the excitability of the postsynaptic cell in two ways: by eliciting a 
hyperpolarising current which is thought to have a subtractive effect on neuronal 
output, or by increasing the conductance of the cell, which is considered to produce a 
divisive effect (Chance et al. 2002). This divisive effect is known as gain 
modulation, and is essential for network balance, as it modulates the input-output 
function of a neuron - by changing the slope of its firing rate curve (Chance et al. 
2002). Models suggest that inhibition produces a divisive effect on postsynaptic 
potentials if the change in conductance is large and located near the soma, whereas a 
subtractive effect will be produced if conductances are small and distally located 
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(Silver 2010). For these reasons, GABAergic interneurons are understood to be key 
components in regulating the dynamics of recurrent excitatory circuits at distinct 
spatial and temporal scales. 
The employment of qualitatively different interneuron subtypes to the same network, 
albeit in small numbers, provides a substantial expansion of computational 
possibilities (Roux & Buzsáki 2015). Essentially every compartment of the 
somatodendritic surface of cortical principal cells is under the specific control of a 
particular class (Fig 1.2), each determining the nature of inhibition produced and its 
net effect on the output of the postsynaptic cell (Markram et al. 2004). This is 
particularly important because many principal cells exhibit elaborate dendritic fields 
differentially associated with distinct excitatory inputs and intrinsic active properties. 
The functional capacity of principal cells can therefore be multiplied using mostly 
local interneuron wiring which act to modulate the gain and dynamic range of 
cortical circuits (Roux & Buzsáki 2015). The differences in interneuron subtypes and 
how they integrate into circuits with specific computational impacts are discussed 
below. 
Basket cells within the PV group primarily target the somata and proximal dendrites 
of principal cells in addition to other PV cells (Fig 1.2), which places them in a 
unique position to powerfully influence the output of their targets. Consequently, 
these interneurons are believed to be critical for the precise timing of pyramidal cell 
firing, coordinating their synchrony though gamma oscillations (Buzsáki & Wang 
2012). Chandelier cells however, exclusively target pyramidal cells at the AIS, and 
have recently been suggested to induce a depolarising rather than a hyperpolarising 
postsynaptic response due to an unusually depolarised ECl at the AIS, due to the 
absence of the Cl- extrusion transporter KCC2 (Szabadics et al. 2006). Despite these 
important differences, both cell types within the PV group typically have multipolar 
morphology and share very similar electrophysiological features. They fire high-
frequency non-accommodating trains of action potentials comprised of fast and deep 






adaptation (Erisir et al. 1999). This enables fast and precise signalling onto target 
neurons, allowing them to participate in numerous functions including controlling 
feedforward inhibition (see section 1.2.4) of many cortical circuits, which is 
important in establishing a strict window for temporal summation of excitatory 
inputs in principal cells (Hu et al. 2014). 
In contrast to PV cells, the SST group are dendritic targeting (Fig 1.2), and therefore 
have different functional dynamics as they specifically control the kinetic properties 
of distal processes (Tremblay et al. 2016). Most PV interneurons have strongly or 
moderately depressing excitatory inputs, whereas SST cells, regardless of subtype, 
are strongly facilitating (Kapfer et al. 2007). This key feature is likely of 
considerable physiological interest, as it allows for a very few number of excitatory 
inputs to drive EPSP summation and induce SST cell firing. While PV interneurons 
require synchronous firing of many presynaptic cells to make them discharge, the 
facilitation of inputs onto SST cells allows for even a single excitatory cell to recruit 
them (Kapfer et al. 2007), and therefore SST cells are reliably recruited to perform 
important functions such as providing feedback inhibition (see section 1.2.4). 
Martinotti cells, which make up the majority of the SST group, are typically bitufted 
or multipolar in morphology, and are found throughout layers II-VI but are more 
abundant in layer V (Wang et al. 2004). Their axons usually extend into layer I 
where they spread out horizontally into neighbouring columns and make synapses on 
dendritic tufts of pyramidal cells, as well as many types of interneurons (Pfeffer et al. 
2013). Given the facilitating dynamics of their inputs and their axonal arborisation, 
the inhibition mediated by these cells escalates as a function of rate and duration of 
presynaptic firing, which subsequently spreads into distal areas where they can 
influence neighbouring columns.  
The 5HT3aR group are more heterogeneous than the PV and SST groups, despite 
them all expressing functional 5HT3a and nicotinic receptors (Lee et al. 2010). They 
primarily populate supragranular cortical layers, where they represent the largest 
interneuron population. VIP cells, which constitute approximately 40% of all the 
20 
 
cells in the 5HT3aR group, are found mostly in layers II/III, and have a vertically 
oriented, bipolar-like, translaminar dendritic morphology. Their axons, also being 
vertically extended, often span many or even all cortical layers in a narrow columnar 
fashion (Fig 1.2). This suggests that this subtype not only integrates a large range of 
inputs spanning over long distances, but also provides feedforward and feedback 
inhibition across all cortical layers. These cells exhibit an array of firing patterns that 
can be irregular, bursting, and adapting. Perhaps the most important intrinsic 
electrophysiological feature of VIP cells is their high input resistance, which is 
higher than most cortical neurons, and makes them particularly sensitive to 
excitatory inputs. For example, although thalamic stimulation generates relatively 
weak excitatory synaptic currents onto deep layer III VIP cells, their high input 
resistance enables substantially larger depolarising inputs (Lee et al. 2010). 
Importantly, VIP cells have been reported to target many other interneuron groups, 
particularly SST interneurons (Fig 1.2), and therefore specialise in disinhibitory 
control (Pi et al. 2013). Furthermore, their ability to respond to long range input 
allows for translaminar inhibition across multiple cortical layers (Xu & Callaway 
2009). 
Non-VIP cells account for the remaining 60% of the 5HT3aR group (Rudy et al. 
2011). They are usually reelin positive and make up more than 90% of all the 
neurons in layer I. They include neurogliaform cells which have small multipolar 
dendritic arbors, and although predominant in layer I, are also located in other layers 
(Hestrin & Armstrong 1996). These cells typically display a late-spiking firing 
pattern characterised by a slow depolarisation ramp preceding firing at threshold. 
During larger suprathreshold depolarisations, the cells fire adapting firing trains 
(Kawaguchi & Kubota 1997). Neurogliaform cells are unique because they elicit 
slow, long-lasting IPSPs on pyramidal cells and other interneurons, via a 
combination of slow GABAA and GABAB receptor activation. In addition to this, 
their highly dense axonal plexuses and high release-site densities, many of which are 
not associated with synapses contribute to volume transmission of GABA (Oláh et al. 
2009). Unlike other interneuron types that specifically synapse onto particular 
compartments of postsynaptic neurons, neurogliaform cells, in part, regulate non-
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synaptic, spatially non-specific input to surrounding cells and therefore dampen 
down the neural activity in a local area (Tamás et al. 2003).  
1.2.4 Balance between excitation and inhibition 
Neurons in the cerebral cortex form dense mosaics of excitatory and inhibitory 
connections that illustrate both convergence and divergence (Haider et al. 2006). 
Crucially, the response of any specific neuron is determined by the impact of 
thousands of synaptic inputs (Binzegger et al. 2004). The balance between excitation 
and inhibition is therefore essential for cortical function. Within a given local cortical 
network, neurons gather inputs from other nearby neurons which form recurrent 
excitatory, as well as feedforward and feedback inhibitory circuits (Markram et al. 
2004). Considering the great diversity of interneurons in terms of their connectivity 
and functional properties, cortical excitation can be robustly controlled to form a 
dynamic equilibrium between excitation and inhibition (Shu et al. 2003). This 
dynamic control of excitation that governs cortical network activity is accomplished 
through feedback and feedforward inhibition (Isaacson & Scanziani 2011). This 
provides a way for interneurons to mediate precise gating of information through 
specific signalling pathways, and limits the time window for the summation of 
excitatory inputs. They accomplish these goals by controlling both spatially and 
temporally the measure of excitatory and inhibitory inputs that specific neurons 
receive (Vogels & Abbott 2009), which is often dependent on the brain state (T. 
Klausberger et al. 2003). 
Both feedforward and feedback inhibitory circuits can produce rapid sequences of 
excitation and inhibition (Fig 1.3). In the feedforward scenario, afferent inputs 
contact both principal cells and interneurons, resulting in the onset of excitation 
recorded in principal cells preceding the onset of inhibition by a monosynaptic delay 
(Gabernet et al. 2005). In principal cells of the somatosensory barrel cortex, for 
example, whisker deflections induce excitation followed rapidly by inhibition 




synaptic excitation that is accompanied by a surge in inhibition within a couple of 
milliseconds (Wehr & Zador 2003). Feedback circuits where local principal cells are 
followed by the recruitment of interneurons which ‘feedback’ on the principal cells 
also provide stability as it prevents runaway excitation. These rapid discrepancies in 
the ratio between excitation and inhibition can have fundamental consequences in 
tuning cortical neurons to individual stimuli and in temporally shaping their activity 
patterns. 
Finally, the counterbalance of excitatory and inhibitory conductances within the 
brain is maintained at comparable values across different cortical layers (Zhang et al. 
2011). As cortical transmission is largely enforced by GABAergic and glutamatergic 
ionotropic receptors that produce fast synaptic conductances, the possibility of 
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shifting the ratio between synaptic excitation and inhibition allows for the membrane 
potential in neurons to be effectively altered. Interneurons therefore contribute to the 
global balance of activity which is essential to maintain the stability of cortical 
networks. It is believed that this balance is fundamental for the maintenance of 
cortical network rhythms responsible for higher order cognitive functions (Haider et 
al. 2006). 
1.2.5 PV interneurons 
Out of the extensive diversity of GABAergic interneurons in the cerebral cortex 
(Markram et al. 2004), PV cells are the largest interneuron population in the 
neocortex (Rudy et al. 2011). The activity of basket and chandelier cells – which 
comprise most of the PV group - is important in regulating the membrane potential at 
proximal regions of postsynaptic neurons, since PV cells primarily synapse onto the 
somata, AIS and proximal dendrites (Hu et al. 2014). The proximity of their 
perisomatic inputs to the site of action potential generation puts them in a favourable 
position to robustly inhibit the activity of target neurons. 
PV basket cells have diverse axonal and dendritic arborisation territories (Staiger et 
al. 2015). In layer IV of the somatosensory cortex for example, PV basket cells 
maintain mostly locally projecting axons, while in other layers they can project 
across multiple layers, which include PV cells in layer V. Since these cells target the 
perisomatic region of principal cells, local cells will inhibit mostly local populations, 
while translaminar cells enable interlaminar interactions via inhibition. Furthermore, 
some supragranular and infragranular - but not layer IV – PV basket cells contain 
axons that extend across several columns, suggesting that they can influence 
neighbouring columns in addition to their own column. 
The morphological properties of PV cell axons differ from most other types of 
interneuron. PV cell axons in rats show extensive arborisation, where an individual 
PV cell can have a cumulative axonal length of 20 and 50 mm in the frontal cortex 
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and hippocampal CA1 region, respectively (Karube et al. 2004; Sik et al. 1995). It 
has been reported that their axon arbors in the cortex can make 3,000-5,000 en 
passant terminals onto postsynaptic targets, enabling them to inhibit the vast 
majority of nearby cells (Karube et al. 2004). Each PV cell innervates target principal 
cells with 5-15 boutons, and is therefore considered to contact 200-1000 principal 
cells. Consequently, PV cells produce a massively divergent inhibitory output, 
utilising their strategically placed perisomatic terminals to form a blanket of 
inhibition in territories covered by their axons. 
PV cell dendrites are also intriguing as they often span across cortical layers, which 
enable them to sample input from a large population of neurons (Gulyá et al. 1999). 
Their somata and dendrites are densely covered with synapses, making them 
extremely receptive to picking up local activity from individual neurons as well as 
neuronal ensembles. It is estimated that in CA1 or CA3, a single PV cell can have 
between 16,000 to 35,000 synapses, 94% of which are excitatory and 6% inhibitory 
(Gulyá et al. 1999; Tukker et al. 2013). A large fraction of inhibitory synapses are 
made from other PV terminals, but inhibitory inputs from SST and VIP interneurons 
are also present (Hioki et al. 2013). PV cells therefore receive convergent excitatory 
synaptic input from principal cells, and inhibitory input predominantly from other 
PV cells. Interestingly, a large proportion of PV cell dendrites are gap junction-
coupled with dendrites from adjacent PV cells. These are constructed from 
membrane-inserted connexin 36 proteins, and are present in approximately 80% of 
PV cells (Ma et al. 2011). PV cells are therefore highly interconnected both 
synaptically and electrically, which may help widen the spatial range of detection of 
principal neuron activity. Thus, excitatory input synapses onto one PV cell could still 
influence the activity of an unconnected PV cell, via electrical coupling of adjacent 
PV cells (Galarreta & Hestrin 2001). As a result, gap junctions have been suggested 
to boost the efficacy of distal inputs (Vervaeke et al. 2012), in addition to supporting 
synchrony between PV cells. This may also function in reinforcing the population of 
inhibition in the cortical microcircuit. 
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PV basket cells can fire repetitively at up to 400 Hz, faster than any other cell in the 
brain (Kawaguchi 2001). Action potential frequency however is much lower in vivo 
because of functionally powerful autapses, which provide feedback inhibition that 
reduces excitability (Bacci et al. 2003). It has become apparent that PV basket cells 
respond to excitatory stimulation with remarkable speed and with exquisite temporal 
precision. During sharp-wave ripples or theta rhythms in vivo, basket cells are 
recruited by inputs from principal cells with short latency and minimal jitter 
(Klausberger et al. 2003). These neurons set narrow time windows for temporal 
summation in principal neurons through fast feedforward and feedback inhibition. It 
is becoming clear that this neuronal population is extremely important in tasks 
requiring rapid and temporally precise modes of inhibitory signalling; from cellular 
functions such as coincidence detecting to network-wide maintenance of network 
oscillations. 
1.2.6 Role of PV interneurons in cortical networks 
A fundamental characteristic of cortical activity is the rhythmic and synchronous 
oscillation of the membrane potential of neuronal populations. Fast oscillations at 
gamma frequencies (30-80 Hz) have been hypothesised to be essential for 
information processing in cortical neurons by increasing the reliability of both spike 
probability and timing (Buzsáki & Schomburg 2015). These fast oscillations occur 
under a range of behavioural states, either spontaneously or in response to sensory 
stimuli, and are believed to be involved in coordinating large numbers of neurons, 
distributing information within and across different areas of the brain. As target 
neurons are depolarised more efficiently when excitatory inputs are actively 
synchronised instead of distributed in time, oscillations allow neurons to contribute 
to the depolarisation of cell assemblies for efficient transmission of downstream 
targets (Azouz & Gray 2000). Information processed in distinct cortical areas can 
therefore be consolidated through gamma oscillations, which may underlie cognitive 
processes related to temporal binding, where two distinct groups of neurons recruit a 
third group to which they both project, thereby ‘binding’ them into functionally 
coherent assemblies (Engel et al. 2001). 
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Inhibition mediated by PV basket cells has not only been demonstrated to be directly 
involved in the generation of these fast oscillations, but also in synchronising 
participating neurons as well as maintaining their coherence in space (Cardin et al. 
2009; Cobb et al. 1995). Several important properties of PV basket cells appear to be 
essential in the generation of synchronised oscillations. Firstly, these cells synapse 
onto the perisomatic region of their target cells, which minimizes the effects of 
dendritic filtering and the time required for signal propagation, placing them in a 
strategic position to control action potential generation (Miles et al. 1996). Secondly, 
they form reciprocal synaptic connections onto each other (Gibson et al. 1999), a 
functional property that has been shown to be valuable for the robustness of 
oscillations in models (Bartos et al. 2007). These reciprocal connections produce a 
shunting rather than a hyperpolarising effect on neighbouring PV cells, which 
shortens the interspike interval for low levels of drive but prolongs it at high levels 
(Vida et al. 2006). Lastly, PV basket cells are electrically coupled via gap junctions, 
enabling large populations to be synchronised with millisecond precision (Galarreta 
& Hestrin 1999). It has been suggested that both electrical and synaptic coupling act 
synergistically to reinforce the degree and precision of neuronal synchronisation. The 
relative timing of gap junction potentials and IPSPs derived from the same 
presynaptic cell has been shown to be invariant, resulting in the generation of 
precisely sculpted, biphasic postsynaptic potentials which accurately lays down the 
timing of postsynaptic action potentials (Tamás et al. 2000). 
Two alternative models for circuit mechanisms implicated in gamma oscillations 
have been proposed: pyramidal-interneuron network gamma (PING) and interneuron 
network gamma (ING) (Tiesinga & Sejnowski 2009). The PING model hypothesises 
that the excitatory cells generate the gamma oscillations, where reciprocal 
connectivity between pyramidal cells and interneurons are important. In this model, 
pyramidal cells conduct phasic excitation to interneurons on each cycle, timing the 
firing of interneurons to a specific phase of the gamma cycle. Furthermore, the pace 
of the oscillation is set by the decay time constant of inhibition of pyramidal cells. 
The ING model however highlights the significance of the strength and timing of 
GABAergic synaptic connectivity, in addition to the importance of electrical 
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coupling between PV basket cells and their intrinsic membrane properties 
(Whittington et al. 1995). Given the right conditions, the synaptically-coupled PV 
basket cells generate fast synchronous oscillations of the network, resulting in the 
entrainment of pyramidal cells (Van Vreeswijk et al. 1994). Regardless of whichever 
model is correct, the fact that individual basket cells contact a very large proportion 
of neighbouring pyramidal cells – and vice versa – adds to the concept that both PV 
basket cells and pyramidal cell types are essential for gamma oscillations to occur. 
The interaction between excitation and inhibition in response to sensory stimuli 
displayed in gamma oscillations is tightly balanced. Two groups of neurons that 
synchronously oscillate in phase may act synergistically to recruit downstream 
neurons by exciting them simultaneously. However, even the slightest alteration in 
phase or frequency of the oscillations between the two groups may dramatically alter 
this synchrony and the ensuing recruitment of target neurons (Fell et al. 2001; 
Schoffelen et al. 2005). Despite the changes in frequency of this information, the 
neuronal network has been shown to maintain the magnitude of inhibition 
proportional to excitation during each oscillation cycle (Atallah & Scanziani 2009). 
Moreover, oscillations depict a time lag between the excitatory and inhibitory 
components, where the inhibitory phase is delayed by 1-2 ms relative to the 
excitatory phase (Atallah & Scanziani 2009). The outcome of this action favours 
excitation early in the oscillation cycle while shifting the balance towards inhibition 
later. This progression of events results in relatively narrow time windows for 
neuronal firing, which is exhibited in the tightly phase-locked firing patterns of 
pyramidal cells relative to oscillations (Poo & Isaacson 2009). This time window 
which is approximately 10-30 ms in the cortex is also in the same range as the 
membrane integration time for pyramidal cells during spontaneous activation in vivo 
(Léger et al. 2005). Moreover, this narrow temporal window governs the capability 
of how the network responds to the timing of synaptic inputs (Azouz 2005). The 
transmission of information during gamma oscillations is therefore a highly dynamic 
process that relies on precise timings of oscillations, and further emphasises the role 
that PV basket cells play in carrying out sophisticated neuronal operations underlying 
cognition and behaviour. 
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1.2.7 Deficits in network oscillations in neurological and psychiatric diseases 
The formation of functional networks through synchronised gamma oscillations is 
heavily dependent upon excitatory and inhibitory dynamics that create transient 
connections between neuronal ensembles by modulating the degree of neuronal 
responsiveness (Haider & McCormick 2009). In addition to the role of neuronal 
synchrony in temporal coding, integration of neuronal assemblies and top-down 
modulation of sensory stimuli, there is growing evidence indicating aberrant neural 
synchrony as a pathophysiological mechanism in neuropsychiatric disorders 
(Spencer et al. 2003; Marín 2012). Impaired synchronisation of oscillatory activity 
has been suggested to result in cognitive deficits linked to working memory, 
attention, and perceptual organisation (Marín 2012). 
A large body of electroencephalographic (EEG) and magnetoencephalographic 
(MEG) studies now indicate deficits in gamma-band oscillations during cognitive 
tasks in patients with schizophrenia. Recent MEG studies have reported impairments 
in the performances of visual tasks accompanied by widespread deficits in the power 
of gamma oscillations (Grützner et al. 2013). Similar results were found using EEG 
recordings of auditory and visual steady-state responses to repetitive stimulation 
where reductions in the power of the stimulus-locked response in the beta and 
gamma frequency range, but not in the lower frequencies were uncovered (Krishnan 
et al. 2005; Kwon et al. 1999). In addition to analyses of spectral power, the 
synchronicity of gamma oscillations has also been found to be reduced during 
cognitive tasks in patients with schizophrenia (Spencer et al. 2003; Uhlhaas et al. 
2006). This is important because it is now being considered that functional networks 
underlying perception and attention rely on coordination across widely distributed 
cortical regions by the phase-locking of oscillatory activity (Fries 2005). As a 
consequence, reductions in long-range phase synchronisation may lead to 
dysconnectivity across neuronal ensembles thus resulting in abnormal functional 
integration of processes within the brain (Stephan et al. 2009). 
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Similar to work in schizophrenia, pathophysiological mechanisms associated with 
cognitive dysfunctions in autism are believed to converge, in part, on deficits in 
temporal coordination of distributed neuronal activity (Uhlhaas & Singer 2007). Both 
disorders for example are characterised by shortfalls in perceptual integration during 
auditory and visual perception (Happé & Frith 2006; Uhlhaas & Silverstein 2005). In 
analogy to the findings in schizophrenia, subjects with autism display a marked 
reduction in auditory steady-state gamma-band power in response to repetitive 
stimulation (Wilson et al. 2007). In addition, deficits in task-related gamma-band 
power were identified in autistic individuals during visual perceptual integration 
(Milne et al. 2009). 
1.2.8 K+ channels in schizophrenia 
The fast rhythmic activity governed by the coordinated firing of PV cells largely 
relies on the rapid properties of voltage-gated K+ channels specific to this cell-type. 
In order for this highly dynamic process to occur, each PV cell undergoes rapid 
repolarisation of their action potential before it can robustly fire again. Voltage-gated 
Kv3.1 and Kv3.2 channels which are kinetically optimised for high-frequency action 
potential generation (see section 1.3.3) have been shown to be highly expressed in 
PV cells to give them their fast-spiking phenotype (Rudy & McBain 2001). Post-
mortem tissue from individuals with schizophrenia revealed reduced expression 
levels of the Kv3.1 channel protein in the prefrontal cortex (Yanagi et al. 2014). 
Furthermore, a loss of the fast-spiking electrophysiological phenotype as well as 
impairment in neuronal synchrony have been reported in Kv3.1 knockout mice (Joho 
et al. 1999; Porcello et al. 2002), suggesting that deficits in this channel could 
underlie some of the pathophysiology found in schizophrenia. Alterations in cortical 
EEG patterns as well as an increased susceptibility to epileptic seizures consistent 
with deficits in cortical inhibitory mechanisms were also reported in Kv3.2 knockout 
mice (Lau et al. 2000). This highlights the functional importance of a key ionic 
channel responsible for maintaining rapid firing kinetics within PV cells, and how 
they are essential for the generation of fast network synchrony. 
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Other K+ channels have also been suggested to be involved in neuropsychiatric 
disorders. Mutations in the small-conductance Ca2+-activated K+ channels type 3 
(KCNN3) gene has been reported in subjects with schizophrenia. This channel 
functions to regulate neuronal excitability in the CNS. Case-control studies revealed 
expanded polyglutamine (CAG) repeats in the second CAG triplet of the KCNN3 
gene in individuals with schizophrenia from two separate human populations (Tsai et 
al. 1999; Dror et al. 1999). The dysfunction of KCNN3 channels could therefore 
modify the ability of a cell to regulate the slow component of afterhyperpolarisations 
(AHPs). Finally, Ca2+-activated BK channels may also be involved in schizophrenia 
as antipsychotics used to treat the disorder have been reported to alter the Ca2+-
activated conductance in neurons (Zhang et al. 2006). 
1.2.9 PV interneurons in schizophrenia 
GABAergic circuits have been shown to possess a variety of abnormalities in adults 
with schizophrenia (Fig 1.4). One of the most consistent observations found from 
independently performed studies is that only certain interneuron subtypes seem to be 
affected. A marked reduction in the levels of GAD67 and PV mRNA exclusively in 
PV cells have been reported in layers III-V of the prefrontal cortex from post-mortem 
schizophrenic brains (Akbarian et al. 1995; Hashimoto et al. 2003). In addition, 
GAD67 mRNA levels are left unaltered in other interneurons between subjects with 
schizophrenia and healthy controls (Hashimoto et al. 2003), suggesting that the 
pathology is restricted to the PV cell population. Levels of the GAD67 protein itself 
has also been reported to be lower in PV cells, indicating a downstream reduction in 
the functional enzyme required for GABA synthesis within this cell type (Guidotti et 
al. 2000; Curley et al. 2011). In patients with schizophrenia, the expression of the a1 
subunit of the GABAA receptor (see section 1.3.4) is reduced in cortical pyramidal 
cells at postsynaptic sites made by PV basket cells (Glausier & Lewis 2011). This 
could indicate fewer inputs from basket cell axons onto pyramidal cells, further 
supported by a decline in the density of PV-immunoreactive boutons (putative basket 
cell axon terminals) in layers III-IV of the prefrontal cortex in schizophrenia (Lewis 
et al. 2001). Another study demonstrated that genetic knockdown of GAD67 in PV 
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cells during development leads to a decline in PV basket cell axonal arborisation and 
synapse formation (Chattopadhyaya et al. 2007). Thus, diminished levels of GAD67 
mRNA in PV cells in schizophrenia, if prompted early in life, could give rise to 
fewer PV basket cell synapses, and therefore a reduction in synapses requiring the a1 
subunit in postsynaptic cells (Fig 1.4). 
Furthermore, the expression of a2 is upregulated in pyramidal cells at postsynaptic 
inputs from chandelier cells (Volk et al. 2002), while the expression of GAT-1 is 
downregulated in chandelier cell terminals (Pierri et al. 1999). It is possible that these 
are compensatory mechanisms carried out by chandelier cells in the attempt to rectify 
weakening perisomatic inhibitory signalling from basket cells. Increasing the content 
of GABAA receptors with a2 subunit may amplify the effect of GABA on these 
synapses, while simultaneously reducing GAT-1 expression slows down GABA re-
uptake and increases the time during which the transmitter is present in the synaptic 
cleft to maximise its effect (Fig 1.4). 
The observation that NMDA receptor antagonists reproduce behaviours reminiscent 
of schizophrenia in mice led to the assumption that NMDA receptor hypofunction 
may implement an essential role in the disease (Rotaru et al. 2012). Genetically 
modified mice with reduced NMDA receptor expression are reported to have 
cognitive, negative and positive symptoms linked to the disorder in humans (Mohn et 
al. 1999). Moreover, administration of NMDA receptor antagonists produces 
elevated cortical activity (Breier et al. 1997), indicating that NMDA receptor 
hypofunction may principally occur in interneurons. There is also evidence that 
NMDA antagonists reduce the activity of GABAergic interneurons in the prefrontal 
cortex of rats (Homayoun & Moghaddam 2007). Because PV expression is reduced 
in the brains of individuals with schizophrenia, and PV cells are believed to be 
critical for the generation of gamma oscillatory activity, it has been hypothesised that 
NMDA receptor hypofunction specifically in PV cells is a core feature of the disease. 
Indeed, NDMA receptor antagonists have been reported to downregulate PV 






It should be considered however that there is also evidence to argue against NMDA 
receptor hypofunction in adult PV cells as a causal factor in schizophrenia. In the 
healthy forebrain, NMDA receptor expression in PV cells compared to NMDA 
receptor expression in pyramidal cells and other interneurons is already low in the 
first place (Wang & Gao 2009), and NMDA receptors in PV cells might actually be 
less prone to activation than those on pyramidal cells (Hull et al. 2009). Similarly, 
PV cell-mediated disynaptic inhibition onto pyramidal cells in the somatosensory 
cortex – which is critical for regulating the coincidence detection window in 
principal neurons – is NMDA receptor-independent (Wang & Gao 2009). This 
suggests that dysfunctional NMDA receptors in PV cells might not necessarily 
underlie the cause for schizophrenia, as other cell types that depend more heavily on 
NMDA receptors would be more susceptible to NMDA receptor-mediated 
impairments. Nonetheless, since NMDA receptor expression is higher during 
development than in adulthood (Wang & Gao 2009), it is still possible that NMDA 
receptor hypofunction in PV cells during development, rather than in adulthood, 
could be responsible, in part, in the progression of the disease. The selective ablation 
of NMDA receptors in a fraction of interneurons including PV cells in the mouse 
forebrain was shown to induce deficits attributable to schizophrenia in humans only 
if the ablation is carried out during early postnatal development but not in adulthood 
(Belforte et al. 2010). Hence, deficient NMDA receptor function during development 
may lead to impaired PV cell activity and consequently result in the reduction in 
GAD67 and PV expression. 
Deficits in the maturation of PV cells have been linked to susceptibility genes in the 
development of schizophrenia. Neuregulin 1 (NRG1) and its receptor tyrosine 
kinase, ErbB4, are associated with an increased risk of schizophrenia as well as 
abnormities in interneuron development (Stefánsson et al. 2003). NRG1 is important 
in a variety of roles during neuronal development, including regulation of neuronal 
migration, synaptogenesis and neurotransmission (Harrison & Law 2006). Recent 
studies have found that ErbB4 is expressed exclusively in interneurons, particularly 
in PV cells, where the NRG1 protein stimulates GABA release, inhibiting pyramidal 
cells in the prefrontal cortex (Wen et al. 2010). NRG1/ErbB4 signalling cell-
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autonomously promotes the formation of axo-axonal synapses from chandelier cells 
onto pyramidal cells as well as the formation of glutamatergic synapses onto PV cells 
(Fazzari et al. 2010). Moreover, the conditional deletion of ERBB4 in PV cells 
resulted in a reduction in the frequency of miniature inhibitory currents (mIPSC) in 
pyramidal cells which was paralleled by a reduction in the number of inhibitory 
synapses onto pyramidal cells (Fig 1.4) (Fazzari et al. 2010). It can therefore be 
presumed that disruption of NRG1 function can have a considerable effect on the 
balance between excitatory and inhibitory input in the network. More evidence 
suggests that ErbB4 exerts its effects on PV cells: the ablation of ErbB4 receptors 
specifically in PV cells in mice exhibit schizophrenia-like phenotypes similar to 
those observed in NRG1 or ErbB4 null mutants (Wen et al. 2010). Another 
susceptibility gene, DISC1, which displays behavioural abnormalities when mutated 
in mice, has also been linked to the development of PV cells. Dominant-negative 
DISC1 mice were shown to have a reduced density of PV cells in the prefrontal 
cortex (Hikida et al. 2007). Furthermore, the genetic knockout of dysbindin 
(DTNBP1) – a possible binding partner of DISC1 – revealed similar deficits in PV 
cell function to those found in conditional ERBB4 mutant mice (Fig 1.4) (Ji et al. 
2009). 
In addition to perturbed maturation of PV cells, there is also evidence to suggest that 
molecular pathways associated with schizophrenia regulate the migration of 
interneurons during development. NRG1/ErbB4 signalling has been shown to 
support the migration of immature cortical GABAergic interneurons (Flames et al. 
2004). Similarly, DISC1 is necessary for the tangential migration of MGE-derived 
cortical GABAergic interneurons, which is impaired following knockdown of the 
gene during early development (Steinecke et al. 2012). Abnormal interneuron 
migration is consistent with the increased density of interneurons found in the 
superficial white matter of the orbitofrontal cortex in schizophrenic brains (Joshi et 
al. 2012). Thus, the possibility that MGE-derived interneurons including PV cells 
becoming inadequately connected to cortical networks during development, in 
addition to receiving reduced excitatory inputs could all contribute to the 
development of schizophrenia. 
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1.2.10 PV interneurons in autism 
Deficits in GABAergic signalling have also been described in autism (Gao & Penzes 
2015). Many studies point to an imbalance between excitation and inhibition in 
autism, providing evidence for impairments in both excitatory and inhibitory 
synaptic transmission (Gao & Penzes 2015). Evidence for alterations in GABAergic 
circuits also originate from post-mortem examinations showing significantly reduced 
expression of GAD65 and GAD67 (Fatemi et al. 2002) together with reduced 
expression of GABAA and GABAB receptors (Fatemi et al. 2010) in the cortex and 
cerebellum of autistic patients. These alterations may branch from widespread 
transformations in GABA innervation and release, which may reduce the threshold 
for developing seizures, given the strong correlation of autism with network 
hyperexcitability and its high comorbidity with epilepsy (Brooks-Kayal 2010). In 
support of this hypothesis, a recent study showed a decline in the absolute number of 
PV cells in the prefrontal cortex of subject brains with autism (Zikopoulos & Barbas 
2013). As PV cells provide robust perisomatic contacts onto pyramidal cells - which 
is fundamentally required in maintaining network balance - a decline in their number 
could explain the aberrant GABAergic signalling and predisposition for epilepsy in 
autism. Collectively, these matters demonstrate that heterogeneous changes in 
glutamatergic and GABAergic circuitry in the autistic brain can converge upon an 
overall increase in the ratio between excitation and inhibition. 
Alterations of PV cells is one of the most noticeable features in animal models of 
autism (Fig 1.4). Prenatal exposure to valproic acid - an animal model of autism - 
resulted in a large reduction in the number of PV cells in the neocortex of mice 
(Gogolla et al. 2009). Similarly, mice designed to carry a mutation of the urokinse 
plasminogen activator receptor (uPAR) gene, which has been found to be mutated in 
the cerebral cortex of post-mortem brains with autism (Campbell et al. 2008), 
showed a 50% decline in neocortical GABAergic interneurons including a near-
complete loss of PV cells (Powell et al. 2003). These mice also exhibited 
spontaneous seizures and behaviours associated with autism (Powell et al. 2003). 
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It is possible that these effects result from pathophysiological mechanisms upstream 
of GABAergic signalling, however, there is evidence that indicates causal roles of 
GABAergic mechanisms in nonsyndromic autism. For example, mutations in genes 
coding for cell adhesion molecules of the neurexin-neuroligin families which are 
expressed at glutamatergic and GABAergic synapses are often found in autism (Chih 
et al. 2005). Mice with a point mutation in neuroligin 3 (R451C) developed impaired 
social behaviours (Tabuchi et al. 2007), while over half of PV cell numbers were 
abolished (Gogolla et al. 2009). Finally, genes associated with syndromic autism 
have been linked to alterations in PV cells. Mice lacking the Fragile X mental 
retardation 1 (FMR1) gene exhibited autistic-like behaviours (Spencer et al. 2005), 
and displayed significant reductions in PV cell density in addition to alterations in 
their lamina distribution in the somatosensory cortex, whereas other interneurons 
were unaffected (Selby et al. 2007). 
1.2.11 Specific targeting of PV interneurons as a treatment for neurological and 
neuropsychiatric diseases 
The full sequence of developmental processes that are disrupted in both 
schizophrenia and autism is far from being completely understood. However, it is 
clear from growing evidence that disruptions in the GABAergic circuitry particularly 
in PV cells play a fundamental role in these disorders. PV cells are essential in 
establishing the opening and closing of critical periods in multiple brain regions 
(Fagiolini et al. 2004; Le Magueresse & Monyer 2013), which in humans takes place 
during early postnatal development - when the initial symptoms of autism are also 
detected (Le Magueresse & Monyer 2013). One could assume that deficits in PV cell 
function impairs plasticity, leading to improperly developed cortical wiring during a 
very confined period of early postnatal maturation. The abnormal function of PV 
cells may also manifest at later stages of postnatal development affecting their ability 
to drive gamma oscillations, consistent with altered gamma oscillations found in the 
cortex of subjects with schizophrenia. 
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Throughout development and into adulthood, PV cells are crucial in mediating rapid 
feedforward and feedback inhibition, temporal sculpting of information transfer in 
neuronal networks, maintaining the balance between excitation and inhibition, as 
well as contributing to fast network oscillations. GABA-mediated plasticity of 
cortical networks throughout the developmental period could therefore be used to 
develop new therapies aimed at selectively targeting specific cell types in the attempt 
to rectify part of the network dysfunctions. Many mutations that provoke and lead to 
neurodevelopmental disorders disrupt genes that are also expressed in adult brain. 
Therefore, in addition to structural and functional effects on the developing brain, it 
is conceivable that modified gene function in adulthood may be partly responsible 
for associated cognitive phenotypes. With this in mind, several studies using animal 
models of neurodevelopmental disorders demonstrated that reversing the disrupted 
molecular deficits can restore proper cognitive function even if treatments are started 
in adulthood. (Ehninger et al. 2008). These studies validate the idea that treatment 
specifically in adults may successfully amend some of the disrupted molecular and 
cellular mechanisms resulting in noticeable improvements in cognitive function. 
New pharmacological strategies could be implemented either during development, 
before cortical circuits lose their developmental plasticity, or even in adult patients 
suffering from neurological disorders. Thus, in patients with schizophrenia and 
autism where there are deficits in the function of PV cells, it could be beneficial to 
develop a drug that selectively targets PV cells to increase their activity. This could 
then be administered to patients during development or in adulthood, with the goal of 
either correcting part of the aberrant wiring from an early postnatal stage, or to 
alleviate part of the symptoms later in the adult brain. 
1.3 Modulation of PV interneurons 
Given the deficits in PV cells associated with neurodevelopmental disorders, the 
ability to selectively modulate PV cells and increase their excitability in the network 
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could be extremely useful in patients. There are undoubtedly many approaches that 
could be explored in order to restore normal PV cell function at the cellular level as 
well as within the network circuitry which is heavily reliant on the proper function of 
PV cell inputs. Studies looking into the pathophysiological mechanisms of 
schizophrenia and autism indicate a number of distinct malfunctions present in PV 
cells: reductions in GAD67 and PV mRNA thought to be essential for their proper 
function may result in reduced activity; a decline in the number of synapses between 
PV cells and pyramidal cells potentially gives rise to poor synaptic transmission; and 
reductions in the number of PV cells themselves, which again reduces the overall 
synaptic contacts between PV cell and pyramidal cells (Fig 1.4). An attempt to 
increase the number of PV cells or PV cell synapses in patients would be extremely 
difficult as the former would require the manipulation of complex machinery to 
induce cell proliferation, while the specific targeting of distal processes to induce 
synaptogenesis would be exceptionally challenging due to the number of intricate 
mechanisms that would need to be considered. Accordingly, an easier approach 
would be to target PV cells in their entirety and exploit their electrophysiological 
properties to increase their excitability. A drug could be applied to target key 
attributes unique in PV cells to make them more excitable and fire with a higher 
probability, without directly altering other cell populations. Increasing the 
excitability of PV cells could also compensate for the reduction in cell number and 
synaptic inputs. 
1.3.1 Intrinsic properties of PV interneurons 
In order to manipulate PV cells and increase their excitability, it is necessary to 
understand the functional features that make them so fast and efficient in the first 
place. PV basket cells have developed numerous molecular and cellular properties to 
ensure that they generate fast, strong, reliable, and temporally precise inhibition onto 
their target cells. The speed and precision of PV cell firing relies upon a combination 
of biophysical and molecular specialisations covering the entire cell; from excitatory 
synapses PV cells receive in their dendrites, to distinctive attributes that span their 
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axon and presynaptic terminals. These intrinsic features are highlighted in three main 
categories below (and summarised in table 1.3): 
1.3.2 Specialisations promoting fast excitation of PV cells 
The first key feature of PV cells incorporates characteristics favouring fast 
excitability. Large amplitude AMPA receptor-mediated postsynaptic conductances 
with fast time courses ensure rapid and reliable excitation of PV cells, whilst 
narrowing EPSP summation to near-synchronous inputs, enabling fast coincidence 
detection sensitive to spatially distributed inputs (Hull et al. 2009; Hu et al. 2010). 
PV cells express specialised AMPA receptors containing GluA1 or GluA4 subunits 
that have fast deactivation kinetics, which contribute to the rapid time course of 
excitatory inputs (Geiger et al. 1997). PV cells functionally express AMPA receptors 
composed of GluA2-lacking subunits allowing for high Ca2+ permeability and fast 
gating, resulting in larger and faster excitatory inputs compared to other neurons 
(Geiger et al. 1995). It has been demonstrated that thalamic excitation of putative PV 
cells displaying fast-spiking phenotypes produces AMPA-mediated EPSCs with a 
fourfold larger underlying quantal amplitude compared with inputs onto non-PV 
regular-spiking cells (Hull et al. 2009). Since GluA2-lacking AMPA receptors are 
known to have single channel conductances that are several-fold larger than GluA2-
containing AMPA receptors (Swanson et al. 1997), the presence of these receptors 
may provide an explanation for the large quantal amplitude, although alterations in 
the number of postsynaptic receptors between PV cells and other neurons may also 
play a role. 
An important characteristic designed to speed up the time course of EPSPs is the 
phenomenon that PV cells possess a low membrane resistance (Doischer et al. 2008). 
This is driven by a developmentally regulated expression of leak K+ channels 
mediated by Kir2 subfamily inward rectifier K+ channels and TASK subfamily two-
pore K+ channels, the latter reaching mature levels by the end of the third postnatal 
week (Goldberg et al. 2011; Okaty et al. 2009). This accelerates the membrane time 
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constant and therefore sharpens EPSPs, which in turn narrows the time window for 
integration of inputs (described in further detail in the next paragraph). 
Consequently, TASK-1/3 double knockout mice were found to have an 
approximately twofold increase in membrane resistance, approaching values similar 
to that observed in pyramidal cells, as well as a similar increase in the membrane 
time constant (Goldberg et al. 2011). The input resistance is further reduced by the 
presence of gap-junctional coupling between PV cells (Galarreta & Hestrin 1999). 
PV cells in connexin 36 knockout mice were reported to have a 25% reduction in 
resting leak conductance in layer IV of the barrel cortex (Deans et al. 2001). 
Similarly, mefloquine, which blocks connexion 36 channels, increases PV cell input 
resistance by 15% in the same cortical region in rats (Cruikshank et al. 2004). 
Another observation routinely demonstrated in acute brain slices recordings is the 
high frequency of spontaneous synaptic activity onto PV cells, which may reduce the 
input resistance at rest via a shunting mechanism. Studies have demonstrated that 
blocking glutamatergic neurotransmission results in an input resistance increase of 
over 40%, suggesting that continuous synaptic activity contributes to the 
conductance at rest (Cruikshank et al. 2004). Furthermore, somatodendritic 
recordings reveal that cable properties across the axis of PV basket cells are 
nonuniform, where the membrane resistance is lowest in the soma and proximal 
dendrites, intermediate in the distal dendrites, and highest in the axon (Nörenberg et 
al. 2010). Computational analysis demonstrate that these unique properties accelerate 
the time course of EPSPs at the soma in response to fast inputs, while enhancing the 
efficacy of slow distal inputs (Nörenberg et al. 2010). 
Specialisations in the active dendritic properties in PV cells facilitate the generation 
of fast, temporally independent EPSPs (Hu et al. 2010). This is thought to be 
important in the detection of temporally coincident inputs, whilst promoting fast, 
reliable and temporally precise conversion of EPSPs to action potentials. Basket cell 
dendrites possess low densities of voltage-gated Na+ channels but are enriched with 
specialised voltage-gated K+ channels belonging to the Kv3 subfamily – particularly 
Kv3.1 and Kv3.2 - which accelerates EPSP kinetics (Hu et al. 2010). This shortens 
the time period for temporal summation allowing basket cells to detect the 
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synchronous activity of converging, spatially distributed excitatory inputs. During 
EPSP action potential conversion, the high expression of dendritic K+ channels 
ensures precise 1:1 coupling between EPSP and action potential, repressing the 
generation of action potential bursts by large excitatory inputs. Furthermore, these 
channels maintain a constant action potential initiation threshold during repetitive 
stimulation. These characteristics are likely to be important in vivo during network 
activity including sequential activation of feedforward and feedback inputs on basket 
cells. K+ channels therefore shape the electrical properties of PV cells at the level of 
input as well as during EPSP action potential conversion. 
1.3.3 Specialisations promoting high frequency firing of action potentials in PV 
cells 
The second key group of features are conveyed in specialised intrinsic properties that 
enable PV cells to generate spikes with short latency, and the capability to discharge 
brief action potentials repetitively at high frequencies with minimal adaptation 
during sustained stimulation (Erisir et al. 1999). The diverse action potential 
waveforms of cortical neurons are regulated by the interplay between voltage-gated 
Na+ and K+ channels in addition to morphological properties as well as channel 
distribution along the somatodendritic axis (Mainen & Sejnowski 1996). Previous 
studies have suggested that differences in firing patterns are largely determined by 
the expression of distinct K+ channels. In this manner, PV cells in the cortex and 
hippocampus have been shown to express K+ channels that activate and deactivate 
with remarkable speed, but inactivate very slowly (Du et al. 1996). These properties 
allow for rapid fluctuations in the membrane potential in PV cells necessary for their 
fast-spiking phenotype. 
High levels of Kv3 channels, which activate at more depolarised potentials than most 
other voltage-gated K+ channels in other cells, but with fast deactivation rates, ensure 
rapid repolarisation of the membrane without compromising spike initiation or height 
(Rudy & McBain 2001). Kv3 channels reinforce the generation of deep and fast 
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AHPs which facilitates the recovery of voltage-gated Na+ channels from inactivation 
(Fig 1.5) (Rudy et al. 1999). The large AHP produced by the activation of Kv3 
channels also functions to rapidly terminate the outward K+ current, which, due to 
their fast deactivation rate does not extend the refractory period, thereby keeping the 
inter-spike interval short (Rudy et al. 1999). Kv3 channels also shorten the half-
width of action potentials (Du et al. 1996), which reduces the amount of Na+ channel 
inactivation that occurs, yielding a population of Na+ channels that are primed and 
ready to go for the next action potential. Low concentrations of tetraethylammonium 
(TEA) and 4-aminopyridine (4-AP), which block Kv3 channels results in the near-
abolishment of the fast AHP, the reduction in the maximum rate of spike 
repolarisation, increased spike broadening, and the decline in maximal firing 
frequency (Erisir et al. 1999; Du et al. 1996). It should be noted that other known K+ 
channels including Kv1, KCNQ2 and BK Ca2+-activating channels are also blocked 
with low concentrations of TEA, however the application of various toxins known to 
block these other channels were shown to have little effect on the action potential 
waveform (Erisir et al. 1999). These electrophysiological properties are therefore 
essential for sustained high frequency firing of action potentials as large and rapid 
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repolarisations of the membrane ensures that it is ready for the next depolarisation to 
take place. 
High frequency action potentials are further maintained in PV cells through the 
expression of specialised voltage-gated Na+ channels comprising slower inactivation 
and faster recovery (Martina & Jonas 1997). A decrease in the overlap between 
inactivation and activation in PV cells may prevent an increase in the slow 
depolarising potential during repetitive firing seen in principal neurons, which in a 
subset of cells may lead to their intrinsic bursting phenotype. The recovery of Na+ 
channels from inactivation is quicker in PV cells compared to principal neurons, thus 
enabling a constant supply of Na+ channel availability during spike trains, thereby 
preventing spike frequency adaptation and spike threshold accommodation (Martina 
& Jonas 1997). Na+ channels may therefore enable the generation of spike trains that 
retain the precise temporal structure of synaptic input. Their fast recovery could also 
allow PV cells to fire doublets that may synchronise neuronal ensembles that are 
spatially distributed (Traub et al. 1996). 
Subthreshold-operating Kv1 channels specifically localised in the AIS exert a 
considerable influence on the excitability of PV basket cells by regulating near-
threshold responsiveness (Goldberg et al. 2008). The low activation threshold and 
slower gating of these channels suppresses the generation of spikes to long current 
pulses. In contrast, large EPSPs fast enough to bypass Kv1 channel activation 
successfully result in action potential initiation with short delay (Goldberg et al. 
2008). Thus, Kv1 channels filter slowly rising depolarisation events, making them 
fire in response to large-amplitude or synchronous inputs, with rapid kinetics. 
GABAergic interneurons have previously been subdivided into delay-type, where 
cells fire after a delay of variable duration; continuous fast-spiking; and stuttering 
types, based predominantly on firing patterns in slice recordings (Ascoli et al. 2008; 
Gupta et al. 2007). Interestingly, Kv1 channel blockade eliminates the characteristic 
delay to first spike observed with near-threshold current injections, converting PV 
cells with delay-type firing patterns to continuous fast spiking patterns suggesting 
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that these channels are responsible for the delayed spiking phenotype in a subset of 
PV cells. 
1.3.4 Specialisations promoting fast spike propagation and synchronous 
transmitter release in PV cells 
The third key feature that ensures PV cells are built for speed and precision 
incorporate specialisations that enable fast and reliable spike propagation in their 
axon and terminals. PV basket cell axons contain unusually high densities of voltage-
gated Na+ and K+ channels in their axon, which allow for the transmission of high-
frequency action potentials with increased conduction velocity and with minimal 
delay (Hu & Jonas 2014). Their high expression of Na+ channels and prominent 
expression of Kv3 channels compensate for unfavourable morphological properties 
of PV axons - small diameter, extensive branching, high density of boutons (Hu et al. 
2014). Na+ channels in PV cell axons preferentially contain Nav1.1 and Nav1.6 
subunits, although the contribution of other subunits is also present (Ogiwara et al. 
2007; Lorincz & Nusser 2008). Loss-of-function mutations in the SCN1A gene 
encoding Nav1.1 in mice – which is found exclusively in GABAergic interneurons - 
results in the development of epileptic seizures within the first postnatal month 
(Ogiwara et al. 2007), further supporting the importance of Na+ channels in PV cell 
function. 
PV basket cells have been shown to exhibit a distinct distribution of Na+ channels: 
their density increases from the soma to the proximal axon in a stepwise fashion, 
followed by a further gradual increase into the distal axon, where the Na+ 
conductance density has been reported to be around 600 pS µm-2 (Hu & Jonas 2014). 
Thus, PV cells confer a weakly excitable somatodendritic domain and a highly 
excitable axonal domain connected by a steep transition zone. It has been speculated 
that approximately 99% of all Na+ channels are located in the PV cell axon (Hu et al. 
2014). Hence, the means of excitability in PV cells is essentially axonal, which again 
highlights the rationale of expressing such a high density of Na+ channels in the 
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axonal membrane. Although experiments and simulations indicate that the density of 
Na+ channel expression is greater than the critical value required for action potential 
propagation reliability (calculated to be around 200 pS µm-2), it has been suggested 
that this ‘supercritical’ value ultimately increases action potential propagation speed 
and maximum frequency (Hu & Jonas 2014).  
In addition to expression in other regions, Kv3 channels have also been shown to be 
expressed in PV cell terminals, suggesting additional roles that these rapidly 
activating/deactivating channels play in neurotransmitter release. As well as keeping 
action potentials brief, synaptically localised Kv3 channels limit Ca2+ influx into the 
presynaptic terminal and decrease the release probability (Goldberg et al. 2005). 
Blocking Kv3 channels with low concentrations of TEA enhanced PV-cell spike-
evoked GABA release onto neocortical pyramidal cells nearly twofold, and reduced 
the paired pulse ratio (PPR) (Goldberg et al. 2005). Furthermore, the large effects of 
TEA were absent in Kv3 knockout mice, spike-evoked GABA release was larger, 
and the PPR was reduced compared to wildtype mice (Goldberg et al. 2005). Thus, it 
is likely that Kv3 channels in PV cells keep action potentials brief, thus limiting Ca2+ 
influx and hence release probability, resulting in fast and synchronous transmitter 
release (Hu & Jonas 2014). 
PV cells have special adaptations facilitating fast, reliable, efficient and temporally 
precise transmitter release. Whereas several types of synapses use combinations of 
P/Q-, N-, and R-type Ca2+ channels for transmitter release, PV cells rely exclusively 
on P/Q-type Ca2+ channels (Zaitsev & Povysheva 2007), which comprise faster 
kinetics (Li et al. 2007), and maintain tight nanodomain coupling between Ca2+ 
influx and transmitter release (Bucurenciu et al. 2008). The fast gating of P/Q-type 
channels results in minimal synaptic delay and enhanced temporal precision of 
transmitter release while their tight coupling with release sensors of exocytosis 
additionally boosts the efficacy of release. Furthermore, only a small number of Ca2+ 
channels are required for GABA release (Bucurenciu et al. 2010), which may help 
prevent the broadening of presynaptic action potentials, resulting in fast and 
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temporally precise transmitter release. Moreover, a subset of cortical and 
hippocampal PV cells employ synaptotagmin 2 as a release sensor instead of 
synaptotagmin 1, which is predominantly used in principal neurons (Sommeijer & 
Levelt 2012; Kerr et al. 2008). Synaptotagmin 2 displays the fastest Ca2+-binding 
kinetics across the synaptotagmin family which further highlights specialised 
mechanisms that result in rapid PV cell signalling (Xu et al. 2007). 
Finally, in addition to functional specialisations that exist within PV basket cells, the 
GABAergic synapses that they create with principal cells and other PV basket cells 
are also important in maintaining rapid signalling as well as network synchrony. 
Synapses made from PV basket cells onto the somata of pyramidal cells have been 
shown to have a much higher density GABAA receptors containing the a1 subunit 
compared to synapses from non-PV cells (Klausberger et al. 2002). Furthermore, 
synapses interconnecting PV basket cells also contain high densities of a1 subunit-
containing receptors (Klausberger et al. 2002). These synapses exhibit faster IPSC 
decay kinetics which not only contributes to fast and precise signalling at the cellular 
level, but also in the regulation of fast postsynaptic conductance changes required for 
the generation of oscillatory activity in the network (Bartos et al. 2002; Galarreta & 
Hestrin 2002). 
1.3.5 Targeting PV cells to increase their excitability 
The proper function of PV cells in the healthy brain clearly relies upon a multitude of 
properties enabling the execution of fast, efficient, and temporally precise 
GABAergic transmission (Table 1.1), as previously discussed. These comprise 
functional specialisations along the entire somatodendritic axis including both input 
and output synapses that serve to maximise the speed of PV cell signalling. With the 
aim of increasing their excitability, a suitable target is therefore required to induce a 
functional change in PV cells to enable them to fire with higher probability. Given 
the intrinsic properties that enable PV cells to fire so quickly in the first place (Table 
1.1), there would be little reason to specifically target them as they are already  
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Property Functional consequence Molecular mechanism 
Fast and brief EPSCs Rapid EPSP time course; 
coincidence detection 
GluA1 and GluA4 
AMPA receptor subunits, 
TASK-like channels 
(low input resistance) 
 




GABAA receptor with 
a1-containing subunits 
High density of Na+ 
channels in axon 
(fast recovery from 
inactivation) 
 






Perisomatic K+ channels 
(fast deactivation, high 
activation threshold) 
 
Brief action potentials; 
fast-spiking action 
potential phenotype 
Kv3.1 and Kv3.2 
Dendritic K+ channels 




sensitivity to distributed 
inputs 
Kv3.1 and Kv3.2 
K+ channels in AIS 
(low activation threshold, 
slow gating) 
 
Filters out slow events 
suppressing firing 
Kv1 
Fast presynaptic Ca2+ 
channels 
Speed and temporal 




Tight coupling between 
presynaptic Ca2+ channels 
and release sensors 
 
Speed and temporal 
precision of GABA 
release 
Not known 
Fast release sensors Speed and temporal 




Table 1.1 Summary of fast signalling properties of PV cells Table adapted from 




functioning at full capacity. For example, it would be impractical to increase the 
output of voltage-gated Na+ or K+ channels in PV cells. Firstly, both channel 
populations already inactivate very slowly during sustained stimulation. Secondly, 
Na+ channels are already designed to rapidly recover from inactivation, and K+ 
channels have fast deactivation kinetics. Finally, a ‘supercritical’ density of Na+ 
channels in the axon ensures rapid and reliable action potential propagation. Hence, 
increasing the number or function of these channels would not be an effective 
method of increasing the overall excitability of PV cells as they are already operating 
at a high capability. 
Teasing out properties that could impede the overall excitability of PV cells would 
instead be a better approach to increase the basal firing of PV cells and boost their 
excitability. Given that PV cells express leak K+ channels mediated by Kir2 
subfamily inward rectifier K+ channels and TASK subfamily two-pore K+ channels 
(Goldberg et al. 2011; Okaty et al. 2009), one possible method of selectively 
increasing the excitability of PV cells focuses on targeting part of the leak K+ 
conductance. This prominent background conductance, present in both excitable and 
non-excitable cells – although most non-PV cells will express other two-pore K+ 
channels instead of the TASK subfamily - is a major factor in the maintenance of the 
negative resting membrane potential (RMP) of all neurons in the brain. The 
magnitude of the RMP is determined by the equilibrium potentials for all permeant 
ions and their relative conductances through the membrane. In most neurons, K+ 
governs the background conductance which drives the RMP towards the K+ 
equilibrium potential (EK), while the influences of other permeant ions (such as Cl-, 
Na+ and Ca2+) move the RMP away from EK. Thus, due to the electrochemical 
gradient of K+ across the membrane, the blockade of a leak K+ channels will prevent 
the efflux of K+, thereby resulting in membrane depolarisation. The blockade of leak 
K+ channels could therefore be a useful method of increasing the excitability of PV 
cells. Blocking part of the K+ leak conductance would result in the depolarisation of 
the RMP, thereby increasing electrical activity and enhancing calcium entry to 
provoke transmitter release. Although leak K+ channels belong to large family that 
are expressed in all cell types within the brain, the specific targeting of a subset of K+ 
49 
 
channels exclusive to PV cells should only result in membrane depolarisation in the 
PV cell population. 
In addition to membrane depolarisation, blocking a subset of leak K+ channels will 
also increase the membrane resistance of the cell. This could have a substantial effect 
on the integration of synaptic inputs because postsynaptic potentials will be 
amplified. An increase in input resistance not only increases the amplitude, but also 
the duration of EPSPs that the cell receives, thereby increasing the time window for 
temporal summation of inputs. Thus, blocking the leak K+ conductance incorporates 
two mechanisms that boosts the excitability of the cell: First, the combined effect of 
passive membrane depolarisation (via the preventability of K+ efflux) and larger 
amplitude EPSPs (due to higher input resistance) will bring the cell closer to firing 
threshold. Second, the increase in input resistance will increase the membrane time 
constant of the cell, widening the window for temporal summation, consequently 
increasing the likelihood of action potential generation in response to multiple inputs. 
1.3.6 Two-pore-domain K+ channel family 
Mammalian K+ channels form the largest and most diverse ion channel family in the 
genome, with almost 80 separate genes encoding the principal pore-forming subunits 
(Wei et al. 2005; Gutman et al. 2005; Kubo et al. 2005; Goldstein et al. 2005). These 
subunits can be divided into four major structural classes comprising either two or 
four transmembrane segments, which relate to inwardly rectifying (Kir) and two-pore 
domain (K2P) K+ channels (Kubo et al. 2005; Goldstein et al. 2005), respectively; or 
six transmembrane segments, constituting voltage-gated (Kv) and Ca2+-activated 
(KCa) K+ channels (Gutman et al. 2005; Wei et al. 2005). All K+ channels share a 
common conserved pore loop motif called the P domain, which establishes part of 
the K+ conduction pathway, however the number of P domains vary between the 
distinct classes. Kir channels, which contain a single P domain and are formed of 




influence the RMP (Kubo et al. 2005). Kv and KCa channels, which similarly contain 
a single P domain and consist of tetramers, are predominantly activated at 
depolarised potentials, and mediate the repolarisation phase of the action potential 
(Gutman et al. 2005; Wei et al. 2005). By contrast, K2P channels contain two P 
domains per one subunit stoichiometry forming functional channels as dimers (Fig 
1.6 A) (Goldstein et al. 2005). Each P domain is therefore flanked by two 
transmembrane segments which assemble in the membrane as dimers forming a K+-
selective pore. The leak activity of these channels contributes to the setting of the 
RMP and therefore reduce excitability (Goldstein et al. 2005). 
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The K2P channel family comprises fifteen distinct genes encoding pore-forming 
subunits (Goldstein et al. 2005), although their diversity is increased due to 
alternative splicing and translation initiation, heteromerisation and post-translational 
modifications that also take place (Feliciangeli et al. 2014). K2P channel subunits are 
further divided into six main groups that display similar molecular architecture: 
TWIK (Tandem of pore domains in a weak inward rectifying K+ channel); TREK 
(TWIK-related K+ channel); TASK (TWIK-related acid-sensitive K+ channel); 
TALK (TWIK-related alkaline-sensitive K+ channel); THIK (Tandem pore domain 
halothane-inhibited K+ channel); and TRESK (TWIK-related spinal cord K+ channel) 
(Feliciangeli et al. 2014). 
Theoretically, any K+ channel active near the RMP contributes to the background K+ 
conductance, and persistent activity of both voltage-gated (Kv) channels and 
inwardly rectifying (Kir) channels can indeed play a small part. Nonetheless, K2P 
channels, appear to be uniquely positioned to maintain a leak K+ conductance. In 
contrast to Kv channels, K2P channels display weak voltage dependence, as they lack 
a voltage sensor and are not gated by the membrane potential (Duprat et al. 1997; 
Lesage et al. 1996). They can produce non-inactivating currents over a wide range of 
membrane potentials, and a subset of the K2P family follows the Goldman-Hodgkin-
Katz constant field equation – which maintains ionic flux across the cell membrane 
as a function of transmembrane potential and ionic concentrations inside and outside 
of the cell. TASK-1 currents fit this equation well (Fig 1.6 B) (Duprat et al. 1997), 
whereas others display slightly inward or outward rectifications, such as TWIK-1 
(Lesage et al. 1996) and TREK-1 (Fink et al. 1996), respectively. 
The pharmacology of K2P channels are unique as they are relatively insensitive to 
classical K+ channel blockers such as TEA, 4-AP and caesium (Lesage 2003); 
however, half of the fifteen known K2P channels have been demonstrated to be Ba2+ 
sensitive (Goldstein et al. 2005). Furthermore, K2P channels are responsive to a range 
of physical and chemical stimuli, including temperature, membrane stretch, acidosis, 
lipids and inhalational anaesthetics (Patel & Honoré 2001). Except for THIK and 
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TRESK, K2P channels are regulated by extracellular pH: TASK and TALK channel 
subfamilies are strongly inhibited by extracellular acidification (Duprat et al. 1997; 
Kang & Kim 2004), in addition to two TREK subfamily channels, TREK-1 and 
TRAAK (Sandoz et al. 2009). TWIK-1 also exhibits a marked sensitivity to 
extracellular acidification although with a very different effect: instead of 
terminating ion flow at acidic pH, the channel reversibly switches selectivity to Na+, 
demonstrating a unique dynamic ion selectivity mechanism (Chatelain et al. 2012). 
Sensitivity to pH is mediated by a positively charged histidine residue in the P1 
domain of TASK-1 (Fig 1.6 A) (Morton et al. 2003) and TASK-3 (Yangmi Kim, 
Hyoweon Bang 2000) and by a basic residue in the 4th transmembrane segment 
projected towards the P2 domain of TALK channels (Niemeyer et al. 2007). The pH 
sensor in TREK-1 is mediated by a histidine residue in the extracellular loop 
preceding the first P domain (Sandoz et al. 2009). 
1.3.7 The modulation of PV cells via TASK and TREK 
With the aim of modulating PV cells to increase their excitability, it is necessary to 
distinguish specific leak K+ channels that substantially contribute to the background 
conductance so that their blockade will produce a convincing effect. In the mouse 
cortex, PV cells undergo a dramatic developmental transition both molecularly and 
electrophysiologically during the second and third postnatal weeks (Goldberg et al. 
2011). During this time period, the high frequency discharge pattern that defines PV 
cells emerge, driven by the expression of specialised Kv3.1 channels. This is 
paralleled by a reduction in PV cell input resistance, thought to be induced by the 
developmentally regulated expression of K2P and Kir channels (Goldberg et al. 2011). 
As numerous channels exist within these two families, the elucidation of a specific 
target is therefore required to generate a change that should significantly increase the 
input resistance and depolarise PV cells closer to firing threshold. 
Recent studies looking at electrophysiological, pharmacological and molecular 
properties indicate that distinct subfamilies of leak K+ channels are responsible for 
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K+ leak conductances in PV cells. For a start, the application of Ba2+ (which blocks 
half of the K2P channel family in addition to Kir channels) has been demonstrated to 
block at least part of the linear leak current in PV cells putatively mediated by K2P 
channels, in addition to the blockade of a strong inwardly rectifying current in PV 
cells, suggesting the presence of both K2P and Kir channel families in the background 
conductance (Goldberg et al. 2011). In spite of this, various Ba2+-sensitive K2P 
channels are known not to be responsible for the background conductance in cortical 
neurons and can therefore be excluded: THIK-1 has been reported to be blocked by 
Ba2+ in heterologous expression systems however appears not to be expressed in the 
neocortex (Rajan et al. 2001), and is therefore an unsuitable target. Similarly, TALK-
1 and TALK-2 are sensitive to Ba2+, but are essentially blocked at physiological pH, 
and are expressed specifically in the pancreas. While Ba2+-sensitive TWIK-1 appears 
to be markedly expressed in PV cells during development (Fig 1.7), and is known to 
be expressed in the brain (Lesage et al. 1996; Goldberg et al. 2011), it is not known 
whether it is active in the membrane due to post-translational modifications of 
TWIK- 1 channels (Rajan et al. 2005). This process known as sumoylation is 
conserved from yeast to humans, and results in the covalent modification and 
inactivation of TWIK-1 channels by small ubiquitin-related modifier proteins (Rajan 
et al. 2005). 
TASK and TREK channels however may represent a subfamily of K2P channels that 
make a significant contribution to the K+ leak conductance in PV cells. These 
channels, known to be expressed in various tissues including the brain (Goldstein et 
al. 2005), are sensitive to Ba2+, and are strongly inhibited by extracellular pH as well 
as to the anaesthetic bupivacaine (Kindler et al. 1999; Leonoudakis et al. 1998). 
Moreover, TASK-1 expression has been shown to increase developmentally in 
cortical PV cells using microarrays (Okaty et al. 2009). Furthermore, qPCR data 
from fluorescence-activated cell sorting (FACS) of PV cells in mice reveal a high 
abundance of TASK-1 and TASK-3 mRNA expression in the neocortex, which 
increases between P10 and P18 (Fig 1.7) (Goldberg et al. 2011). Interestingly, this 
increase in expression correlates with a negative shift in the RMP as well as with a 
decrease in input resistance during the same time period (Goldberg et al. 2011), 
54 
 
consistent with the properties of a developing leak K+ channel. The input resistance 
and membrane time constant in PV cells are also increased in TASK-1/3 double 
knockout mice (Goldberg et al. 2011), further demonstrating a role of TASK 
channels in the background conductance in PV cells. Immunolabeling also indicates 
an increase in TASK-1 protein expression in PV cells throughout early development 
(Okaty et al. 2009). Similarly, TREK-1 is also expressed in the neocortex (Talley et 
al. 2001), although qPCR data indicate that mRNA transcripts are reduced between 
P10 and P18 (Fig 1.7) (Goldberg et al. 2011). 
TASK, and to a lesser degree TREK channels, could therefore represent suitable 
targets for the modulation of PV cells. Both channels directly regulate the RMP in 
heterologous expression systems (Kindler et al. 1999; Leonoudakis et al. 1998), 
indicating that these channels are well established as background leak channels. The 
molecular profile of TASK channels in PV cells in addition to pharmacological 
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evidence of a K2P or TASK-like background conductance in PV cells as well as the 
physiological effect of ablating TASK in mice makes these channels an ideal target. 
TASK-1 is known to dimerise with TASK-3, forming TASK-1/3 heterodimers 
(Goldstein et al. 2005), so it would be appropriate to block these channels with a 
blocker specific for both TASK-1 and TASK-3. 
1.3.8 TASK-1/3 and TREK-1 pharmacology 
This thesis represents the first study to analyse the functional effects of blocking 
TASK-1/3 and TREK-1 channels in PV cells using specific K2P blockers. Three 
distinct structurally unrelated TASK-1/3 blockers were used in experiments 
throughout the thesis (Fig 1.8). These blockers were provided by Eli Lilly and 
Company (Surrey, UK) and include: A293 (2-(Butane-1-sulfonyl-amino)-N-[1-(R)-
(6-methoxypyridin-3-yl)-propyl]-benz-amide) (Decher et al. 2011); A1899 (2’-{[2-
(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid 2, 4-difluoro- 
benzylamide), which acts as an open channel blocker that binds to the 2nd and 4th 
transmembrane segments forming the central cavity of the channel; (Streit et al. 
2011); and compound 23 (1-{1-[6-(biphenyl-4-ylcarbonyl)-5,6,7,8-
tetrahydropyrido[4,3-d]-pyrimidin-4-yl}propan-1-one) (Coburn et al. 2012). 
Two TREK-1 channel blockers were used in experiments. They include: amlodipine 
– which is also a classic L-type Ca2+ channel blocker but blocks TREK-1 with much 
higher affinity; and spadin – which is a peptide based on a secreted propeptide as a 
result of the maturation of the neurotensin receptor 3/sortillin protein, which is 











1.3.9 Aims of this thesis 
The overall aim of the thesis is to increase the excitability of PV cells and thus, 
increase the probability of action potential firing. If successful, this novel approach 
of modulating PV cells could be used as a treatment for neuropsychiatric disorders 
linked to PV cell abnormalities. TASK-1/3 and TREK-1 channels were blocked in 
PV cells in the attempt to depolarise the RMP and increase the input resistance. 
Mechanistically, depolarising the cell will bring the cell closer to firing threshold, 
while increasing the input resistance will increase the amplitude and duration of 
EPSPs that the cell receives, which could summate and drive the cell to fire.  
Direct recordings of PV cells were performed to test whether TASK-1/3 and TREK-
1 blockade increased PV cell output and intrinsic excitability. The output of PV cells 
was assayed using the thalamocortical circuit (see section 3.2.1). Intrinsic excitability 
of PV cells was measured based on changes in the RMP and input resistance, and 
probability of action potential firing. The following chapters test whether TASK-1/3 
blockade (chapter 3) and TREK-1 blockade (chapter 4) increases the excitability of 
PV cells. 
Chapter 3: The effect of TASK-1/3 blockade on PV cell excitability 
















2.1 Animals and Cell Lines 
2.1.1 Housing and Breeding 
All animals were housed and maintained in a facility that was subject to 12 hr 
light/dark cycles with ad libitum access to food and water. All procedures were 
treated in accordance with UK Home Office regulations. 
2.1.2 Generation of PV/EYFP mice 
PV/EYFP mice were created by crossing a female PV-Cre knockin mouse 
(Hippenmeyer et al. 2005) with a male Rosa26EYFP mouse (Srinivas et al. 2001). 
The PV-Cre knockin allele from the female contains the endogenous parvalbumin 
promoter which directs Cre recombinase expression in parvalbumin-expressing 
neurons. The R26-stop-EYFP allele from the male contains an Enhanced Yellow 
Fluorescent Protein gene (EYFP) inserted into the ubiquitously expressed 
Gt(ROSA)26Sor locus (Friedrich & Soriano 1991). Expression of EYFP is halted by 
an upstream loxP-flanked STOP sequence. When crossed together, the STOP 
sequence is deleted exclusively in parvalbumin-expressing neurons, yielding EYFP 
expression only in this cell type. Mice homozygous for both PV-Cre and EYFP were 
maintained for breeding. Both male and female mice were used in experiments. 
2.1.3 Genotyping 
Animal tissue was collected from ear clips and genotyped in order to select between 
the littermates to produce PV/EYFP mice: 
DNA was extracted using the Hot Shot method: Tissue samples were digested in 600 
µl NaOH (50 mM) at 100ºC for 45 min and then neutralised with 50µl Tris-HCl (1 
M, pH 8) at 100ºC for a further 2 min. Samples were centrifuged at 13,000 x g for 20 
min and subsequently stored at 4ºC. DNA was present in the supernatant. 
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Each polymerase chain reaction (PCR) contained 12.5 µl of Promega GoTaq master 
mix, 10.5 µl ddH2O, 1 µl of total primers (300 nM) and 1 µl of extracted DNA. 
Thermocycling conditions are summarised in Table 2.1. PCR products were run on a 
1.5% agarose gel with SYBR Safe DNA gel stain at 100 V for 45 min with a 1 kb 
DNA ladder. 
For the Cre reaction, two sets of primer pairs were used: Cre537 (5’ – CCA CGA 
CCA AGT GAC AGC AAT G – 3’), Cre538 (5’ – AAG TGC CTT CTC TAC ACC 
TGC G – 3’), which amplifies the 350 bp product of Cre; and Beta-globin forward 
(5’ – CCA ATC TGC TCA CAC AGG ATA GAG AGG GCA GG – 3’), Beta-
globin reverse (5’ – CCT TGA GGC TGT CCA AGT GAT TCA GGC CAT CG – 
3’), which amplifies the control 150 bp band for Beta-globin. 
For EYFP, two separate reactions were required, one for the WT allele and one for 
the mutant allele: Both reactions utilised a common forward primer R26WTF (5’ – 
AAA GTC GCT CTG AGT TGT TAT – 3’); in conjunction with either the WT 
reverse primer R26WTR (5’ – GGA GCG GGA GAA ATG GAT ATG – 3’), or the 
mutant reverse primer R26KOR (5’ – GCG AAG AGT TTG TCC TCA ACC – 3’). 
A large 550 bp or small 250 bp band indicated that at least one of the alleles was WT 
or mutant, respectively. 
Table 2.1 Thermocycling conditions for Cre and EYFP genotyping 
 Cre EYFP 
Step Temperature (ºC) Duration Temperature (ºC) Duration 
1 95 5 min 94 15 min 
2 95 30 s 94 30 s 
3 58 30 s 59 45 s 
4 72 30 s 72 2 min 
5 Repeat steps 2-4 30X Repeat steps 2-4 37X 
6 72 5 min 72 10 min 




2.1.4 Expressing TASK-3 in HEK cells 
For TASK-3 channel recordings, human embryonic kidney 293 cells (HEK-293) 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) with 10% foetal calf 
serum and 1% ampicillin. The cells were passaged twice weekly and placed onto 
cover slips precoated in poly-D-lysine (0.05 mg/ml) to assist in binding. The density 
of cells on the coverslips were approximately 10-30% on the day of recording. 
Mouse TASK-3 cDNA constructs were kindly provided by Prof Mathew Nolan. 
HEK-293 cells were transfected with TASK-3 cDNA using Lipofectamine 
(Thermofisher). Plasmids containing the TASK-3 construct under the control of a 
CAMK2 alpha promoter sequence allowed for TASK-3 to be expressed when 
exposed to the transcription machinery native to HEK-293 cells. 500 ng of DNA was 
added to each well of a 24 well plate, each containing a coverslip with HEK cells 
submerged in culture media described above. For each well, plasmids containing the 
TASK-3 construct and eGFP (enhanced green fluorescent protein) were combined 
with 25 µl opti-MEM (Thermofisher) before being added to another 25 µl opti-MEM 
containing 2 µl lipofectamine. This transfection mix was left at room temperature for 
20 min. 50 µl of the transfection mix was subsequently added dropwise to each well 
containing the HEK cells and left to transfect for 2-5 hours. The transfection mix was 
subsequently replaced with fresh media. Recordings were made 24-72 hours after 
transfection. HEK-293 cells transfected with TASK-3 were identified by eGFP 
expression (excitation at 470 nm). Recordings from TASK-3-trasfected cells were 
interleaved with recordings from untransfected HEK-293 cells, which underwent the 








All chemicals and compounds were obtained from Sigma Aldrich (St Louis, MO, 
US), Abcam (Cambridge, UK), Tocris (Bristol, UK) or Eli Lilly and Company 
(Surrey, UK). 
Table 2.2 External solution composition 
 Sucrose based cutting solution 
(mM) 
Recording aCSF solution 
(mM) 
NaCl 80 130 
KCl 2.5 2.5 
NaH2PO4 1.25 1.25 
NaHCO3 25 25 
Glucose 10 10 
Sucrose 90 - 
CaCl2 0.5 2.5 
MgSO4 4.5 1.5 
All solutions were equilibrated with 95% O2, 5% CO2 to stabilise the pH to 7.4. CO2 








Table 2.3 Internal patch pipette solution composition 
 CsMeSO3 based internal (mM) KMeSO3 based internal 
(mM) 
Cs/KMeSO3 135 135 
NaCl 8 8 
Mg-ATP 4 4 
Na-GTP 0.3 0.5 
HEPES 10 10 
EGTA 0.5 0.5 
QX 314 5 - 
Solutions were adjusted to pH 7.3 with CsOH (for CsMeSO3 based internal) or KOH 
(for KMeSO3 based internal) and adjusted to have an osmolarity of 295 mOsm.L-1 
by adding water if required. 
2.2.2 Drugs 
All drugs were prepared into stock solutions (1000X). All TASK channel blockers 
were provided by Eli Lilly and Company (Surrey, UK). Final concentrations of most 










Table 2.4 Drugs dissolved in recording aCSF solution 
 Drug (Supplier) Final Concentration 
µM (Solvent) 
TASK channel blockers A293 (Eli Lilly) 10 (DMSO) 
A1899 (Eli Lilly) 1 (DMSO) 
Compound 23 (Eli Lilly) 3 (DMSO) 
TREK channel blockers Spadin (Tocris) 1 (H2O) 
Amlodipine (Abcam) 43 (H2O) 
Isolating TREK currents  CNQX (Abcam) 20 (H2O) 
D-APV (Abcam) 50 (H2O) 
Nifedipine (Abcam) 20 (DMSO) 
Picrotoxin (Sigma) 50 (DMSO) 
TEA (Abcam) 1000 (H2O) 
Two-pore potassium 
channel blocker 
Bupivacaine (Sigma) 100 (H2O) 
Cholinergic receptor 
agonist 
Carbachol (Abcam) 30 (DMSO) 
Bupivacaine blocks voltage-gated sodium channels as well as two-pore potassium 
channels. In experiments where bupivacaine was used, the voltage-gated sodium 
channel blocker QX314 (5 mM) was included in the pipette solution before 
bupivacaine application, so that its observed effects were mediated exclusively by 
blocking two-pore channels. 
In some control conditions, the pH of the recording aCSF solution was lowered to pH 
6.3 by reducing the concentration of NaHCO3. This reduces the concentration of 
HCO3- in the CO2/HCO3- buffer system resulting in an increase in acidity. 
2.2.3 Preparation of acute tissue slices 
Thalamocortical slices were prepared from male and female P20-26 mice (Fig 2.1) as 
described previously (Agmon & Connors 1991). Briefly, mice were anaesthetised 
65 
 
using isoflurane and decapitated. The brain was quickly removed and placed in ice-
cold (<4ºC) sucrose based cutting solution (Table 2.2). It was then cut at ~60º to the 
midline - angled at 10º from the dorsal-ventral axis - and glued to a vibrating 
microtome stage on the cut surface. 500 µm slices (unless specified otherwise) were 
cut in ice-cold sucrose based cutting solution using a Leica VT1200 microtome 
(Leica, UK) and transferred to a submerged storage chamber where they were 
maintained in the same solution at 35ºC for 30 min. Slices were allowed to recover 
for at least 30 min at room temperature before the start of experiments. In a subset of 
experiments, horizontal hippocampal slices were prepared in identical conditions. 
2.2.4 Whole-cell patch clamp recordings 
Slices were transferred to a submerged recording chamber and perfused with aCSF 
solution (Table 2.2) at a rate of 4-5 ml/min and maintained at 31ºC. Cells were 
visualised with a 40X objective with infrared differential interference contrast optics 
(Q Imaging, BC, Canada) on a Scientifica Slicescope (Scientifica, UK). Patch 
pipettes (3-5 MΩ) were made from boroscillate glass capillaries (Harvard Apparatus, 
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UK) using a P-97 Flaming Brown micropipette puller (Sutter Instrument Company, 
CA, USA) and filled with internal solution (Table 2.3). 
Signal waveforms were amplified and lowpass filtered at 4 kHz with a Multiclamp 
700B amplifier (Molecular Devices, CA, USA), digitized at 10 kHz using a 
Micro1401 (Cambridge Electronic Design Limited, UK) and stored on a computer 
using Signal 4 (Cambridge Electronic Design Limited, UK). Firing patterns were 
filtered at 10 kHz and digitized at 40 kHz. Amplifier gain was set at 5 unless stated 
otherwise. 
Whole-cell recording configuration was established once an appropriate neuron was 
identified. Following the application of positive pressure, a motor micromanipulator 
(PatchStar, Scientifica, UK) was used to lower the recording electrode to approach 
the cell. Positive pressure was released when both a dimple was observed on the cell 
surface and when there was an increase in pipette resistance, measured with a -5 mV 
square test step function at 10 Hz in Signal 4. Gradual negative pressure was applied 
until a GΩ seal was obtained, and pipette capacitance was compensated. The cell 
membrane was then ruptured which was demonstrated by the emergence of large 
capacitive transients in response to the test pulse. Recordings were only acquired 
from cells with a series resistance <25 MΩ and that required a holding current less 
negative than -100 pA when voltage clamped at -70 mV, or with a resting membrane 
potential (RMP) more negative than -60 mV for current clamp experiments. 
2.2.5 Thalamocortical recordings 
A 2.5X objective was used to identify layer IV barrels in the somatosensory cortex 
and ventrobasal thalamus (VB), and to allow quick and easy movement of the 
electrodes. In order to detect a robust thalamocortical connection, a bipolar 
stimulating electrode was initially placed in the VB and an extracellular recording 
electrode placed outside a layer IV barrel. The recording electrode was filled with 
NaCl (2 M) and broken at the tip to enable better electrical access to the extracellular 
space. Reliable thalamocortical input was achieved by stimulating different areas 
within the VB and measuring field EPSPs just outside each barrel with the recording 
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electrode until a field potential of >0.1 mV was established, indicating a strong 
connection. Amplifier gain was set at 100 during field recordings to increase signal 
sensitivity. 
Once a good thalamocortical connection was found around a specific barrel, the 
extracellular recording electrode was removed and replaced with a patch pipette 
filled with CsMeSO3 based internal (Table 2.3). Stellate cells were located and 
patched within the same barrel. Whole-cell synaptic currents were measured in 
voltage clamp, in response to thalamic excitation. 
Afferent fibres were electrically stimulated, subsequently activating PV cells in the 
layer IV barrel, and in turn, transmitting disynaptic feed-forward inhibition onto local 
stellate cells. Thalamocortical feedforward IPSCs were evoked at a frequency of 0.1 
Hz and recorded in the stellate cell clamped at the glutamatergic reversal potential 
(+5 mV). The amplitude of the IPSC was calculated by subtracting the steady-state 
holding current from the peak of the IPSC. In multiple stimulation experiments, a 50 
Hz triplet of three IPSCs were elicited at 0.1 Hz. 
The stimulation intensity was adjusted so that the amplitude of feedforward IPSCs 
ranged between 200 pA and 2000 pA. This was to ensure that the strength of 
stimulation was large enough to recruit several PV cells to fire, yet weak enough to 
prevent saturation of PV-mediated inhibition. Activating several but not all PV cells 
allowed for the possibility to recruit near-threshold PV cells – in addition to the PV 
cells activated from baseline period – during the time course of the experiment. As 
such, an increase in the number of PV cells firing in response to thalamocortical 
stimulation would translate to an increase in the amplitude of the feedforward IPSC 
which can therefore be measured (Fig 3.1 A). 
2.2.6 PV cell recordings 
PV cells were identified by YFP fluorescence. To excite YFP, an X-Cite 120Q 
illuminator (Excelitas Technologies Corp, Waltham, MA, US) was used with a filter 
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(Chroma Technology Corp, Bellows Falls, VT, US) with excitation/emission 
wavelength 500/530 nm. 
Thinner 300 µm thalamocortical slices were prepared in order to help distinguish 
fluorescent PV cells from other non-PV cells. Whole-cell recordings were performed 
using KMeSO3 based internal (Table 2.3) in current clamp configuration. Recorded 
cells displayed a fast-spiking phenotype typical of PV cells. These included non-
accomodating, non-adapting trains of action potentials during depolarising current 
steps, occasionally interrupted by intervals with subthreshold oscillations, notably 
around threshold. In addition to this, they exhibited deep afterhyperpolarising 
potentials (AHPs) and had a maximum firing frequency of >120 Hz in response to 
strong current steps. 
2.2.7 Measuring RMP, IR and action potential firing in PV cells 
10, 250 ms current steps, in 1 s sweeps, were delivered every 30 s to PV cells. The 
first step was hyperpolarising, with the following steps incrementally depolarising. 
The current step amplitude was adjusted so that each set of depolarising steps both 
contained subthreshold and suprathreshold firing. The input resistance was obtained 
from the average of 4 hyperpolarising steps, 5 s apart, that were interleaved between 
each set of the 10 current steps described above. This allowed for a more accurate 
input resistance measurement. 
The RMP (Vm) was the average potential during the first 50 ms of the first sweep 
before any current step was injected. Input resistance (Rin) was calculated using 
Ohm’s law (Rin = ∆V / I) by subtracting Vm during the last 50 ms of the 
hyperpolarising current step from Vm during the preceding 50 ms to the step, and 
dividing it by the injected current. Rin was determined from the average of 4 traces. 
The number of action potentials per 250 ms was plotted against injected current. 
Rheobase was classified as the first current step to elicit at least one action potential. 
Action potential threshold was determined from a membrane potential change greater 
than 30,000 mV.s-1.  
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2.2.8 Whole-cell TREK currents in PV cells 
TREK currents were analysed in relation to their current-voltage function. To isolate 
TREK currents, synaptic blockers and ion channel blockers were added to the 
recording aCSF solution (Table 2.4). Whole-cell recordings were performed using 
CsMeSO3 based internal (Table 2.3) in voltage clamp configuration. 14, 500 ms 
voltage steps (-90 mV to +40 mV, ∆10 mV) were injected into PV cells from a 
holding voltage of -70 mV, followed by a 500 ms ramp (-90 mV to +40 mV) in the 
final. The duration of each sweep was 1 s. Data were normalised to the current 
response at  +40 mV for analysis. 
The gradient of the current-voltage relationship in response to voltage ramps was 
determined from the positive voltage range between +30 mV to +40 mV. The 
rectification index of the measured current was calculated by dividing the 
conductance at +40 mV by the conductance at -90 mV. The conductance was 
calculated by the following equation: I / Vm – Erev where I = normalised current, Vm 
= membrane voltage and Erev = reversal potential of current response. 
2.2.9 Hippocampal gamma oscillations 
The cholinergic agonist carbachol was used to trigger synchronous rhythmic 
oscillations in pyramidal cells in the CA3 region of the hippocampus (McMahon et 
al. 1998). To induce gamma oscillations in hippocampal slices, carbachol (30µM) 
was added to the aCSF solution (Table 2.2) and perfused at a rate of 10-12 ml/min. A 
high flow rate allowed for an increased oxygen supply to the slices to induce the 
network activity (Hájos et al. 2009). 
An extracellular recording electrode was placed into the pyramidal cell layer in CA3 
of the hippocampus. Gamma power (35-50 Hz) was computed using Signal 4. 
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2.2.10 Data analysis 
All recordings were normalised to baseline values. These data were averaged across 
groups and presented as means and the standard error of the mean (SEM; error bars). 
Comparisons between multiple means were carried out by ANOVA while 
comparisons between multiple means where there were several drug conditions 
within experiments were performed by repeated measures ANOVA (RM-ANOVA). 
Comparisons between two means were performed by two-tailed t-tests. The 
significance level used was p<0.05, and corrected for multiple comparisons using the 
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The balance between excitation and inhibition is essential for cortical function 
(Yizhar et al. 2011). This balance relies on the maintenance of appropriate ratios of 
excitatory and inhibitory synaptic inputs which are dynamically regulated throughout 
development and into adulthood (Maffei et al. 2006; Haider & McCormick 2009). 
GABAergic interneurons are the major cellular elements that control 
hyperexcitability in the brain, and consequently, many of the genes that regulate 
interneuron development and function have been linked to epilepsy (Dichter & Ayala 
1987). Furthermore, imbalances in cortical network activity as a result of disrupted 
interneuron function have been associated with other neurological disorders 
including schizophrenia and autism (Marín 2012). 
Knowledge of functional roles that interneurons play in the healthy brain should 
yield insight into the possible contribution of aberrant interneuron function to 
psychiatric diseases. Due to the large diversity of interneurons however, 
development of such knowledge has been challenging, with more than 20 different 
classes in the cortex alone (Markram et al. 2004). Nonetheless, growing evidence 
suggests that functional abnormalities particularly in PV cells are implicated in these 
diseases (Marin 2012, and see sections 1.2.8 and 1.2.9) These cells maintain fast, 
rhythmic inhibition through the generation of gamma oscillations to create narrow 
time windows for effective excitation, synchronising pyramidal cells to fire at precise 
oscillatory patterns (Bartos et al. 2007). This is essential for the integration of 
information between different brain regions, believed to underlie cognition, memory 
and behaviour. Thus, abnormalities in the function of PV cells may lead to 
desynchronisation across neuronal ensembles, resulting in deficits in working 
memory, attention and perceptual organisation found in schizophrenia and autism 
(Wang & Buzsáki 1996). 
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The ability to selectively modulate PV cells and increase their activity could be 
extremely useful as a treatment for patients with neuropsychiatric disorders. As PV 
cells have a distinctively low input resistance presumed to be mediated in part by 
TASK subfamily K2P channels (Goldberg et al. 2011), the blockade of these channels 
could therefore be applied to increase the basal activity of PV cells. Mechanistically, 
this would prevent the passive efflux of K+ through TASK channels, resulting in 
membrane depolarisation which would bring the cell closer to firing threshold. 
Additionally, their blockade would increase the input resistance which produces two 
effects: Firstly, an increase in input resistance will increase the depolarisation 
produced by a given inward current. Secondly, it will increase the membrane time 
constant which will widen the window for temporal summation of excitatory inputs. 
This chapter focuses on the effects of blocking TASK-1 and TASK-3 channels in PV 
cells predominantly in the mouse primary somatosensory cortex. Initially, the effects 
of TASK-1/3 blockers on the output of cortical PV cells were analysed using the 
thalamocortical circuit (Fig 3.1), where PV cell-mediated IPSCs can be reliably 
measured in voltage-clamped principal cells. Finally, the effects of TASK-1/3 
blockers on the intrinsic properties of PV cells were assessed using direct recordings 
of patch-clamped PV cells. 
3.2 Modulation of PV cell output using TASK channel blockers 
Two distinct TASK-1/3 channel blockers, A293 and compound 23 were used in an 
attempt to increase the intrinsic excitability of PV cells and subsequently increase the 
probability of action potential firing. In doing so, PV cells close to firing threshold 
that would have remained silent may therefore activate. When incorporated into the 
global network, an increase in firing will lead to an increase in the frequency of PV 
cell-mediated IPSCs. Moreover, the amplitude of feedforward inputs onto excitatory 
cells in response to sensory stimuli will be enhanced as more PV cells are recruited. 
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The amplitude of stimulus-evoked PV cell-mediated IPSCs can therefore be 
exploited to provide a suitable measure of network PV cell output as part of a circuit. 
3.2.1 Thalamocortical circuit as an assay of PV cell output 
In order to assess the effect of a drug on the activity of PV cells, a reliable assay of 
cell output is required. A conclusive method for analysing PV cell output lies within 
the thalamocortical network, and incorporates the barrel cortex, where the thalamus 
provides robust excitatory input to the neocortex (Daw et al. 2007; Cruikshank et al. 
2007). In the intact rodent brain, vibrissal sensory input from the thalamus contacts 
both excitatory and inhibitory neurons, predominantly in layer IV of the 
somatosensory cortex (Daw et al. 2007). This region of the cortex contains a precise 
topographic map of the whiskers, where each whisker input stimulates its 
corresponding layer IV barrel (Fox 2002). Thalamocortical input into layer IV has 
since been demonstrated to activate inhibitory interneurons more strongly than 
excitatory neurons, producing powerful feedforward inhibition (Cruikshank et al. 
2007). Importantly, PV cells are activated even more robustly than other 
interneurons, due to strong thalamocortical excitatory conductances, which allows 
them to fire before feedforward inhibition emerges in the recipient cells in layer IV 
(Cruikshank et al. 2010). Paired recordings in the barrel cortex demonstrated that 
unitary IPSCs from fast-spiking cells onto principal cells occurred without failures 
and produced similar decay kinetics to thalamically stimulated feedforward IPSCs, 
further supporting the role of PV cells as a primary mediator of thalamocortical 
feedforward IPSCs (Gabernet et al. 2005). Direct thalamocortical excitation of PV 
cells in vitro provides robust, disynaptic, feedforward inhibition onto excitatory 
stellate cells in the same barrel (Daw et al. 2007). 
PV cell-mediated IPSCs can therefore be accurately measured with very little 
contamination from other cell types. A bipolar stimulating electrode placed in the 
ventrobasal thalamus (VB) can be used to electrically stimulate afferent 
thalamocortical axons, activating PV cells in layer IV, and subsequently producing 
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GABAergic inhibition onto stellate cells in the same barrel (Fig 3.1 A). IPSCs can 
then be recorded from stellate cells voltage-clamped at the glutamatergic reversal 
potential. As the feedforward IPSCs are almost exclusively mediated by PV cells 
(Cruikshank et al. 2010), this assay is therefore a clean and reliable method for 
examining the output of PV cells as part of a circuit. 
3.2.2 Results 
Recordings were carried out using thalamocortical slices (P20-26) with identifiable 
layer IV barrels and a robust thalamocortical connection. Single disynaptic 
feedforward IPSCs were evoked, and recorded as outward currents in stellate cells 
voltage-clamped at the glutamatergic reversal potential in response to extracellular 
stimulation of the VB at 0.1 Hz (Fig 3.1 B). A stable 5 min baseline IPSC amplitude 
was obtained in all experiments before a TASK channel blocker was applied for 10 
min. 
In all experiments, it was imperative to stimulate the VB at a suitable intensity to 
recruit several but not all PV cells to fire (Fig 3.1 A). This was to ensure that a 
reliable feedforward IPSC was generated whilst allowing for the opportunity to 
recruit other PV cells that had initially failed to fire during baseline period, but were 
close to threshold. Thus, PV cells that may have been close to firing threshold in 
response to thalamocortical stimulation during the baseline period of experiments 
could then begin to fire during drug application if they became more excitable. The 
GABAergic inhibition transmitted from these newly recruited PV cells in addition to 
the GABAergic inhibition from the PV cells already activated during the baseline 
period would therefore summate and translate to an increase in IPSC amplitude in the 
stellate cell (Fig 3.1 A). On the other hand, if the drug had no effect on the 








Due to poor solubility of all TASK channel blockers in water, all drugs were 
dissolved in dimethyl sulfoxide (DMSO) yielding a final DMSO concentration of 
0.1% when dissolved in the recording solution. Trials were interleaved between drug 
application and DMSO (control), and their effect on IPSC amplitude was compared 
between the two groups. 
3.2.3 TASK-1/3 channel blockers have no effect on PV cell output 
The TASK-1/3 channel blocker A293 (Decher et al. 2011) was initially used in 
thalamocortical experiments. A293 has IC50s of 0.2 µM and 0.95 µM for TASK-1 
and TASK-3, respectively at heterologously expressed TASK channels in Xenopus 
oocytes (Putzke et al. 2007). 3 µM of A293 was therefore used in all experiments 
(approximately tenfold of the IC50 value for TASK-1 and threefold of the IC50 value 
for TASK-3) to ensure saturation of TASK-1/3 channels in the slice without inducing 
a non-specific effect on other channels. 
No difference in IPSC amplitude was detected between A293 and DMSO groups 
(Mean amplitude 5-10 min after application as a percentage of baseline 0-5 min 
before application, DMSO 85.1% ± 7.2, n=9 cells; A293: 101.1% ± 7.8, n=9 cells; 





3.2.4 TASK-1/3 channel blockers have no effect on PV cell output during 
multiple stimulation 
The assay so far has only examined PV cell output in response to single 
thalamocortical stimulation, however neurons in vivo typically receive multiple 
inputs at high frequency. The integration of these inputs depends upon the amplitude 
and duration of EPSPs that cells receive, which can summate and propagate to the 
soma, resulting in action potential firing. The duration of EPSPs is set in part by the 
time constant which sets the time window for temporal summation of inputs. Cells 
with a low input resistance will have a fast time constant and therefore EPSPs will be 
brief. By increasing the input resistance and therefore the time constant, the duration 
of EPSPs will increase, making them more likely to summate with temporally 
impeding inputs and result in action potential firing. Thus, repetitive stimulation of 
PV cells at high frequency would also examine changes in the amplitude of PV cell-
mediated IPSCs induced by changes in the integration of PV cell inputs. 
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As A293 failed to alter the amplitude of IPSCs in response to single thalamocortical 
stimulation, multiple stimulation at high frequency was then tested. This would elicit 
multiple EPSPs onto PV cells which could summate and result in action potential 
firing. Such an assay would then be sensitive to changes in the membrane time 
constant. An increase in the input resistance during TASK-1/3 blockade could 
increase the time constant of PV cells and therefore increase the time window for 
temporal summation of inputs. This would increase the amplitude and duration of 
EPSPs that PV cells receive, which could summate with subsequent EPSPs and drive 
the cells to fire. By stimulating PV cells repetitively at high frequency, the effects of 
blocking TASK-1/3 channels on the summation of multiple inputs can be examined.  
The VB was stimulated three times at 50 Hz, eliciting three IPSCs in the recorded 
stellate cell (Fig 3.3). PV cells that would normally have remained inactive could 
therefore be recruited during high-frequency stimulation, resulting in an increase in 
amplitude of subsequent IPSCs. Thus, PV cells that may have been close to firing 
threshold during the baseline period of experiments could then become excitable 
from the second or third thalamocortical stimuli. This would translate into an 
increased amplitude of the second or third IPSC recorded in the stellate cell, 
corresponding to the temporal stimuli responsible for exciting the PV cell. The 
amplitudes of all three IPSCs were analysed. 
All recordings were used for analysis of the 1st peak, however a subset of recordings 
was excluded from analysis due to failures in the 2nd and 3rd IPSCs during the first 5 
min baseline period of experiments. Out of the 20 cells recorded in total, 3 cells from 
DMSO and 4 cells from A293 groups were excluded from analysis of the 2nd and 3rd 
IPSCs in the triplet.  
No difference in the amplitude of any of the three IPSCs was detected between A293 
and DMSO groups (Mean amplitude 5-10 min after application as a percentage of 
baseline of respective IPSC 0-5 min before application. IPSC 1, DMSO: 82.0% ± 
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9.0; A293: 95.5% ± 8.5; p>0.99. IPSC 2, DMSO: 76.4% ± 11.4; A293: 111.9% ± 
12.3; p=0.18. IPSC 3, DMSO: 84.0% ± 31.6; A293: 75.6% ± 9.6; p>0.99. n=7 cells 
for DMSO, n=6 cells for A293, Two-way ANOVA with Bonferroni correction; Fig 
3.4). Similarly, no difference in the amplitude of the 1st IPSC in the triplet was 
detected between A293 and DMSO groups (Mean amplitude 5-10 min after 
application as a percentage of baseline of respective IPSC 0-5 min before 
application, DMSO: 80.7% ± 6.6, n=10 cells; A293: 98.4% ± 6.4, n=10 cells; 










Given the lack of an effect of A293 on the amplitude of IPSCs, other structurally 
unrelated TASK-1/3 channel blockers were tested. The drug compound 23 has been 
demonstrated to be a more specific and much more potent TASK-1/3 channel 
blocker than A293 (Coburn et al. 2012). Although the mechanism for blocking 
TASK-1/3 channels is not fully understood in both agents, they are structurally 
dissimilar from each other (see section 1.3.8), and therefore offer alternative 
approaches in blocking TASK-1/3 channels. This would help verify the results 
observed with A293. Compound 23 has IC50s of 0.3 µM and 0.035 µM for TASK-1 
and TASK-3, respectively (Coburn et al. 2012). 3 µM of compound 23 was used in 
all experiments (tenfold of the IC50 value for TASK-1 and a hundredfold of the IC50 
value for TASK-3). This increase in potency was to assure that all TASK-1 and 
TASK-3 channels were completely blocked. 
Compound 23 equally failed to influence PV cell output in response to stimulation at 
50 Hz (Fig 3.5). Again, none of the three IPSCs in the triplet were altered by the 
more potent TASK-1/3 channel blocker between drug and DMSO (Mean amplitude 
5-10 min after application as a percentage of baseline of respective IPSC 0-5 min 
before application. IPSC 1, DMSO: 88.3% ± 7.6; Compound 23: 87.4% ± 5.1; 
p>0.99. IPSC 2, DMSO: 79.6% ± 36.6; Compound 23: 85.5% ± 15.0; p=0.18. IPSC 
3, DMSO: 105.9% ± 28.7; Compound 23: 51.6% ± 14.3; p=0.09. n=4 cells for 
DMSO, n=6 cells for A293, Two-way ANOVA with Bonferroni correction; Fig 3.5 
B). 
3.3 Effects of TASK channel blockers on PV cell excitability 
As both TASK-1/3 channel blockers A293 and compound 23 did not appear to 
increase the output of PV cells, it was imperative to look more closely at PV cells 
themselves. It would be expected that the blockade of a key K+ channel thought to be 
important in the maintenance of the background K+ conductance would result in 
membrane depolarisation and an increase in input resistance. PV cells are presumed 
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to express a high level of TASK-1/3 channels (Goldberg et al. 2011; Okaty et al. 
2009) and should therefore depolarise and increase in input resistance during the 
application of a TASK-1/3 channel blocker. To test if this was the case, direct PV 
cell recordings were performed to observe the effects of TASK-1/3 channel blockers 
on their RMP and input resistance. 
Recordings were performed on PV cells which displayed electrophysiological 
properties typical of the fast-spiking cell type. These included rapid firing 
frequencies (>120 Hz), short width action potentials (<0.6 ms) and deep AHPs with 
fast rise times in response to strong current injection (Erisir et al. 1999; Rudy et al. 
2001). In the majority of experiments, mice with a PV-Cre knocking allele 
containing the endogenous PV promotor were crossed with lox-P flanked EYFP mice 
generating PV/EYFP reporter mice. This enabled visualisation of PV cells under blue 
light, allowing them to be targeted for direct recordings. 
3.3.1 TASK-1/3 channel blockers have no effect on RMP and input resistance in 
PV cells in cortex 
Recordings were carried out in thalamocortical slices and in the same region of the 
cortex. PV cells were targeted in layer IV of the barrel cortex and recorded in current 
clamp configuration to determine RMP as well as input resistance. Both parameters 
were monitored to ensure a stable 5 min baseline was acquired before a TASK-1/3 
channel blocker was applied. Once again, trials were interleaved between drug 
treatment and DMSO (control), and their effect on RMP and input resistance was 
compared between the groups. 
When compared between control and drug groups, the potent TASK-1/3 channel 
blocker compound 23 did not alter the RMP or input resistance (Fig 3.6). No 
significant difference in RMP was found between DMSO and compound 23 









before application, DMSO: 0.7 ± 0.6 mV, n=7 cells; Compound 23: 0.6 ± 0.7 mV, 
n=8; p=0.92, Student’s unpaired t-test; Fig 3.6 B). Importantly, both groups 
displayed similar absolute RMP values confirming that similar populations of cells 
were sampled in each group (Mean baseline potential, DMSO: -69.6 ± 2.5 mV, n=7 
cells; Compound 23: -64.8 ± 1.4 mV, n=8 cells; p=0.08, Student’s unpaired t-test). 
Similarly, no significant difference in input resistance was found between the two 
groups (Mean resistance 5-10 min after application as a percentage of baseline 0-5 
min before application, DMSO: 107.9% ± 4.0, n=7 cells; Compound 23: 99.6% ± 
4.1, n=8 cells; p=0.15, Student’s unpaired t-test (Fig 3.6 C).  
To further validate these results, two other TASK-1/3 channel blockers were applied 
together to establish their effects on RMP and input resistance. 3 µM A293 was 
combined with the 1 µM of the TASK-1/3 channel blocker A1899. IC50 values for 
A1899 were 0.035 µM and 0.32 µM for TASK-1 and TASK-3 respectively, at 
heterologously expressed TASK channels in Xenopus oocytes (Streit et al. 2011). 
Once again, the combined application of A293 and A1899 did not alter the RMP or 
input resistance between control and drug groups (Fig 3.7). No significant difference 
in RMP was found between DMSO and A293/A1899 (Difference in mean potential 
5-10 min after application from baseline 0-5 min before application, DMSO: 2.4 ± 
1.3 mV, n=6 cells; A293/A1899: 0.8 ± 0.9 mV, n=5; p=0.32, Student’s unpaired t-
test; Fig 3.7 B). Both groups displayed similar absolute RMP values (Mean baseline 
potential, DMSO: -70.3 ± 2.3 mV, n=6 cells; A293/A1899: -66.4 ± 1.5 mV, n=5 
cells; p=0.17, Student’s unpaired t-test). Similarly, no significant difference in input 
resistance was found between the two groups (Mean resistance 5-10 min after 
application as a percentage of baseline 0-5 min before application, DMSO: 109.8% ± 
2.9, n=6 cells; A293/A1899: 106.2% ± 2.6, n=5 cells; p=0.34, Student’s unpaired t-
test; Fig 3.7 C). 
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3.3.2 Acidification and bupivacaine depolarises RMP and increases input 
resistance in PV cells 
As three different TASK-1/3 channel blockers had no effect on the RMP and input 
resistance in PV cells, it was important to determine whether it was possible to detect 
the effects of TASK blockade with this recording procedure. Since TASK-1/3 
channels mediate K+ efflux at rest, a control experiment was performed to test 
whether the blockade of background K+ currents could be detected through changes 
in the RMP and input resistance. A control leak potassium channel blocker was used 
to confirm whether it was possible to detect the effects of blocking a large population 
of the background K+ conductance in this recording procedure. Problems in the 
experimental procedure could have impacted a potential effect of the drug which 
may have masked its overall outcome. A positive control was therefore used to 
confirm that changes in the RMP and input resistance could reliably be measured in 
PV cell recordings. 
Extracellular acidification (pH 6.4) and the anaesthetic bupivacaine are known to 
strongly inhibit background TASK-like currents, typical of most K2P channels with 
open rectification properties (Taverna et al. 2005; Torborg et al. 2006). The blockade 
of the TASK-like conductance should dramatically depolarise the RMP and increase 
the input resistance in PV cells. 
Extracellular acidification (pH 6.4) and bupivacaine were applied separately for 10 
min after the initial 5 min baseline period was established in PV cells. Although the 
effects of acidification were obtained from the last 5 min of the treatment, the effects 
of bupivacaine were instead obtained from the last 2 min of drug application as it did 
not plateau until the last 2 min. As bupivacaine is known to block voltage-gated Na+ 
channels (Olschewski et al. 1998; Zhang et al. 2014), QX314 was included in the 
internal pipette solution to ensure full blockade of Na+ channels prior to the start of 
recordings. A robust depolarisation of the RMP and a strong increase in input 






significantly depolarised between baseline and pH 6.4 conditions (Difference in 
mean potential at pH 6.4 5-10 min after application from baseline 0-5 min before 
application: 5.6 ± 1.6 mV; n=3 cells, p=0.008, One-way RM-ANOVA with 
Bonferroni correction; Fig 3.8 B) and between baseline and bupivacaine (Difference 
in mean potential 8-10 min after application from baseline 0-2 min before 
application, Baseline: 0.4 ± 0.4 mV; Bupivacaine: 6.3 ± 1.1 mV; n=3 cells, p=0.006, 
One-way RM-ANOVA with Bonferroni correction; Fig 3.8 B). Furthermore, the 
input resistance was significantly increased between baseline and pH 6.4 conditions 
(Mean resistance at pH 6.4 5-10 min after application as a percentage of baseline 0-5 
min before application: 140.0% ± 3.2; n=3 cells, p<0.0001, One-way RM-ANOVA 
with Bonferroni correction; Fig 3.8 C) and between baseline and bupivacaine (Mean 
resistance 8-10 min after application as a percentage of baseline 0-2 min before 
application, Baseline: 115.2% ± 4.3; Bupivacaine: 129.9% ± 0.8; n=3 cells, p=0.01, 
One-way RM-ANOVA with Bonferroni correction; Fig 3.8 C). This result confirms 
that a general blockade of background currents can be targeted, and importantly, that 
this blockade can be detected from changes in the RMP and input resistance. 
3.3.3 Compound 23 has no effect on RMP and input resistance in PV cells in 
CA1 hippocampus 
Neurons display distinct molecular profiles depending on their location within the 
brain (Ko et al. 2013). It is well established that the molecular expression of various 
proteins including ion channels can be different between brain regions, which may be 
contingent on a number of circumstances including growth factors during 
development as well as other molecular cues in the extracellular environment 
(Sharma et al. 2015; Ko et al. 2013). Different ratios of specific K2P channel 
subfamilies within different brain areas could explain why some cells would be 
responsive to their blockade and why some would not. For example, a larger 
proportion of the leak conductance could be mediated by TREK-1 channels relative 
to TASK-1/3 channels in the cortex, whereas in the hippocampus this relative 
proportion might be inversed.  
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Given that the blockade of TASK-1/3 channels did not alter the intrinsic properties of 
PV cells in the cortex, the effects of TASK-1/3 blockers on PV cells in other brain 
areas were explored. In situ hybridisation studies reported TASK-1 and TASK-3 
mRNA expression throughout the hippocampus (Talley et al. 2001). Moreover, 
mRNA expression was also detected in cells – presumably interneurons – in 
nonpyramidal layers of the hippocampus (Talley et al. 2001). Furthermore, the effect 
of the TASK-1/3 channel blocker compound 23 was reported to depolarise the RMP 
in putative fast-spiking cells in CA1 stratum oriens by a collaborator (Keith Phillips, 
Eli Lilly, data not shown). A set of recordings was therefore performed on PV cells 
in CA1 to compare results. At the end of each experiment, the acidification control 
was applied to further validate the presence of a TASK-like conductance in the 
recordings. 
The application of the TASK-1/3 channel blocker compound 23 did not alter the 
RMP or input resistance in hippocampal PV cells (Fig 3.9). No significant difference 
in RMP was found between baseline and drug (Difference in mean potential 5-10 
min after compound 23 application from baseline 0-5 min before application: 0.5 ± 
0.4 mV; n=5 cells, p=0.78, One-way RM-ANOVA with Bonferroni correction; Fig 
3.9 B). Similarly, there was no change in input resistance between baseline and drug 
(Mean resistance 5-10 min after compound 23 application as a percentage of baseline 
0-5 min before application: 113.8% ± 5.3; n=5 cells, p=0.27, One-way RM-ANOVA 
with Bonferroni correction; Fig 3.9 C). 
As predicted, the acidification control significantly depolarised the RMP of PV cells 
(Difference in mean potential 3-5 min after application from baseline 0-2 min before 
application, Baseline: 0.3 ± 0.6 mV; pH 6.4: 8.0 ± 0.7 mV; n=5 cells, p<0.0001, 
One-way RM-ANOVA with Bonferroni correction; Fig 3.9 B) in addition to 
increasing the input resistance (Mean resistance 3-5 min after application as a 
percentage of baseline 0-2 min before application, Baseline: 110.4% ± 3.6; pH: 






correction; Fig 3.9 C), confirming that a TASK-like conductance remains present in 
PV cells that was not blocked by compound 23. 
3.3.4 TASK-1/3 channel blockers have no effect on gamma oscillation power in 
CA3 hippocampus 
Gamma oscillations (30-80 Hz) are a hallmark of neuronal network function in a 
number of brain areas including the thalamus, hippocampus and neocortex (Buzsaki 
& Draguhn 2004). This fast network activity predominantly mediated by PV cell 
firing (Cardin et al. 2009), contributes to the pacing of pyramidal cell ensembles to 
fire simultaneously. This activity can be extracellularly recorded in vitro in response 
to the bath application of the cholinergic agonist carbachol. Moreover, although no 
effect on PV cell activity was established with TASK-1/3 channel blockers, 
compound 23 was reported to reduce gamma power in carbachol (30 µM)-induced 
gamma oscillations in CA3 hippocampus by a collaborator (Keith Phillips, Eli Lilly, 
data not shown). Thus, as a positive control, a set of experiments were performed in 
CA3 hippocampus, where oscillatory activity can be generated relatively easily. 
Horizontal slices were prepared and perfused with 30 µM of carbachol at a high flow 
rate (10-12 ml/min). Extracellular network oscillations were measured using a field 
electrode placed in the pyramidal cell layer of CA3. Compound 23 was applied for 
10 min three times in 10 min intervals and the power of gamma oscillations was 
analysed (Fig 3.10). The 35-50 Hz frequency band was used for gamma oscillation 
analysis as this was the range that consistently displayed the highest power between 
recordings (Green bars in power vs frequency histogram; Fig 3.10 A). Compound 23 
did not alter the power of gamma oscillations in the 35-50 Hz band (Mean power 
during last 5-10 min of each drug treatment period as a percentage of the mean 
power during last 5-10 min of each control period: 92.5% ± 9.1; n=8 recordings, 






3.4 Analysis of efficacy of TASK channel blockers 
The TASK-1/3 channel blockers A293, A1899 and compound 23 produced no effect 
on the RMP and input resistance, while the latter two blockers also failed to 
influence the output of PV cells. Moreover, the corresponding hippocampal data on 
the effects of compound 23 on the RMP of PV cells in CA1 combined with its effects 
on gamma oscillations in CA3 did not match between the results in this thesis and 
results attained from a collaborator (Keith Phillips, Eli Lilly). The effects of 
compound 23 were therefore assayed in a heterologous system where TASK 
channels are known to be expressed.  
3.4.1 Effects of TASK-1/3 channel blocker compound 23 on heterologously 
expressed TASK-3 in HEK-293 cells 
HEK-293 cells were transfected with TASK-3 constructs to produce cells expressing 
functional TASK-3 channels. These cells were subsequently patched between 24-72 
hours after transfection. The RMP and input resistance was monitored and a 5 min 
baseline was established before the TASK-1/3 channel blocker compound 23 was 
applied. Untransfected cells which underwent the same transfection process as 
transfected cells but with the absence of TASK-3 cDNA in the transfection mix were 
used as a control. 
Current clamp recordings revealed that compound 23 significantly depolarised the 
RMP between untransfected cells and transfected TASK-3 cells (Difference in mean 
potential 3-5 min after application from baseline 0-2 min before application, 
Untransfected: 4.2 ± 1.6 mV, n=7 cells; Transfected: 27.2 ± 2.8 mV, n= 4 cells; 
p<0.0001, Two-way RM-ANOVA with Bonferroni correction; Fig 3.11 B) while the 
acidification control had a similar effect (Difference in mean potential 3-5 min after 






n=7 cells; Transfected: 29.6 ± 3.8 mV, n=4 cells; p<0.0001, Two-way RM-ANOVA 
with Bonferroni correction; Fig 3.11 B). 
Furthermore, compound 23 also significantly increased the input resistance between 
untransfected cells and transfected TASK-3 cells (Mean resistance 3-5 min after 
application as a percentage of baseline 0-2 min before application, Untransfected: 
96.4% ± 3.0, n=7 cells; Transfected: 223.5% ± 21.9, n=4 cells; p<0.0001, Two-way 
RM-ANOVA with Bonferroni correction; Fig 3.11 C) while the acidification control 
again had a similar effect (Mean resistance 3-5 min after application as a percentage 
of baseline 0-2 min before application, Untransfected: 107.3% ± 7.5, n=7 cells; 
Transfected: 170.2% ± 38.8, n=4 cells; p=0.0005, Two-way RM-ANOVA with 
Bonferroni correction; Fig 3.11 C) 
These results validate that compound 23 effectively blocks TASK-3 channels and 
therefore it can be assumed to be a functional blocker. The similar magnitude of 
RMP depolarisation between compound 23 and the acidification control in 
transfected TASK-3 cells further supports its functional efficacy suggesting that it 
fully blocks all TASK-3 channels that the acidification control is blocking 
(Difference in mean potential 3-5 min after application from baseline 0-2 min before 
application, Compound 23: 27.2 ± 2.8 mV; pH 6.4: 29.6 ± 3.8 mV, n=4 cells; 
p=0.47, Student’s paired t-test). Despite this conclusion, pharmacological occlusion 
experiments between compound 23 and external acidification would be required to 
confirm this. 
Finally, to confirm that the effect of compound 23 is mediated by the blockade of an 
outward cation current, a single TASK-3-transfected HEK-293 cell and a single 
control HEK-293 cell were voltage-clamped at -70 mV to monitor the effect of the 
blocker. As expected, the blockade of TASK-3 channels in the TASK-3-transfected 
cell was paralleled by a strong inward current in the presence of compound 23  
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(Holding current before application: 295.7 pA; holding current after application: -
119.9 pA; Fig 3.12 A) and during acidification (Holding current before application: 
165.3 pA; holding current after application: -59.5 pA; Fig 3.12 A). As expected, the 
holding current required to voltage clamp the untransfected cell at -70 mV was 
unaffected. The current-voltage relationship of the same TASK-transfected cell in 
response to a set of voltage steps again indicated that compound 23 and acidification 
had similar effects in reducing TASK-3-mediated currents (Mean current amplitude 
during last 5-10 min of each condition, Baseline: 0.46 nA; Spadin: 0.20 nA; pH 6.4: 








In this chapter, I demonstrated that the blockade of TASK-1/3 channels has no effect 
on the RMP or input resistance in PV cells in the somatosensory cortex and CA1 
hippocampus, and therefore does not increase their excitability, contrary to what was 
predicted. This finding was further validated by the failure of TASK-1/3 channel 
blockers to increase the amplitude of PV cell-mediated IPSCs. These results were 
surprising given the high level of TASK-1 and TASK-3 mRNA expression in PV 
cells (Goldberg et al. 2011; Okaty et al. 2009), as the blockade of TASK-1/3 
channels would have been expected to increase cell excitability due to their 
contribution to the passive background K+ conductance. A set of positive controls 
which included extracellular acidification and bupivacaine treatment known to target 
most K2P channels with open rectification properties demonstrated that blocking this 
TASK-like conductance had the expected effects on PV cells and that these effects 
could be measured. Moreover, the TASK-1/3 channel blocker compound 23 failed to 
alter the power of network gamma oscillations, contrary to results obtained with the 
same drug from a collaborator (Keith Phillips, Eli Lilly). The efficacy of compound 
23 was therefore assayed in TASK-3-expressing HEK-293 cells to confirm that it 
was indeed an effective TASK channel blocker. It remains possible however that the 
discrepancy in the effect of compound 23 between PV cells in mice and HEK-293 
cells could be explained by differences in the accessibility of the drug between the 
two systems, or even by differences in the molecular composition of the channels. 
Native channels in mice are likely to be bound by different subunits which could 
alter their pharmacological profile. Nonetheless, as all TASK-1/3 channel blockers 
failed to induce changes in all parameters tested in this chapter, it is likely that the 
blockers are functional and that the results are consistent with the absence of TASK-
1/3 channels in PV cells. In summary, these results confirm that TASK-1/3 channels 
are either not functionally expressed, or present at extremely low levels relative to 
other background K+ channels in PV cells. 
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3.5.1 TASK-like conductance in PV cells mediated by K2P channels other than 
TASK-1/3 
Whilst the TASK-1/3 channel blockers A293, A1899 and compound 23 did not alter 
the RMP and input resistance in PV cells, both bupivacaine and acidification controls 
significantly depolarised the RMP and increased the input resistance in the same 
population of cells. The bupivacaine- and acid-sensitive background K+ 
conductances typically mediated by TASK-like channels function to reduce the input 
resistance in most cell types (Taverna et al. 2005; Torborg et al. 2006). These results 
thus confirm two functional properties attributable to PV cells: Firstly, PV cells do 
not express a large enough population of functional TASK-1/3 channels to 
significantly modulate the background K+ conductance that regulates their RMP. 
Secondly, the RMP in PV cells is evidently maintained by other bupivacaine- and 
acid-sensitive background conductances. 
PV cells have an unusually low input resistance compared to pyramidal cells and 
other interneurons (Doischer et al. 2008; Taverna et al. 2005). This makes the lack of 
effect of compound 23 on PV cells even more surprising, especially because of the 
considerable magnitude of effect observed with both bupivacaine and acidification 
on the RMP and input resistance. This suggests that there is still a large contribution 
of background K+ channels mediating the TASK-like conductance responsible for 
their low membrane resistivity. 
Although bupivacaine and acidification depolarised the RMP by approximately 6 
mV and increased the input resistance by approximately 30-40%, it is important to 
clarify that both these conditions affect many proteins within the membrane other 
than TASK. Bupivacaine blocks several other channels within the K2P family 
including TREK-1 and TWIK-1 (Kindler et al. 1999), highlighting other functional 
background K+ channels that could be regulating the membrane potential and 
membrane resistivity in PV cells. In addition to blocking TASK-like channels, 
bupivacaine also blocks voltage-gated Na+ channels with high potency (Olschewski 
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et al. 1998; Zhang et al. 2014) in addition to blocking both high and low voltage-
activated Ca2+ channels to a lesser effect (Liu et al. 2001). Although the voltage-
gated Na+ channel blocker QX314 was included in the internal pipette solution to 
compensate for the blocking action of bupivacaine on Na+ channels, other non-
specific mechanistic effects may not have been accounted for. Local anaesthetics 
including bupivacaine have been shown to interact with membrane phospholipids 
and proteins which can act on a variety of cellular processes. For example, local 
anaesthetics can modify the signalling of NMDA receptors (Furutani et al. 2010), as 
well as the signalling of protein kinase C (PKC), adenosine 3’, 5’-cyclic 
monophosphate-dependent kinases (PKAs) and guanosine triphosphate-binding 
proteins (G proteins) including downstream receptors that they activate (Yanagidate 
& Strichartz 2006). Electrophysiologically, this could lead to altered levels of 
intracellular Ca2+ which could affect the RMP in addition to the input resistance, as 
Ca2+-activated K+ channels would also be affected (Johnson et al. 2002). 
Furthermore, acidification modulates several acid-sensing and proton-sensing 
channels within the cellular membrane (Wang & Xu 2011). Protons have been shown 
to decrease neurotransmitter release in presynaptic terminals through feedback 
inhibition of voltage-gated Ca2+ channels and reduce the activity of NMDA receptors 
in the postsynaptic terminals (Tang et al. 1990; DeVries 2001). Although these 
effects will not necessarily be detected in whole-cell patch clamp recordings - as 
glutamatergic terminals are located distally from the soma – their impact may affect 
other secondary messengers that could influence electrophysiological properties in 
the soma. Acid-sensing ion channels permeable to Na+ and Ca2+ are activated by a 
reduction in extracellular pH to generate rapid depolarising currents (Waldmann et 
al. 1997). Activation of acid-sensing ion channels has thus been demonstrated to 
result in substantial intracellular Ca2+ elevation, which may contribute to the 
depolarisation of the RMP observed in this thesis. 
Nonetheless, two control conditions (acidification and bupivacaine) both 
significantly depolarised the RMP and increased the input resistance in PV cells, 
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consistent with the blockade of a TASK-like conductance. It therefore remains likely 
that although many non-specific effects of both conditions persist, they are both 
reasonable indicators showing the presence of a clear majority of the K+ background 
conductance that remains to be targeted in PV cells. Furthermore, this suggests that 
the core aims of the thesis – which is to depolarise the RMP and increase the input 
resistance in PV cells – can be achieved using blockers that target different leak 
channels, but might not simply involve canonical TASK-1/3 channels. The effects of 
blocking other TASK-like currents such as TREK-1 could therefore be explored in 
PV cells. 
3.5.2 Confirmation of efficacy of TASK-1/3 channel blockers 
Previous studies assaying the molecular profile of PV cells confirmed the presence of 
TASK-1 and TASK-3 mRNAs using qPCR and microarrays from FACS-sorted PV 
cells (Goldberg et al. 2011; Okaty et al. 2009). Moreover, TASK-1 immunolabeling 
revealed an increase in TASK-1 protein expression throughout early development 
(Okaty et al. 2009). Although no previous work has used specific blockers to reliably 
demonstrate the presence of TASK-1/3 currents in PV cells, both acidification and 
bupivacaine conditions suggested that TASK-1/3 channels may have been 
functionally expressed in this cell type (Torborg et al. 2006). Furthermore, the 
membrane resistance of PV cells was reported to be approximately twofold larger in 
TASK-1/3 double knockout mice (Goldberg et al. 2011).  
The lack of an effect that the TASK-1/3 channel blockers had on the RMP and input 
resistance of PV cells was surprising, given the evidence for TASK-1 and TASK-3 
expression and the functional effects in TASK-1/3 double knockout mice. It was for 
this reason that the efficacy of the blocker compound 23 was tested. Nonetheless, 
compound 23 significantly depolarised the RMP and increased the input resistance in 
TASK-3-expressing HEK-293 cells, confirming that it was a successful blocker of 
TASK. This suggests that the increased input resistance reported in TASK-1/3 
double knockout mice could be due to other developmental effects of the TASK-1/3 
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knockout. Another possibility could involve changes in protein-protein interactions 
between PV cells and HEK-293 cells, which could alter the pharmacological effects 
of the drug between the two systems. For example, A1899 was reported to have IC50s 
of 0.035 µM and 0.32 µM for TASK-1 and TASK-3 respectively, at heterologously 
expressed TASK channels in Xenopus oocytes, whereas IC50s at heterologously 
expressed TASK-1 and TASK-3 in Chinese hamster ovary cells were 7 nM and 70 
nM respectively (Streit et al. 2011). The discrepancy in the drug affinity between 
both systems could also be due to differences in the molecular composition of the 
channels which could alter the binding efficacy of the drug. 
3.5.3 The effect of compound 23 failed to replicate findings in hippocampal cells 
and network gamma oscillations 
Prior to testing the efficacy of compound 23 on TASK-3-expressing HEK-293 cells, 
the effect of the drug was assessed on the power of extracellular gamma oscillations 
in CA3 hippocampus. This was a simple method to quickly determine the 
effectiveness of the compound on the rhythmic output of the neuronal network. 
Compound 23 was previously reported to reduce the power of carbachol-induced 
gamma oscillations in CA3 (Keith Phillips, Eli Lilly) whereas the results in this 
thesis did not show a difference. It is difficult to interpret the disparity between these 
results; however, it is possible that the discrepancy is due to different strains of mice 
used in the experiments. Mice express distinct levels of mRNA between strains, 
resulting in various quantities of proteins produced in the brain which can affect the 
downstream physiology between them (Keane et al. 2011; Korostynski et al. 2006). 
The fluorescent protein (EYFP) expressed in PV cells in the mice used in this thesis 
could have influenced the working function of PV cells which may have biased the 
effects of the drug. In spite of this, a subset of experiments was performed on fast-
spiking interneurons from wildtype C57 mice, which displayed similar results to 
PV/EYFP mice, thus arguing against this possibility. 
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The effect of compound 23 on the RMP in hippocampal PV cells was also performed 
and compared with similar data from a collaborator. Compound 23 was previously 
reported to depolarise the RMP in PV cells in CA1 stratum oriens (Keith Phillips, Eli 
Lilly), whereas the results in this this thesis did not show an effect. Upon later 
examination of the cells that were recorded, it was clear that several cells used in the 
comparable data (Keith Phillips, Eli Lilly) were not exclusively fast-spiking 
interneurons. These included cells that displayed spike frequency adaptation and 
exhibited a variety of non-fast-spiking characteristics that included shallow AHPs in 
addition to AHPs with slow rise times. This diversity in cell population likely 
explains the discrepancy in the results between the two groups of data. 
3.5.4 Dynamics of the output of cortical PV cells upon multiple stimulation 
The excitation of thalamic fibres produces robust feedforward inhibition of neurons 
in layer IV of the somatosensory cortex (Daw et al. 2007). Importantly, the dynamics 
of thalamocortical feedforward inhibition are governed by mechanisms that extend 
beyond the properties of each individual synapse. Thalamocortical feedforward 
IPSCs have been previously shown to reduce in amplitude in response to repetitive 
stimulation (Gabernet et al. 2005). Whilst the ratio between peak monosynaptic 
EPSC and peak disynaptic feedforward IPSC conductances remain stable over a 
range of stimulation intensities in response to single stimulation, the balance is 
altered during repetitive stimulation where the amplitude of feedforward IPSCs 
decrease (Gabernet et al. 2005). This effect was observed in this thesis, where high 
frequency thalamic stimulation triggered IPSCs in voltage-clamped layer IV stellate 
cells that depressed in amplitude.  
Paired recordings from fast-spiking cells to principal cells in layer IV revealed that 
trains of action potentials triggered at 10 Hz in fast-spiking cells resulted in a 
reduction in unitary IPSCs by approximately 50% of their original amplitude after 
the fifth stimulus (Gabernet et al. 2005).  This reduction in IPSC amplitude is 
consistent with a depression in the second GABAergic synapse in thalamocortical 
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feedforward inhibition. Nonetheless, 10 Hz thalamic stimulation showed an even 
more striking reduction of approximately 90% in feedforward IPSCs in the same 
population of principal cells. By comparing the amplitudes of unitary monosynaptic 
IPSCs and thalamically evoked disynaptic IPSCs between the first and fifth IPSCs, it 
has been shown that by the fifth stimulus only around 20% of fast-spiking cells were 
activated (Gabernet et al. 2005). Thus, an effective blockade of the TASK-like 
conductance could have targeted this element of PV cell depression by increasing the 
proportion of cells that remained active during multiple stimulation. Furthermore, 
glutamatergic EPSCs onto fast-spiking cells were found to significantly decrease in 
amplitude in response to 10 Hz thalamic stimulation. It is therefore clear that 
although both input and output synapses of PV cells contribute to feedforward IPSCs 
depression, afferent thalamic stimulation onto PV cells are responsible for most of 
the effect. 
The reduction in IPSC amplitude during multiple stimulation in this thesis can 
therefore be explained by the depression in one of two synapses: the glutamatergic 
thalamic inputs onto PV cells, or GABAergic layer IV cortico-cortical inputs from 
PV cells onto stellate cells. Depression of the first synapse would reduce the 
proportion of PV cells recruited to fire, and thus participate in the generation of 
feedforward transmission; whereas depression of the second synapse would directly 
reduce the amplitude of feedforward inhibition. Paired recordings examining the 
unitary monosynaptic IPSCs between layer IV PV cells and stellate cells combined 
with thalamically-evoked disynaptic IPSC recordings would confirm the origin of 
depression within the thalamocortical circuit used in this thesis. 
In summary, PV cells receive thalamic EPSCs which reduce in amplitude with 
repeated stimulation. GABAergic transmission from PV cells is also reduced 
following multiple action potential firing. Due to their high probability of release, it 
is possible that this reduction in transmission is due to the depletion of available 
vesicles containing neurotransmitter. Moreover, any effect of a drug designed to 
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increase the excitability of PV cells may have resulted in a reduction in the 
magnitude of PV cell depression. 
3.5.5 DMSO appears to reduce the amplitude of PV cell-mediated feedforward 
IPSCs 
DMSO is a solvent widely employed in cell biology as an effective penetration 
enhancer for various water-insoluble pharmacological agents. In this thesis, 0.1% 
DMSO treatment alone appeared to diminish the amplitude of thalamocortical PV 
cell-mediated IPSCs in single stimulation recordings (Mean amplitude 5-10 min after 
application as a percentage of baseline 0-5 min before application, DMSO 85.1% ± 
7.2, n=9 cells; p=0.04, Student’s unpaired t-test) as well as the first IPSC in multiple 
stimulation recordings (Mean amplitude 5-10 min after application as a percentage of 
baseline 0-5 min before application, DMSO 82.2% ± 5.9, n=12 cells; p=0.005, 
Student’s unpaired t-test). During single stimulation, IPSC amplitudes decreased 
over time in the presence of DMSO by approximately 15%, which appeared to be 
corrected for, by the application of the TASK-1/3 channel blocker A293 (Fig 3.2). 
The reduction in IPSC amplitudes may have been caused by a direct effect of DMSO 
or related to another mechanism which could have exerted its effects over the time 
course of the experiment. It was therefore important that control vehicle experiments 
were interleaved with drug trials to ensure that any drug effect was not contaminated 
by undesirable effects of DMSO. 
Although reports on the effects of DMSO exposure are limited, several studies have 
described changes in cellular activity from whole-cell recordings in vitro. DMSO 
pre-treatment of slices at 0.05% was reported to have no effect on the RMP but 
significantly reduce the input resistance in hippocampal CA1 pyramidal cells by 
approximately 30%, compared to untreated tissue slices (Tamagnini et al. 2014). 
Furthermore, DMSO exposure resulted in a reduction in pyramidal cell firing in 
response to given current stimuli, thus reducing their excitability. However, unlike 
experiments in this thesis where DMSO was administered for 10 min, the slices used 
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for recordings in the Tamagnini et al (2014) study were treated with the solvent for 
2-5 hours prior to recordings. 
The mechanism of DMSO-treatment on reducing the input resistance in CA1 
pyramidal cells is unknown, however it is likely that it increases the number of open 
ion channels in the plasma membrane. Although its target population of ion channels 
in not known, one possible candidate is the Cl- channel. This is supported by 
DMSO’s lack of effect on the RMP which could be expected given that the reversal 
potential of Cl- is close to resting potential. The enhanced function of Cl- channels 
has been demonstrated in other interactions: One study reported that amyloid beta 
treatment increased the surface expression of Cl- channels which resulted in elevated 
Cl- conductance (Novarino et al. 2004). In addition to the reduction in input 
resistance, DMSO was also shown to increase the membrane capacitance of 
pyramidal cells (Tamagnini et al. 2014). It is therefore possible that DMSO has a 
direct effect on the capacitive properties of the lipid bilayer which could modulate 
the integration of multiple synaptic inputs. 
Although DMSO did not appear to affect the input resistance of PV cells in this 
thesis, it did appear to reduce the amplitude of PV cell-mediated feedforward IPSCs 
to near significance. As the effects of DMSO on input resistance in the Tamagnini et 
al (2004) study was recorded exclusively from pyramidal cells, it is not known 
whether PV cells are affected. Although the data in this thesis suggests that PV cell 
input resistance is not affected by DMSO, these experiments did not pretreat the 
slices with the solvent for several hours. Nonetheless, it is still plausible that the 
input resistance of thalamic neurons is reduced in the presence of DMSO, thus 
depressing their glutamatergic output onto PV cells in layer IV cortex upon 
thalamocortical stimulation, resulting in a reduction in feedforward inhibition. 
Finally, the reduction in IPSC amplitudes may not be related to DMSO at all, as the 
effects did not appear to wash out. Other factors such as tissue health could be 
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responsible for this detrimental effect. As the stimulation and recording sites were in 
different brain areas, the likelihood of adverse effects induced by deteriorating tissue 
may have increased, given the expanse of tissue that the signal would have to have 
travelled through. The reduction in IPSC amplitudes may have therefore developed 
over the duration of the recordings and thus decreased as a function of time. Control 
recordings would need to be performed with or without the solvent to confirm 
whether the decline in IPSC amplitude was influenced by DMSO or if another 
mechanism reduced it over time. 
3.5.6 Summary 
The aim of this chapter was to increase the intrinsic excitability of PV cells by 
blocking TASK-1/3 channels. This would have resulted in membrane depolarisation 
accompanied by an increase in input resistance if the channels were functionally 
present. Several studies suggested that TASK-1/3 channels may have contributed to 
the large K+ leak in PV cells (Goldberg et al. 2011; Okaty et al. 2009), however the 
application of three distinct TASK-1/3 channel blockers failed to alter the RMP and 
input resistance, and therefore had no effect on modulating the background K+ 
conductance. 
External acidification and bupivacaine treatment known to block the TASK-like 
conductance however significantly depolarised the RMP and increased the input 
resistance, highlighting a family of background channels that remain to be targeted. 
As both conditions target TASK-1/3 channels in addition to several other K2P 
channel subfamilies including TREK-1, it is likely that other acidification- and 
bupivacaine-sensitive channels regulate the background K+ conductance in PV cells. 
Thus, exploring the effects of blocking other leak K+ channels in PV cells may 
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4 .1 Introduction 
The low input resistance in PV cells presumed to be mediated partly by TASK-like 
channels could offer novel targets for blockers in the attempt to increase cell 
excitability. The results from the last chapter suggested that TASK-1/3 channels are 
not implicated in the resting background K+ conductance in PV cells, whereas 
external treatment of acidification and bupivacaine – both of which are known to 
strongly inhibit TASK-like currents – demonstrated the presence of a large 
background current that remains to be targeted. Several other K+ channels known to 
be acidification- and bupivacaine-sensitive include members of the K2P family, 
particularly TREK-1 and to a lesser degree, TWIK-1. Thus, the blockade of TREK-1 
or TWIK-1 could be applied in PV cells to increase their intrinsic excitability. 
In chapter 3, the TASK subfamily of K2P channels believed to contribute to the 
passive background K+ channel conductance was targeted in PV cells. It was 
demonstrated, however, that although PV cells express high levels of TASK-1 and 
TASK-3 mRNA subunits (Goldberg et al. 2011; Okaty et al. 2009), the 
administration of a variety of TASK channel blockers failed to alter their passive 
membrane properties, suggesting that TASK channels are not functionally expressed 
in these cells. Exploring the effects of blocking other K2P channels specific to PV 
cells may therefore provide a better target. 
The substantial effect that external acidification and bupivacaine had on the RMP 
and input resistance in PV cells suggests that there is a large K+ background current 
that remains to be targeted, other than TASK. Other prominent members of the K2P 
channel family that show acidification and bupivacaine sensitivity are TREK-1 and 
TWIK-1 channels (Kindler et al. 1999). Mouse qPCR data from FACS-sorted 
cortical PV cells demonstrated a developmental increase in TWIK-1 mRNA 
expression (Goldberg et al. 2011) indicating that TWIK-1 channels could provide a 
useful target for TASK-like inhibition. In spite of this, their currents have been 
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reported to be small, and display weak inward rectification (Kindler et al. 1999), 
which makes them less likely to contribute significantly to the large magnitude of 
inhibition observed during external acidification and bupivacaine treatments. 
Within the TREK subfamily however, the acidification- and bupivacaine-sensitive 
TREK-1 channel is thought to mediate much larger currents (Kindler et al. 1999). A 
TREK-1 current could therefore be responsible for the depolarisation of the RMP 
and increase in input resistance observed during acidification and bupivacaine 
application. In support of this possibility, TREK-1 transcripts have been reported to 
be highly expressed relative to other background K+ channels in cortical PV cells 
(Goldberg et al. 2011). Furthermore, in situ hybridisation of K2P channel mRNA 
reveal a high expression of TREK-1 in several areas including the striatum, 
hippocampus and predominately layer IV cortex (Talley et al. 2001). Northern blots 
and real-time reverse transcription PCRs further support high levels of TREK-1 in 
the neocortex (Meadows et al. 2000). TREK-1 could therefore be a suitable channel 
to target in PV cells.  
In this chapter, the effects of blocking TREK-1 channels in PV cells were assessed in 
layer IV somatosensory cortex. Direct recordings were made from patch-clamped PV 
cells and their intrinsic properties were measured in response to TREK-1 channel 
blockers. Functional expression of TREK-1 should result in RMP depolarisation and 
an increase in the input resistance during blockade, thus increasing the excitability of 
cortical PV cells. Finally, the effects of TREK-1 blockade on the firing of action 




4.2 Effects of TREK-1 channel blocker amlodipine on PV cell 
excitability 
A suitable TREK-1 channel blocker was required to block TREK-1-mediated 
currents without modifying the activity of other channels. Several Ca2+ channel 
blockers have been reported to block TREK-1 channels. Interestingly, amlodipine 
and niguldipine block TREK-1 channels much more potently than Ca2+ channels (Liu 
et al. 2007). The selective serotonin uptake inhibitor fluoxetine and its metabolite 
norfluoxetine have also been shown to block TREK-1 channels, although with less 
potency (Kennard et al. 2005). Additionally, the neuroprotective drug sipatrigine 
blocks TREK-1 but also targets several other voltage-gated Na+ and Ca2+ channels 
(Meadows et al. 2001; Xie & Garthwaite 1996; McNaughton et al. 2000). 
Amlodipine was chosen for experiments as it was the most potent blocker with an 
IC50 of 0.43 µM for TREK-1 (Liu et al. 2007), compared to 2.4 µM for L-type Ca2+ 
channels (Furukawa et al. 1997). 43 µM was used in all experiments (a hundredfold 
greater than the IC50 value) to ensure full blockade of TREK-1 channels. This 
concentration of amlodipine would also presumably block L-type Ca2+ channels, 
however, these channels are activated at depolarised potentials and therefore are 
likely to be in a closed conformation during recordings at resting potential. 
Nonetheless, any L-type Ca2+ channel blockade would hyperpolarise the cell – 
contrary to the expected effect of blocking TREK-1. 
4.2.1 Amlodipine depolarises RMP but has no effect on input resistance 
The blockade of a key K+ channel known to contribute to the background K+ 
conductance should result in membrane depolarisation and increase the input 
resistance of the cell if the channel is functionally present. To test if PV cells 






passive resting conductance, direct PV cell recordings were performed and 
amlodipine was applied to assess the blocker’s effect on RMP and input resistance. 
Recordings were carried out on PV cells in layer IV of the barrel cortex which 
displayed electrophysiological properties characteristic of the fast-spiking cell type 
(see section 3.3). As amlodipine was dissolved in external recording solution, a 
vehicle control was not required. 
Amlodipine significantly depolarised the RMP (Difference in mean potential 5-10 
min after application from baseline 0-5 min before application: 3.3 ± 0.6 mV; n=8 
cells, p=0.0006, Student’s paired t-test; Fig 4.1 B) suggesting that the intrinsic 
membrane properties of PV cells are robustly modified. In contrast, amlodipine did 
not alter the input resistance of PV cells (Mean resistance 5-10 min after application 
as a percentage of baseline 0-5 min before application: 104.4% ± 2.2; n=8 cells, 
p=0.06, Student’s paired t-test; Fig 4.1 C). This was surprising because the blockade 
of a TASK-like channel would have been expected to alter both parameters 
simultaneously. Furthermore, it appeared that the input resistance may have 
increased, but over a longer timescale in relation to the change in RMP, which again 
was unexpected. 
4.2.2 Amlodipine does not alter the firing of PV cells in response to current steps 
Cells typically receive multiple inputs in vivo which are converted into action 
potentials once voltage-gated Na+ channels reach activation threshold. Depolarisation 
of the RMP will bring the cell closer to activation threshold. As a result, cells 
become more excitable and fire more action potentials to a given input. As 
amlodipine depolarised the RMP of PV cells, their active firing excitability was 
examined in response to a set of current steps, to assess whether the effect of 
depolarisation resulted a higher probability of action potential firing. 
All recordings were performed at resting potential in current clamp configuration 






allowed for the input resistance to be determined from a negative current step (as 
performed in previous recordings) in addition to measuring cell excitability 
calculated from a set of 8 positive current steps. The current amplitude was adjusted 
to ensure that each set of 8 steps resulted in a number of sweeps that preferably 
contained the following parameters: the threshold current (rheobase) required to 
elicit one action potential; the subthreshold current (rheobase -1) that failed to elicit 
an action potential, as well as the suprathreshold current (rheobase +1) that 
discharged more than one action potential (Fig 4.2 A). A set of 8, 250 ms current 
steps were injected into PV cells every 30 s and performed in the presence of 
amlodipine (Fig 4.2 B). 
Amlodipine significantly reduced the rheobase amplitude required to generate one 
action potential (Mean rheobase 5-10 min after application compared to baseline 0-5 
min before application, Baseline: 477.1 ± 59.2 pA; Amlodipine: 404.0 ± 60.3 pA; 
n=8 cells, p=0.03, Student’s paired t-test; Fig 4.3 B), although did not return to 
pretreatment values in the wash (Mean rheobase 5-10 min after application compared 
to last 5-10 min of wash, Amlodipine: 404.0 ± 60.3 pA; Wash: 390.4 ± 55.2 pA; n=8 
cells, p=0.59, Student’s paired t-test; Fig 4.3 B) 
However, amlodipine did not affect the number of action potentials in response to the 
rheobase -1 current step (Mean number of spikes 5-10 min after amlodipine 
application compared to baseline 0-5 min before application, Baseline: 0.0 ± 0.0; 
Amlodipine: 0.7 ± 0.5; n=8 cells, p=0.38, One-way RM-ANOVA with Bonferroni 
correction; Fig 4.3 C). Similarly, amlodipine did not alter the number of action 
potentials in response to the rheobase current step (Normalised number of spikes 5-
10 min after application compared to baseline 0-5 min before application, Baseline: 
1.0 ± 0.0; Amlodipine: 7.5 ± 4.0; n=8 cells, p=0.26, One-way RM-ANOVA with 
Bonferroni correction; Fig 4.3 C; Absolute number of spikes, Baseline: 0.7 ± 0.4; 
Amlodipine: 3.7 ± 2.3) and also failed to affect the number of action potentials in 
response to the rheobase +1 current step (Normalised number of spikes 5-10 min 
after application compared to baseline 0-5 min before application, Baseline: 1.0 ± 
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0.0; Amlodipine: 6.2 ± 3.7; n=8 cells, p=0.81, One-way RM-ANOVA with 
Bonferroni correction; Fig 4.3 C; Absolute number of spikes, Baseline: 8.7 ± 3.5; 
Amlodipine: 12.5 ± 4.7). These data suggest that although the effects of amlodipine 
reduce the rheobase current required to elicit one action potential, it does not 
significantly increase the number of spikes generated in response to given current 
steps. 
Attention must be drawn to the possibility that the dataset used for these experiments 
might have been underpowered. As the dataset only contained 8 cells, the significant 
effects that amlodipine had on the RMP (Fig 4.1 B) and rheobase current (Fig 4.3 B) 
indicate that significant effects on the input resistance (Fig 4.1 C) and number of 
spikes to given current injections (Fig 4.3 C) might have been discovered if more 
cells had been recorded. Nonetheless, power analysis of this data revealed that 37 
cells would have been required to observe a significant effect on the input resistance 
of PV cells. Likewise, power analysis revealed that 36-99 cells would have been 
required to observe a significant effect on the number of spikes generated from given 











4.3 Effects of TREK-1 channel blocker spadin on PV cell excitability 
Although amlodipine significantly depolarised the RMP in PV cells, a more potent 
and specific TREK-1 channel blocker was employed, as it was possible that the non-
specific effects of amlodipine could have impacted on the full effect of blocking 
TREK-1. Interestingly, the peptide spadin has been reported to block TREK-1 
channels with high affinity (Mazella et al. 2010). Spadin is a peptide based on the 
sequence of amino acids derived from a propeptide that is secreted during the 
maturation of the neurotensin receptor 3/sortillin protein, which is located in the 
trans-Golgi network (Mazella et al. 2010). Moreover, spadin is structurally distinct 
from amlodipine, and therefore their specific effects can be accurately compared 
between the two blockers to provide a meaningful conclusion. The effects of 
blocking TREK-1 with spadin have already been explored as an antidepressant in 
mice. The excitability of serotonergic neurons in the Dorsal Raphe Nucleus - which 
express TREK-1 – was reported to increase in response to spadin administration 
(Mazella et al. 2010). Furthermore, mice treated with spadin were shown to behave 
exactly as TREK-1 knockout mice which display a clear antidepressant phenotype 
(Heurteaux et al. 2006; Mazella et al. 2010). This suggests that spadin is a potent 
blocker of TREK-1 channels. Although the IC50 of spadin is 70 nM for TREK-1 - 
reported from COS-7 TREK-1-transfected cells (Mazella et al. 2010) - 1 µM was 
used in all experiments (approximately 2.5-fold of the IC50), likely to result in over 
75% inhibition of TREK-1 channels. 
4.3.1 Spadin depolarises RMP but has no effect on input resistance 
Spadin was administered to PV cells for 10 min after a 5 min baseline was 
established. Similar to the effects of amlodipine, spadin significantly depolarised the 
RMP (Difference in mean potential 5-10 min after application from baseline 0-5 min 
before application: 0.9 ± 0.4 mV; n=15 cells, p=0.02, Student’s paired t-test; Fig 4.4 
B) but did not alter the input resistance (Mean resistance 5-10 min after application 






p=0.22, Student’s paired t-test; Fig 4.4 C). Thus, the results from amlodipine are 
paralleled by the much cleaner TREK-1 channel blocker spadin although to a lesser 
magnitude. 
4.3.2 Spadin increases the firing of PV cells in response to current steps 
The effect of the depolarising action of the TREK-1 channel blocker was 
investigated on the spiking activity of PV cells in response to 8 positive current steps 
(Fig 4.5 A) carried out in the same manner as before. 8, 250 ms depolarising current 
steps were injected every 30 s (Fig 4.5 B). 
Spadin significantly reduced rheobase (Mean rheobase 5-10 min after application 
compared to baseline 0-5 min before application, Baseline: 434.5 ± 64.9 pA; Spadin: 
691.0 ± 68.1 pA; n=15 cells, p=0.02, Student’s paired t-test; Fig 4.6 B), although did 
not return to pretreatment values in the wash (Mean rheobase 5-10 min after 
application compared to last 5-10 min of wash, Spadin: 691.0 ± 68.1 pA; Wash: 
713.3 ± 70.9 pA; n=15 cells, p=0.09, Students paired t-test; Fig 4.6 B). 
Furthermore, spadin increased the number of action potentials in response to the 
rheobase -1 current step (Mean number of spikes 5-10 min after application 
compared to baseline 0-5 min before application, Baseline: 0.1 ± 0.0; Spadin: 0.4 ± 
0.1; n=15 cells, p=0.01, One-way RM-ANOVA with Bonferroni correction; Fig 4.6 
C), although did not return to pretreatment values in the wash (Mean number of 
spikes 5-10 min after application compared to last 5-10 min of wash, Spadin: 0.4 ± 
0.1; Wash: 0.3 ± 0.1; n=15 cells, p=0.33, One-way RM-ANOVA with Bonferroni 
correction; Fig 4.6 C). 
Similarly, spadin significantly increased the number of action potentials in response 
to the rheobase current step (Normalised number of spikes 5-10 min after application 









0.3; n=15 cells, p=0.01, One-way RM-ANOVA with Bonferroni correction; Fig 4.6 
C; Absolute number of spikes, Baseline: 1.0 ± 0.1; Spadin: 1.9 ± 0.3), but again did 
not return to pretreament values (Normalised number of spikes 5-10 min after 
application compared to last 5-10 min of wash, Spadin: 1.8 ± 0.3; Wash: 1.4 ± 0.2; 
n=15 cells, p=0.37, One-way RM-ANOVA with Bonferroni correction; Fig 4.6 C; 
Absolute number of spikes, Spadin: 1.9 ± 0.3; Wash: 1.5 ± 0.2). Nevertheless, spadin 
did not affect the number of action potentials in response to the rheobase +1 current 
step (Normalised number of spikes 5-10 min after application compated to baseline 
0-5 min before application, Baseline: 1.0 ± 0.0; Spadin: 1.8 ± 0.3; n=15 cells, 
p=0.51, One-way RM-ANOVA with Bonferroni correction; Fig 4.6 C; Absolute 
number of spikes, Baseline: 4.4 ± 1.5; Spadin: 8.3 ± 2.9). These data demonstrate 
that spadin increases the excitability of PV cells. 
The effect of spadin on increasing the number of action potentials in response to the 
rheobase -1 and rheobase steps could have been due to a change in the threshold 
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potential for action potential initiation rather than a change in RMP. The membrane 
threshold potential for action potential generation was therefore analysed. Spadin had 
no effect on the action potential threshold (Mean threshold potential 5-10 min after 
application compared to baseline 0-5 min before application, Baseline: -50.2 ± 1.1 
mV; Spadin: -50.6 ± 1.4 mV; n=15 cells, p=0.43, Student’s paired t-test; Fig 4.7) 
4.3.3 Spadin has no effect on PV cell output 
Cells that increase in excitability may generate a higher frequency of action 
potentials either spontaneously or in response to stimulation from afferent inputs. In 
the thalamocortical feedforward microcircuit, several PV interneurons in layer IV 
cortex receive excitatory inputs from the thalamus in response to whisker stimulation 
(Gabernet et al. 2005). Some of these PV cells will reach firing threshold and 
participate in feedforward inhibition onto local principal cells whilst other PV cells 
will not reach firing threshold and remain silent. As spadin depolarises the RMP and 
increases the excitability of PV cells, a greater proportion of them might rest closer 
to firing threshold and thus fire action potentials more effectively upon stimulation. 
PV cell output was therefore examined within the thalamocortical circuit (Fig 3.1 A). 
The evoked feedforward output of PV cells in response to thalamocortical 
stimulation was recorded before and after application of the drug. PV cells that 
become more excitable in response to the application of spadin should contribute to 
feedforward inhibition upon stimulation, and result in an increase in IPSC amplitude 
in the recorded voltage-clamped layer IV stellate cell. 
The VB was stimulated three times at 50 Hz, eliciting three IPSCs in the recorded 
stellate cell. No difference in the amplitude of any of the three IPSCs was detected in 
the presence of spadin (Mean amplitude 5-10 min after application as a percentage of 
baseline of respective IPSC 0-5 min before application. IPSC 1: 102.8% ± 14.3; 
p>0.99. IPSC 2: 172.4% ± 68.9; p=0.46. IPSC 3: 173.5% ± 60.7; p=0.45. n=7 cells, 







given spadin’s effect on the RMP which presumably would have shifted more cells 
closer to firing threshold. 
4.3.4 Spadin does not affect current-voltage relationship in PV cells 
The blockade of a TREK-1 isolated current should reduce its amplitude in response 
to a series of voltage steps. It was important to try and tease out the TREK-1 current 
in PV cells in order to validate that spadin’s effects on PV cell RMP and excitability 
is indeed caused by the blockade of TREK-1 channels and not as a result of another 
non-specific mechanism. 
To isolate TREK-1 currents, PV cells were exposed to a cocktail of external 
glutamatergic blockers, GABAergic blockers, K+ channel blockers and an L-type 
Ca2+ channel blocker (CNQX, D-APV, picrotoxin, TEA, nifedipine). The current-
voltage relationship was measured in response to a series of 500 ms voltage steps (-
90 mV to +40 mV, D10 mV) from a holding potential of -70 mV (Fig 4.9 A) before 
and after spadin application. A voltage ramp was also performed in PV cells to 
measure the effect of spadin on the current-voltage relationship (Fig 4.9 B).  
Spadin did not significantly alter the current-voltage relationship of the isolated 
current in PV cells during square voltage steps (Mean current amplitude 5-10 min 
after application compared to baseline amplitude 0-5 min before application, 
Baseline: 37.0 ± 0.6; Spadin: 36.6 ± 1.2; n=5 cells, p>0.99, Two-way RM-ANOVA 
with Bonferroni correction; Fig 4.9 A). There was therefore no effect between spadin 
and wash (Mean current amplitude 5-10 min after application compared to last 5-10 
min of wash, Spadin: 36.6 ± 1.2; Wash: 34.8 ± 1.3; n =5 cells, p=0.56, Two-way 
RM-ANOVA with Bonferroni correction; Fig 4.9 A). 
Similarly, spadin did not significantly alter the gradient of the current-voltage slope 






range 5-10 min after application compared to baseline gradient 0-5 min before 
application, Baseline: 0.9 ± 0.1; Spadin: 0.9 ± 0.1; n=5 cells, p>0.99, One-way RM-
ANOVA with Bonferroni correction; Fig 4.9 B) and did not significantly affect the 
rectification properties of the slope (Rectification index 5-10 min after application 
compared to baseline 0-5 min before application, Baseline 1.4 ± 0.1; Spadin: 1.4 ± 
0.1; n=5 cells, p>0.99, One-way RM-ANOVA with Bonferroni correction; Fig 4.9 
B). There was therefore no effect on the gradient of the slope between spadin and 
wash (Mean gradient between +30 mV and +40 mV voltage range 5-10 min after 
application compared to last 5-10 min of wash, Spadin: 0.9 ± 0.1; Wash: 0.9 ± 0.1; 
n=5 cells, p>0.99, One-way RM-ANOVA with Bonferroni correction; Fig 4.9 B) and 
no effect on the rectification properties of the slope (Rectification index 5-10 min 
after application compared to last 5-10 min of wash, Spadin: 1.4 ± 0.1; Wash: 1.4 ± 
0.1; n=5 cells, p>0.99, One-way RM-ANOVA with Bonferroni correction; Fig 4.9 
B). 
4.4 Subcellular localisation of TREK-1 channels 
PV cells express an extremely high density of voltage-gated Na+ and K+ channels in 
the AIS (Hu et al. 2014). An action potential is initiated once the local region of the 
AIS is significantly depolarised to induce activation of voltage-gated Na+ channels. 
Any excitatory inputs reaching the AIS are either converted into action potentials or 
filtered out through ion channels. Both spadin and amlodipine depolarise the RMP 
but have no effect on the input resistance in PV cells, while the more potent and 
specific TREK-1 channel blocker spadin increases the excitability of PV cells. The 
discrepancy between RMP and input resistance could be explained by an increased 
density of TREK-1 channels in the axon initial segment (AIS) instead of a uniform 
distribution along the somatodendritic axis of the cell. Previous experiments would 
thus be unable to detect currents carried by TREK-1 channels, and therefore the 
functional effect of spadin on the RMP and input resistance would not be observed if 
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they are located mostly outside of the somatic compartment - where the recording 
patch-pipette would be most sensitive to measuring the input resistance. 
If TREK-1 channels are expressed in the AIS, then their blockade should increase the 
input resistance locally and reduce the filtering of incoming inputs. Furthermore, the 
1 mV depolarisation of the RMP observed during spadin application could suggest a 
much greater depolarising effect occurring locally in the AIS, which would have 
subsequently propagated towards the soma. The local increase in input resistance 
however may have been too distally located for the recording pipette to monitor. This 
could therefore explain the contradicting effects observed with TREK-1 channel 
blockers between the RMP and input resistance. 
To test this hypothesis, a puff pipette could be used to locally apply spadin onto the 
AIS while the cell is injected with a set of depolarising current steps (as conducted 
previously). To verify that its effect is AIS-specific, spadin would also be locally 
applied to the soma and proximal dendrites as a control. An increased expression of 
TREK-1 channels in the AIS may therefore increase the excitability of PV cells to a 
given set of current steps only during local puffs of spadin onto the AIS compared 
with local puffs onto other compartments. 
4.4.1 Effects of locally applied tetrodotoxin (TTX) on cell excitability 
A pilot study was performed to assess the efficacy of locally puffing a drug onto 
distinct subcellular compartments. The voltage-gated Na+ channel blocker 
tetrodotoxin (TTX) was used as a control to block voltage-gated Na+ channels when 
puffed onto the AIS. Cells were filled with standard internal solution containing 
Alexa Fluor 488 dye enabling the axonal and dendritic processes of the cell to be 
visualised under blue light. Layer IV cortical pyramidal cells were selected for 
recordings instead of PV cells as their axons were easily detectable. A pipette filled 






AIS – located approximately 40 µm away from the soma (Kole et al. 2008) –, 
proximal dendrite, or soma. 
A single 250 ms depolarising current step was injected into a pyramidal cell at 0.1 
Hz to elicit two action potentials (Fig 4.10 A). A 2 s puff of TTX was administered 
1.5 s before the start of the current step at 0.05 Hz, to ensure interleaved trials 
consisting of control spiking followed by spiking in the presence of locally applied 
TTX. Initially, puffing was applied onto a proximal dendrite (Fig 4.10 A1) for 18 
sweeps (9 trials each) before puffing was applied onto the AIS (Fig 4.10 A2). Puffing 
TTX onto the dendrite had no effect on action potential firing but appeared to 
decrease firing when administered to the AIS (Fig 4.10 B). In the AIS puffing trial, 
the effect of TTX on reducing the number of action potentials failed to revert to 
baseline (two spikes). This is likely due to the poor reversibility of the effects of 
TTX. Nonetheless, this suggests that localised puffing of a drug can be reliably 
conducted in this experimental configuration. 
Subcellular TTX puffing experiments were subsequently repeated in PV cells. 
Unfortunately, due to the complexity of the morphology of PV cells, it was difficult 
to identify the AIS. Another possible approach for this experiment could employ 
mice in which the AIS is labelled with a fluorescent protein. The protein ankyrin-G is 
expressed at the AIS and nodes of Ranvier of most neurons, where it binds to 
voltage-gated Na+ channels and promotes their clustering (Zhou et al. 1998). 
Ankyrin-G mice tagged with green fluorescent protein (GFP) could provide a 
practical method for visualising the AIS of PV cells. Control TTX puffing on distinct 
subcellular locations during given depolarising steps would initially be performed to 
confirm that puffing specifically onto the AIS region of PV cells produces a robust 
decline in action potential firing. This would validate the spatial specificity of drug 
exposure onto distinct PV cell compartments. Spadin could then be puffed onto 
distinct subcellular compartments of a PV cell during a set of depolarising current 
steps to assess whether its firing excitability increased when the drug was applied 
onto the AIS. An increase in action potential firing during spadin puffing specifically 
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onto the AIS would suggest that TREK-1 channels are functionally expressed 





In this chapter, I demonstrated that the blockade of TREK-1 channels significantly 
depolarises the RMP but does not alter the input resistance in PV cells. Furthermore, 
I showed that the potent TREK-1 channel blocker spadin significantly increases the 
excitability of PV cells in response to a given current stimulus. The significant effect 
of TREK-1 blockade on the RMP but not on the input resistance was surprising 
because any modulation of the TASK-like conductance - which includes TREK-1 - 
should have acted on both properties. Two separate TREK-1 blockers produced 
consistent results in both parameters, suggesting that this effect is robust. 
Nonetheless, PV cell output in response to thalamocortical stimulation is unaffected 
during spadin treatment, and isolated TREK-1 currents in PV cells are unaltered in 
the presence of the drug. One explanation for the discrepancy in these effects is that 
TREK-1 is expressed in the AIS, instead of the soma. The blockade of TREK-1 
channels may boost cell excitability by depolarising the RMP and increasing the 
input resistance locally in the AIS, thereby making it easier for action potentials to be 
generated. A pilot experiment was performed to demonstrate that puffing a drug 
locally onto specific subcellular compartments of PV cells can affect the firing of a 
cell depending on the subcellular location. Future experiments could determine 
whether spadin increases PV cell excitability when applied locally onto the AIS. An 
increase in excitability upon local AIS puffing could support the conception that 
TREK-1 channels are not uniformly expressed throughout PV cells, but expressed at 
higher densities in the AIS. 
4.5.1 Effect of TREK-1 channel blockade on RMP and input resistance 
Both TREK-1 channel blockers spadin and amlodipine significantly depolarise the 
RMP but do not alter the input resistance in PV cells. This demonstrates that this 
effect is conserved between different TREK-1-blocking agents which highlights the 
true function of TREK-1 channels in PV cells, assuming minimal non-specific 
effects on other receptors from both drugs. Amlodipine is known to block L-type 
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Ca2+ channels as well as N- and T-type Ca2+ channels, although to a lesser degree 
(Liu et al. 2007; Furukawa et al. 1997). Nonetheless, as two structurally unrelated 
blockers were employed - and are unlikely to share the same off-target effects - the 
blockade of Ca2+ channels are unlikely to be involved in the effects observed in this 
thesis. 
Both spadin and amlodipine showed a small indication of modulating the input 
resistance in PV cells - although the effect was not significant. Given the low n 
number and huge variability in input resistance in the amlodipine experimental data, 
examination of whether the data was underpowered was considered. However, it was 
discovered that the number of experiments required to reach significance would need 
to have been increased fivefold. This would have been impractical to achieve in the 
timeframe of this thesis, given that there were more important experiments to 
perform with the much more specific and potent drug spadin. 
Upon initial spadin administration, the input resistance appeared to increase very 
slightly but then returned to baseline levels throughout application. Similarly, 
although amlodipine had no effect on the input resistance after 5-10 min of 
treatment, it did appear to increase it over a longer timescale. Previous studies in 
ventricular myocytes described amlodipine as a slow acting blocker on L-type Ca2+ 
channels, suggesting a similar slow mechanism could be implemented with TREK-1 
channels (Kass et al. 1989). However, it was surprising to observe an effect where 
the RMP and input resistance did not change simultaneously, which would have been 
the case if a background K+ channel was modified. One explanation for this could be 
due to non-specific effects of the drug to other channels. This could diminish the 
effect of the drug by influencing a change in the membrane properties through 
another mechanism, and thus depress the change in input resistance. Another 
explanation is that the effects were masked by noise within the recordings. To 
counteract unwanted noise, the input resistance was calculated from an average of 4 
sweeps in response to hyperpolarising current steps, every 30 s. However, it is still 
possible that this measure of input resistance could have been unreliable. 
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4.5.2 Concentration and usage of blockers 
The concentration of amlodipine used in experiments was 43 µM, which is a 
hundredfold greater than the IC50 - determined from cultured bovine adrenal zona 
fasciculata cells (Liu et al. 2007). A high concentration of amlodipine ensured a 
greater efficacy of TREK-1 channel blockade in murine slices. Notably, 
amlodipine’s IC50 for L-type Ca2+ channels - determined from Xenopus oocytes 
(Furukawa et al. 1997) - is one-twentieth of the final concentration that was used in 
experiments. The effects of amlodipine on L-type Ca2+ channels cannot therefore be 
excluded. Nonetheless, it would have been expected that any block of Ca2+ channels 
would hyperpolarise the cell due to the inhibition of an inward cation current. The 
effects observed with amlodipine in this thesis depolarised the RMP instead, 
suggesting that any effect caused by L-type Ca2+ channels present in PV cells are not 
correlated with the result. On the other hand, a decline in the intracellular Ca2+ 
concentration resulting from the blockade of L-type Ca2+ channels could lead to a 
reduction in the activity of Ca2+-activated K+ channels. This would reduce the efflux 
of K+ from inside the cell and result in depolarisation of the RMP - comparable to 
blocking TREK-1 channels. Similarly, the closure of these ion channels could also 
result in an increase in input resistance. 
The magnitude of depolarisation was different between the two TREK-1 channel 
blockers. The effect of amlodipine on the RMP was over threefold greater than that 
of spadin. This could have been due to non-specific effects of amlodipine such as the 
modulation of Ca2+-activated K+ channels (as described above), which could have 
augmented the overall depolarising effect of blocking TREK-1. Another possibility is 
that the discrepancy is due to the use of different concentrations of each blocker. 
Spadin was only applied at a concentration 2.5-fold greater than the IC50 for TREK-1 
whereas amlodipine was applied at a hundredfold. It would be interesting to increase 
the concentration of spadin fortyfold to match the IC50 used for amlodipine, to 
examine whether the effects on the RMP are similar to those observed with 
amlodipine. However, as the potency of TREK-1 blockade by amlodipine has not yet 
been investigated on cloned channels - while spadin has been tested at TREK-1 
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transfected in COS-7 cells (Mazella et al. 2010) – some of the differences in IC50s 
between the two drugs could have been due to the differences between native TREK-
1 channels and cloned channels. Finally, tissue accessibility between the two drugs 
could be different in slice compared to cultured systems, highlighting the difficulty in 
determining a reasonable concentration of blockers to apply to the slice. 
4.5.3 The effect of spadin on the current-voltage relationship of TREK-1 
Spadin failed to influence voltage-clamped TREK-1-isolated currents in PV cells in 
response to both voltage step and voltage ramp protocols. This was surprising given 
its effect on the RMP. Although a cocktail of ion channel blockers was added to the 
bath before spadin was tested, it was possible that other non-TREK-1 currents were 
masking its effects. Internal caesium and external TEA should have blocked most of 
the non-K2P K+ channels, whilst QX314 should have blocked voltage-gated Na+ 
channels. Synaptic blockers were also used to remove contamination by synaptic 
currents. The L-type Ca2+ channel blocker nifedipine should have additionally 
removed a large proportion of Ca2+ currents. 
Subsequent to the completion of experiments, nifedipine was later discovered to 
block TREK-1 channels with a low affinity (IC50 of 8.2 µM) in cultured cells (Liu et 
al. 2007). As 20 µM of nifedipine was used in these experiments it is possible that a 
significant proportion of TREK-1 channels was blocked before spadin was even 
administered. However, as experiments in this thesis were performed in brain slices, 
the concentration of pharmacological agents at their receptors is likely to be much 
lower than in cultured cells. This is partly because cultured cells are readily exposed 
to the external drug solution, however recordings made in slices are usually deep 
under the surface of the slice, making diffusion of compounds more difficult. It is 
likely therefore that nifedipine would have only blocked a small proportion of 
TREK-1 channels. Thus, spadin should have still been able to produce a significant 
block if TREK-1 channels are present. 
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4.5.4 Are TREK-1 channels expressed exclusively in the AIS of PV cells? 
Spadin does not alter the amplitude of TREK-1-isolated currents, nor does it increase 
the input resistance in PV cells. Spadin does however increase the firing of PV cells 
in response to given current injections. Minimal expression of TREK-1 channels 
around the somata of PV cells compared to other cellular compartments could 
explain the lack of effect of spadin on the input resistance and current-voltage 
relationship. Their blockade would not necessarily have been detected by the 
recording pipette which monitors changes in electrophysiological properties close to 
the soma. It was for this reason that the increase in excitability could be explained by 
an increase in TREK-1 channels predominantly in the AIS of PV cells.  
The spatial composition of voltage-gated K+ channels in cerebellar interneurons was 
recently investigated by analysing spiking output in response to the uncaging of 
voltage-gated K+ channel blockers onto various regions of the AIS (Rowan et al. 
2014). A similar approach was conducted in this thesis using puffing of a drug 
instead of photolysis of a caged compound. Pilot puffing experiments confirmed the 
efficacy of locally administering a drug to a specific subcellular location in 
pyramidal cells. Applying the same protocol with PV cells proved to be more 
challenging due to the morphological complexity of PV cell processes, which made it 
difficult to identify the axon from the dendrites in order to locate its AIS. Unlike 
layer IV pyramidal cells which have long and thin axons that usually point towards 
infragranular layers, PV cell axons were much less distinctive, and could point in any 
direction. Thus, it could be useful to conduct similar subcellular puffing experiments 
in a mouse line where the AIS can be visualised using fluorescent proteins tagged to 
structures specifically expressed in this region (as discussed previously). 
4.5.5 TREK-1 channel expression in astrocytes 
Although this thesis aims to specifically increase the excitability of PV cells, it is 
imperative to consider the effects blocking TREK-1 channels on other cells within 
the cortical network. It is possible that the effects observed on the RMP and firing 
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excitability could be mediated by the blockade of TREK-1 channels in a different 
population of cells that may influence the activity of PV cells indirectly.  
Interestingly, astrocytes have been reported to express TREK-1 channels (Zhou et al. 
2009). Astrocytes are the predominant housekeeping cells of the nervous system 
which act to remove neurotransmitter released during synaptic activity, modulate ion 
and water homeostasis and prevent excitotoxicity in surrounding cells (Takano et al. 
2009). Astrocytes have also been shown to release glutamate which can alter the 
level of synaptic activity of neighbouring neurons (Parpura et al. 1994). The 
homeostatic mechanisms of glutamate uptake and K+ buffering modulated by 
astrocytes rely on several electrogenic transporters which work much more 
effectively at negative resting potentials (Olsen & Sontheimer 2009). Although a 
large proportion of the astrocytic RMP is thought to be regulated by Kir4.1 inward 
rectifying K+ channels, recent studies have suggested that TREK-1 channels 
contribute significantly to the passive K+ conductance (Djukic et al. 2007; Zhou et al. 
2009). 
Importantly, the blockade of Kir4.1 channels was demonstrated to result in membrane 
depolarisation and inhibition of glutamate uptake from the extracellular space 
(Djukic et al. 2007). It is therefore possible that the effects of spadin and amlodipine 
on the RMP of PV cells could be due to the blockade of TREK-1 channels in 
astrocytes instead of PV cells. This would lead to a depolarisation of the RMP in 
astrocytes which could reduce the activity of glutamate transporters, resulting in a 
global increase in glutamate in the extracellular space.  This could activate AMPA 
receptors in nearby cells which would result in PV cell depolarisation. The increase 
in extracellular glutamate could also bind to NMDA receptors which have a higher 
affinity for the neurotransmitter, although most NMDA receptors would be inactive 
at rest. Furthermore, the depolarisation of astrocytes upon TREK-1 blockade could 
promote glutamate release from astrocytes themselves, further escalating the 
concentration of glutamate in the extracellular space, and activating more AMPA 
receptors in PV cells. Nonetheless, the activation of glutamate receptors in PV cells 
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would concurrently reduce the input resistance and is therefore unlikely to be the 
mechanism for the observed 1 mV depolarisation of the RMP. 
Several experiments could be implemented to test for the contribution of astrocytic 
TREK-1 blockade on PV cell activity. Firstly, whole-cell patch-clamp experiments 
on astrocytes in response to TREK-1 blockers would confirm the magnitude of 
TREK-1 blockade on the astrocytic RMP. Secondly, glutamate release from 
astrocytes could be pharmacologically or genetically inhibited during PV cell 
recordings to test whether the effect on the RMP and firing excitability persists. 
Astrocytes could be transfected to express archaerhodopsin in their plasma 
membrane which could be light-stimulated to hyperpolarise and therefore silence 
them during experiments. Although it is unlikely that astrocytes modulate the activity 
of PV cells via increases in extracellular glutamate, as the activation of glutamate 
receptors on PV cells would concurrently decrease their input resistance, these 
experiments would nonetheless help to distinguish any role that they may have on the 
effects observed in PV cells in response to TREK-1 blockade. 
4.5.6 Summary 
The aim of this chapter was to increase the intrinsic excitability of PV cells by 
blocking TREK-1 channels. As TREK-1 channels are believed to contribute to the 
background K+ conductance, their blockade would have been expected to depolarise 
the cell and concurrently increase the input resistance, and thus, increase cell 
excitability. Indeed, TREK-1 channel blockade significantly depolarised the RMP 
and increased the firing excitability of PV cells in response to given current stimuli, 
however the measured input resistance remained unchanged. These data indicate a 
possibility that TREK-1 channels might not be uniformly distributed along the 
somatodendritic axis in PV cells, but instead form functional channels in the AIS. 
The observed depolarisation of the RMP in whole-cell patch-clamp recordings could 
indicate a larger magnitude of depolarisation at the AIS where TREK-1 channels 
might be expressed, thus propagating back to the soma where the membrane 
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potential was recorded. Additional experiments including specific subcellular 

















Schizophrenia and autism may share common pathophysiological mechanisms 
emerging from imbalances in neuronal network activity (Gao & Penzes 2015). 
Animal models and human post-mortem studies of the two disorders indicate 
aberrant inhibitory signalling particularly at the level of PV cells and their synapses 
(Marín 2012). New pharmacological strategies aimed at specifically targeting and 
increasing the basal activity of the PV cell population could be used to mitigate some 
of the behavioural symptoms associated with these disorders that current treatments 
have so far failed to address. By connecting recent findings from molecular, genetic 
and electrophysiological studies in mice, a novel approach for increasing PV cell 
excitability through the blockade of TASK-1/3 and TREK-1 channels was 
investigated. Importantly, this was the first time that specific blockers were acutely 
applied to examine the true involvement of TASK-1/3 and TREK-1 channels in 
modulating PV cell activity. Although previous studies support the role of these two-
pore channels in setting the membrane potential and membrane resistance, this thesis 
presents data that argue against the functional expression of TASK-1/3 in PV cells. 
5.1.1 Overall goal 
Although GABAergic interneurons represent a minority of the entire neuronal 
population, they nevertheless manage to reliably provide powerful and temporally 
precise inhibition, which is thought to be essential for regulating global network 
balance (Markram et al. 2004). Several studies have now indicated aberrant activity 
of PV cells as an underlying pathophysiological mechanism for the development of 
schizophrenia and autism (Marín 2012). As PV cells comprise almost half of all 
GABAergic interneurons in the mammalian cortex (Xu et al. 2010), it is therefore 
understandable that any malfunctioning property present in PV cells will have 
substantial consequences on the network circuitry. The fundamental aim of this 
thesis was to explore a method for increasing the excitability of cortical PV cells. 
This method of increasing neuronal excitability focused on exploiting the low input 
145 
 
resistance characteristic of PV cells, and increase it by targeting TASK-like currents 
using TASK-1/3 and TREK-1 blockers. If successful, a novel strategy aimed at 
targeting and elevating the intrinsic excitability of PV cells could one day be 
implemented to rectify part of the deficits in inhibitory signalling linked to 
schizophrenia and autism. As a result, a correction in the underlying network 
imbalance could lead to improvements in several behavioural symptoms associated 
with these disorders. 
5.1.2 Overall outcome 
This thesis represents the first study to incorporate the use of specific TASK-1/3 and 
TREK-1 channel blockers in brain slices to examine their acute effects on the 
intrinsic properties of PV cells. Previous studies analysing the molecular profile of 
PV cells established prominent mRNA expression of TASK-1/3, and to a lesser 
degree TREK-1, in relation to other background K+ channels. The 
electrophysiological data from this thesis however argue against the molecular 
findings in the PV-cell field suggesting that TASK-1/3 channels are either not 
functionally present, or present at extremely low levels in PV cells. Nonetheless, 
TREK-1 blockade significantly increased PV cell excitability. As TREK-1 blockade 
did not affect the somatic input resistance, it was hypothesised that TREK-1 channels 
are expressed particularly in the AIS of PV cells, although further experiments would 
need to confirm this theory. Furthermore, contrary to molecular findings, the 
electrophysiological data from this thesis support a possibility that TREK-1 channels 
are functionally present at higher levels than TASK-1/3 channels. 
In summary, the results in this thesis demonstrate that the leak background 
conductance – which serves to regulate the RMP and intrinsic excitability – is not 
regulated by TASK-1/3 channels, as previously suggested, but involves other leak K+ 
channels. The effects observed during TREK-1 blockade however indicate that the 
modulation of TREK-1 channels could still provide a useful method for increasing 
PV cell excitability, although more experiments would need to be performed to better 
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understand the role they play in this cell type. It could therefore be interesting to 
continue exploring the effects of TREK-1 blockade in PV cells on network function. 
Once more is known about the effects of blocking TREK-1 channels on network 
activity and behaviour, this channel could one day be employed as a mechanism for 
restoring network balance in schizophrenia and autism. 
5.1.3 TASK 
A conserved feature in PV cells is their unusually low input resistance compared to 
other neuronal populations (Doischer et al. 2008; Taverna et al. 2005). This allowed 
for the targeting of a large resting conductance for modulation. Previous studies 
using immunohistochemistry and microarrays from cortical PV cells in mice 
revealed high levels of TASK-1 and TASK-3 mRNA transcripts compared to many 
other K+ channels that are believed to contribute to the passive background 
conductance (Goldberg et al. 2011; Okaty et al. 2009). TASK-1 and TASK-3 
transcripts were shown to increase in expression during development (between P10 
and P18), which was paralleled by a decrease in input resistance, hyperpolarisation 
of the RMP, a decrease in the membrane time constant and a reduction in the half-
widths of action potentials (Goldberg et al. 2011). The magnitude of these 
developmental changes was extreme: The RMP was found to hyperpolarise by 6 mV 
on average, while the input resistance and membrane time constant were reported to 
decrease sixfold during development (Goldberg et al. 2011). Furthermore, mature 
fast-spiking cells in TASK-1/3 knockout mice displayed larger input resistances and 
membrane time constants, approaching values comparable to those observed in 
pyramidal cells (Goldberg et al. 2011). Finally, TASK-1 immunoreactivity in fast-
spiking cells was increased almost twofold during development, indicating the 
presence of the channel protein (Okaty et al. 2009). In summary, microarray, 
immunohistochemical and genetic knockout studies on TASK channels all support 
the expression of TASK in cortical fast-spiking cells. 
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The electrophysiology of TASK-1/3 blockade on cortical PV cells in this thesis 
however do not support the functional presence of TASK-1/3 channels, as the RMP 
and input resistance – two key measures mediated by background K+ currents - were 
unaffected in this neuronal population. Importantly, unlike previous studies on PV 
cells which investigated the role of TASK-like currents using generalised blockers 
(Goldberg et al. 2011; Okaty et al. 2009; Torborg et al. 2006), this was the first time 
that the functional effects of specific TASK-1/3 channel blockers were examined. 
Furthermore, three structurally distinct TASK-1/3 channel blockers yielded 
consistent results – one of which was confirmed to have a functional effect in HEK-
293 cells. Fundamentally, this indicates a number of possibilities: The high 
expression levels of TASK-1/3 mRNA may not necessarily translate to a high 
density of functional TASK-1/3 channels in the PV cell membrane. This could be 
due to TASK-1/3 mRNAs not being translated, or that TASK-1/3 proteins are made 
but are not transported to the membrane. TASK-1/3 proteins may even congregate in 
intracellular pools or may be inactive due to specific post-translational modifications. 
Additionally, the effects reported in TASK-1/3 knockout mice may have been 
determined by the genetic strain. 
The experiments conducted on PV cells in this thesis demonstrate acute 
pharmacological inhibition of specific K2P channels. This is important because the 
acute effects of a drug on a channel can be used to analyse how a cell responds to 
various stimuli before, during and after pharmacological application. This can be 
especially useful for analysing the function of channels during development, where a 
drug can be tested in animals at different developmental time points. The effects 
observed from acute pharmacological inhibition of a channel can then be compared 
with other studies examining channel function to better understand the underlying 
physiology. 
It is difficult to interpret why PV cells in TASK-1/3 knockout mice have larger input 
resistances and membrane time constants compared to wildtype mice (Goldberg et al. 
2011), while the data in this thesis clearly demonstrate that acute pharmacological 
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inhibition of TASK-1/3 channels has no effect on the intrinsic membrane properties. 
This difference could be explained by the different brain regions that were used to 
sample PV cells between the two studies. Although both studies analysed PV cells 
from the mouse barrel cortex, Goldberg et al (2011) examined layer II/III PV cells, 
whereas experiments in this thesis examined layer IV PV cells. This small difference 
in brain region could result in a difference in the expression ratio of specific leak 
channels, thus effecting the function of background currents in PV cells. Another 
possibility for the discrepancy between the two studies may arise from different 
strains of mice used between the studies. This could also result in the expression of 
different proportions of specific leak channels. Finally, variations of protein-protein 
interactions between the mice used in this thesis and TASK-1/3 knockout mice may 
have impacted common TASK-1/3-binding proteins which could have affected the 
function of other leak channels. 
In conclusion, the acute application of specific TASK-1/3 channel blockers 
demonstrates that TASK-1/3 channels are either not functionally expressed, or 
present at extremely low levels in PV cells. This suggests that despite previous 
molecular findings on TASK channels, the resting background conductance in PV 
cells is mediated by a population of background K+ channels other than TASK-1/3. 
This therefore highlights a major challenge in the field for linking molecular 
composition to physiological function.  
5.1.4 TREK 
The blockade of TREK-1 channels significantly depolarised the RMP and increased 
the excitability of cortical PV cells. This is important because the overall goal of this 
thesis is to increase the excitability of PV cells. Unlike TASK-1/3 channel blockade, 
two independent TREK-1 inhibitors clearly modulate the RMP.  However, the lack 
of effect of TREK-1 blockade on the input resistance suggests other possible 
mechanisms beyond the classic interpretation of blocking a leak K+ channel. The 
discrepancy in the effect of TREK-1 blockade between RMP depolarisation and 
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input resistance is surprising considering that any modulation of the K+ background 
conductance should have affected both parameters. 
Spadin significantly increased PV cell excitability. It was therefore hypothesised that 
TREK-1 channels might be expressed in the AIS, where action potential generation 
originates 20 µm from the soma (Hu & Jonas 2014). This would correspond to the 
lack of effect observed with spadin on the somatic input resistance and somatic 
current-voltage relationship (assuming TREK-1 currents were not initially blocked 
by nifedipine). If this is the case, then the 1 mV depolarisation of the RMP detected 
in the somata of PV cells (as the patch-clamp configuration primarily measures 
changes in the membrane voltage near the recording electrode) could indicate a 
substantial local depolarisation in the AIS. Similarly, if TREK-1 channels are indeed 
expressed in the AIS, then the local increase in input resistance in this region could 
greatly influence the excitability of the cell. Two mechanisms would therefore take 
place during local inhibition of TREK-1 channels in the AIS: Firstly, the 
depolarisation of the RMP would bring the AIS closer to firing threshold; and 
secondly, the local increase in input resistance would make it easier for incoming 
inputs to summate and result in action potential firing. These mechanisms could 
therefore explain the robust effect that spadin had on increasing the number of action 
potentials generated in response to given current steps. 
The effects of spadin on the RMP and action potential firing but not on the input 
resistance led to the hypothesis that TREK-1 channels are expressed predominantly 
in the AIS. If this is true, then the manner in which the cell integrates information 
would be altered very differently in comparison to a cell that expresses its ionic 
conductances uniformly. Cells typically receive multiple excitatory inputs onto their 
dendrites and multiple inhibitory inputs along their entire somatodendritic axis 
(Megı́as et al. 2001). Because of this, the integration of inputs will depend on the 
relative amplitudes and kinetics of EPSPs and IPSPs present at distinct subcellular 
locations within the cell (Pouille et al. 2013). An action potential is generated once 
the summation of inputs depolarises the cell sufficiently enough to bring the AIS to 
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firing threshold. The amplitude and duration of EPSPs in response to a change in 
membrane resistance at the soma will not only be affected by the change in 
resistance, but also by competing IPSCs – which will also reduce the local input 
resistance - mediated by other perisomatic PV cell terminals (Pouille et al. 2013). A 
conductance change in the AIS however will not be affected by further inputs, as 
chandelier cells – which preferentially target the AIS of their target cells – do not 
synapse with PV cells (DeFelipe et al. 1989). Thus, a very different effect on the 
integration of inputs will occur if TREK-1 channels are expressed predominantly in 
the AIS in comparison to a uniform distribution. While a uniform distribution of leak 
channels would influence the integration of all inputs by reducing the amplitude and 
duration and therefore the summation of EPSPs, a predominant distribution of 
TREK-1 channels in the AIS would not influence the summation of inputs until 
EPSPs reach the AIS. TREK-1 channels could therefore be functioning as a tonic 
inhibitory method in the AIS by reducing the input resistance and hyperpolarising the 
cell locally, in a critical subcellular location where inputs arrive before the generation 
of an action potential. 
Several additional experiments would need to be performed to confirm whether 
TREK-1 channels are expressed predominantly in the AIS of PV cells. Firstly, 
analysing the activity of action potential firing during subcellular puffing of spadin 
onto the specific compartments in response to a given set of current steps would 
provide an initial understanding of the potentially non-uniform distribution of 
TREK-1 expression. Secondly, the effect of spadin on the RMP and input resistance 
from direct patch-clamp recordings at the AIS region of PV cells would confirm 
whether the depolarising effect observed from whole-cell recordings in this thesis 
was specifically mediated in the AIS: A larger effect of depolarisation (>1 mV) 
compared to the effect observed in somatic recordings would support this theory. 
Finally, immunostaining of TREK-1 and ankyrin-G, a well-established AIS marker, 
could be used to examine whether both proteins are coexpressed in this region. As 
K2P antibodies can unfortunately be unreliable, a TREK-1 antibody would need to be 
characterised first, using TREK-1 knockout tissue. These experiments would 
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therefore help to elucidate whether TREK-1 is expressed exclusively in the AIS of 
PV cells. 
Finally, the depolarisation of the RMP allows for further computational effects in 
response to network inputs. Although the depolarisation of PV cells by 1 mV may 
appear to be negligible (albeit the cells did increase in excitability), the effect on the 
output of cells in response to inputs could nevertheless be considerable. Weak inputs 
restricted to the lower range of a cell’s input-output function can be enhanced by 
increases in tonic depolarisation or decreases in conductance (Chance et al. 2002), 
resulting in a reduction in rheobase. The addition of membrane potential variance – 
which is likely to occur in vivo – induces neurons to fire in a probabilistic fashion 
(Hô & Destexhe 2000).  Thus, the depolarisation of a neuron by 1 mV could result in 
a small increase in activity at the lower end of a cell’s input-output function – which 
was observed by a reduction in rheobase during TREK-1 blockade in this thesis - but 
when combined with barrages of synaptic potentials in vivo, the cell could increase in 
excitability significantly. A 1 mV change in RMP can therefore exert a substantial 
effect on the output of PV cells.  
5.1.5 Other background K+ channels 
The data in this thesis have distinguished that PV cells do not express functional 
somatic TASK-1/3 and TREK-1 channels to a level where they function as main 
contributors to the K+ leak conductance. The effect of external acidification and 
bupivacaine conditions on the RMP and input resistance of PV cells however was 
substantial. This suggests that the presence of a large population of channels - at least 
in the soma – that mediates the background conductance responsible for their low 
resistivity remains to be targeted. Blockers for other bupivacaine- and acid-sensitive 
channels could therefore be explored in the same way as TASK and TREK to 
analyse their effects on the passive properties of PV cells. This would not only help 
to identify other suitable channels that could be modulated to increase cell 
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excitability, but also help to elucidate the relative composition of background 
channels in PV cells. 
Unfortunately, little is known about the ion channels responsible for the 
acidification- and bupivacaine- sensitive currents. In the K2P family, TWIK-1 and 
TASK-2 channels are sensitive to both conditions which could provide interesting 
targets for modulation. While TWIK-1 mRNA transcripts have been reported to be 
expressed in cortical PV cells (Goldberg et al. 2011), TASK-2 however is 
predominantly expressed in the spinal cord and therefore cannot contribute to the 
currents observed in this thesis. Finally, inwardly rectifying K+ channels may 
contribute to the background conductance in PV cells. Kir2.2 and Kir2.3 mRNA 
subunits have been reported to increase during development, similar to TASK-1 and 
TASK-3 (Goldberg et al. 2011). These channels however do not respond to 
extracellular acidification and it is unclear whether they are sensitive to bupivacaine 
(Hibino et al. 2010; Sepulveda et al. 2015). Nonetheless, although these channels 
belong to an additional population that are not represented by the acidification- and 
bupivacaine-sensitive currents, they are however known to pass current at rest and 
could therefore be interesting targets. This highlights the complexity of 
characterising background K+ currents in neurons. 
5.1.6 Experimental approach 
Although the aim of this thesis was to develop a method to increase the excitability 
of cortical PV cells, the primary benefit of a establishing a successful technique 
would have ultimately been applied to target PV cells in individuals with 
schizophrenia and autism. The experiments in this thesis however were performed on 
tissue slices from healthy mice, which may not have incorporated the aberrant 
network signalling characteristic to the diseased states. As a result, the experiments 
focused on elevating normal PV cell signalling instead of restoring the deficits that 
may have been found in the real disorders. The discrepancy between using a healthy 
and a diseased system may have had a significant effect on the outcome of the 
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experiments. Attempting to increase basal excitability of a population of cells in 
healthy tissue may have been restricted by compensatory mechanisms, whereas 
targeting a population of defunct cells in diseased tissue already low in excitability 
could have been more susceptible for modulation, thus restoring abnormalities in the 
underlying network imbalance. Finally, attempting to rectify network pathology in a 
diseased system rather than experimenting in healthy tissue would have directly 
addressed numerous deficits that could have been linked to the disease. These may 
have included alterations in specific protein-protein interactions at the cellular level, 
to changes in network activity, which might not have manifested in healthy tissue. 
Successfully implementing a novel strategy to correct the underlying network 
imbalance in a diseased slice could then have been used to test behaviour in a mouse 
with symptoms representing schizophrenia and autism. 
Several approaches could have been employed to test the effects of two-pore channel 
blockers in disease conditions. Brain slices could have been pretreated with agents 
such as ketamine - which antagonise NMDA receptors – to mimic some of the 
pathophysiology in the brain tissue. Ketamine is known to produce acute psychotic 
states in normal individuals that resemble some of the symptoms of schizophrenia 
(Breier et al. 1997), and may induce the dysfunction of cortical PV cells (Behrens et 
al. 2007). Thus, the effects of two-pore channel blockade on the cellular and network 
function of PV cells could have therefore been analysed specifically in diseased 
tissue where ketamine would have been administered, in the attempt to directly 
rectify the pathophysiology. This would have provided a basis for which experiments 
could have been performed to reverse deficits in signalling from within a 
‘schizophrenic’ slice which, if successful, could have then been applied to awake 
ketamine-administered mice to analyse behaviour. Performing similar in vitro and 
behavioural experiments on mice with the conditional deletion of ErbB4 in PV cells 
may have also provided interesting results. These mice have a reduced number of 
glutamatergic synapses onto PV cells paralleled by a reduction in the number of 
inhibitory synapses onto pyramidal cells (Fazzari et al. 2010) and exhibit 
schizophrenia-like phenotypes (Wen et al. 2010). Hence, two-pore blockers could 
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have been applied in the attempt to rectify cellular and network deficits in the 
diseased system. 
5.1.7 Future directions for the treatment of Schizophrenia and autism 
The experiments conducted in this thesis demonstrate TREK-1 as an interesting 
target for the modulation of PV cells. Although the effects of TREK-1 blockade may 
seem intricate, the overall goal of increasing the excitability of PV cells appears to 
have been achieved. The effect of spadin on increasing the excitability of PV cells in 
response to TREK-1 blockade was substantial. This suggests that targeting TREK-1 
in this way could potentially be useful as a treatment for diseases linked to aberrant 
PV cell signalling, such schizophrenia and autism. TREK-1 channel blockade could 
therefore be used to increase the excitability of PV cells, and potentially restore part 
of the proposed network deficits associated with these disorders. The true molecular 
and functional profile of TREK-1 expression is evidently required before it can be 
identified as an appropriate target. First, a better understanding of the mechanism for 
which TREK-1 blockade exerts its effect is still required. Second, the relative 
expression of TREK-1 between PV cells and other cells types would need to be 
addressed, to prevent the effect of increasing neuronal excitability in multiple cell 
populations. 
Developing a future therapy for the treatment of specific disorders by 
pharmacologically targeting a channel not only requires analysis of the effects on the 
target cell, but also the careful consideration that other cells may also be affected. 
Even if a drug is synthesised that is highly specific to a desired channel, other cells 
may express the same (or similar) channel which may result in the drug’s effect on 
more populations that just the intended target group. Further experiments analysing 
the effects on other cell populations would therefore be required to ensure that the 
effects on their activity were minimal in comparison to the target group. These 
include analysing the effects on cellular and network functions. Moreover, this thesis 
examined a method to modulate PV cell excitability in the cortex - a region of the 
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brain where studies have uncovered abnormalities of this cell type in schizophrenia 
and autism. As such, the effects of a two-pore channel blocker would not only be 
restricted to cortical PV cells, but would also affect cells in other brain regions. 
Finally, target channels may also be present on cells in other organs outside the 
brain. Several two-pore channels including TREK-1 have been reported to contribute 
to electrical activity in the heart (Xian et al. 2006). This global action of a TREK-1 
blocker would therefore need to be considered to prevent unwanted effects in other 
organs as well as in healthy brain areas. 
The pathological complexity of neuropsychiatric disorders unfortunately makes them 
difficult to treat with a single drug (Donegan & Lodge 2016; Young & Findling 
2015). These neurodevelopmental disorders have multiple genetic aetiologies which 
result in complex behavioural phenotypes, suggesting that the cause manifests from a 
wide spectrum of pathological abnormalities (Owen et al. 2016; Levy et al. 2009). In 
schizophrenia for example, antipsychotics appear to be effective for treating positive 
symptoms, such as hallucinations and delusions, but seem to be poor in treating 
negative symptoms, including social withdrawal and apathy, as well as cognitive 
deficits (Miyamoto et al. 2012). It is therefore worth considering that one drug 
designed to rectify aberrant function in a specific biological pathway linked to the 
progression of a disease is unlikely to compensate entirely for deficits associated 
with other pathways. For example, antipsychotics which block dopamine D2 
receptors (Meltzer 1989) might alleviate the positive symptoms of schizophrenia 
because the underlying pathology that contributes to positive symptoms are perhaps 
linked to D2 receptors. Thus, other pathological mechanisms are likely to contribute 
to the negative and cognitive symptoms associated with schizophrenia. In particular, 
cognitive symptoms have been linked to impairments in the synchronisation of 
oscillatory activity (Marín 2012). As PV cells are known to maintain fast network 
synchrony (Bartos et al. 2007), future treatments aimed at increasing PV cell activity 
- such as TREK-1 modulation – could therefore be extremely useful for alleviating 
the cognitive symptoms. It is therefore important to understand the functional 
pathology in order to elucidate novel targets for treatments of neuropsychiatric 
disorders. Moreover, several treatments each designed to rectify distinct 
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neuropathological deficits could then be used in conjunction to alleviate a wider 
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